0000773840-22-000018 | 10-K | XBRL Viewer | Honeywell International INC

Print Document View Excel Document

INCOME TAX (Details) - USD ($) $ in Millions	12 Months Ended
INCOME TAX (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Current Income Tax Expense (Benefit), Continuing Operations [Abstract]
U.S. Federal	$ 415	$ 475	$ 8
U.S. State	146	79	43
Non-U.S.	886	768	1,099
Current tax expense	1,447	1,322	1,150
Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]
U.S. Federal	173	234	332
U.S. State	37	39	63
Non-U.S.	(32)	(448)	(216)
Deferred tax expense	178	(175)	179
Tax expense	1,625	1,147	1,329
Income before taxes
U.S.	3,955	3,318	4,178
Non-U.S.	3,280	2,694	3,381
Income before taxes	$ 7,235	$ 6,012	$ 7,559

PENSION AND OTHER POSTRETIREMENT BENEFITS

12 Months Ended

Dec. 31, 2021

Retirement Benefits, Description [Abstract]

Pension and Other Postretirement Benefits

The Company sponsors a number of both funded and unfunded U.S. and non-U.S. defined benefit pension plans. Pension benefits for many of the Company's U.S. employees are provided through non-contributory, qualified and non-qualified defined benefit plans. All non-union hourly and salaried employees joining Honeywell for the first time after December 31, 2012, are not eligible to participate in Honeywell’s U.S. defined benefit pension plans. The Company also sponsors defined benefit pension plans which cover non-U.S. employees who are not U.S. citizens, in certain jurisdictions, principally the UK, Netherlands, Germany, and Canada. Other pension plans outside of the U.S. are not material to the Company either individually or in the aggregate.

The Company also sponsors postretirement benefit plans that provide health care benefits and life insurance coverage mainly to U.S. eligible retirees. None of Honeywell’s U.S. employees are eligible for a retiree medical subsidy from the Company. In addition, the vast majority of Honeywell’s U.S. retirees either have no Company subsidy or have a fixed-dollar subsidy amount. This significantly limits the Company's exposure to the impact of future health care cost increases. The retiree medical and life insurance plans are not funded. Claims and expenses are paid from the Company's cash flows from operations.

The following tables summarize the balance sheet impact, including the benefit obligations, assets and funded status associated with the Company's significant pension and other postretirement benefit plans.


	Pension Benefits
	U.S. Plans						Non-U.S. Plans
	2021			2020			2021			2020
Change in benefit obligation:
Benefit obligation at beginning of year		$	18,054		$	17,283		$	7,670		$	6,897
Service cost		105			99			26			23
Interest cost		306			461			77			106
Plan amendments		—			—			(3)			2
Actuarial (gains) losses(1)		141			1,331			(403)			509
Benefits paid		(1,221)			(1,100)			(249)			(246)
Settlements and curtailments		—			(21)			—			—
Foreign currency translation		—			—			(121)			291
Other		6			1			2			88
Benefit obligation at end of year		17,391			18,054			6,999			7,670
Change in plan assets:
Fair value of plan assets at beginning of year		20,396			18,995			8,450			7,307
Actual return on plan assets		1,344			2,475			166			918
Company contributions		35			46			101			116
Benefits paid		(1,221)			(1,100)			(249)			(246)
Settlements and curtailments		—			(21)			—			—
Foreign currency translation		—			—			(74)			253
Other		6			1			2			102
Fair value of plan assets at end of year		20,560			20,396			8,396			8,450
Funded status of plans		$	3,169		$	2,342		$	1,397		$	780
Amounts recognized in Consolidated Balance Sheet consist of:
Prepaid pension benefit cost(2)		$	3,528		$	2,695		$	2,105		$	1,688
Accrued pension liabilities—current(3)		(33)			(29)			(14)			(14)
Accrued pension liabilities—noncurrent(4)		(326)			(324)			(694)			(894)
Net amount recognized		$	3,169		$	2,342		$	1,397		$	780

(1)The actuarial losses incurred in 2021 related to the Company's U.S. plans are primarily the result of changes in demographic experience and demographic assumptions, partially offset by actuarial gains due to an increase in the discount rate assumptions used to estimate the benefit obligations as of December 31, 2021 compared to December 31, 2020. Actuarial gains incurred in 2021 related to the Company's non-U.S. plans are primarily the result of an increase in the discount rate assumption used to estimate the benefit obligations as of December 31, 2021 compared to December 31, 2020. Actuarial losses incurred in 2020 related to the Company's U.S. and non-U.S. plans are primarily the result of a decrease in the discount rate assumptions used to estimate the benefit obligations as of December 31, 2020 compared to December 31, 2019.

(2)Included in Other assets on the Consolidated Balance Sheet

(3)Included in Accrued liabilities on the Consolidated Balance Sheet

(4)Included in Other liabilities on the Consolidated Balance Sheet


	Other Postretirement Benefits
	2021			2020
Change in benefit obligation:
Benefit obligation at beginning of year		$	229		$	325
Service cost		—			—
Interest cost		5			8
Plan amendments		—			(65)
Actuarial (gains) losses		(8)			(8)
Benefits paid		(30)			(31)
Benefit obligation at end of year		196			229
Change in plan assets:
Fair value of plan assets at beginning of year		—			—
Actual return on plan assets		—			—
Company contributions		—			—
Benefits paid		—			—
Fair value of plan assets at end of year		—			—
Funded status of plans		$	(196)		$	(229)
Amounts recognized in Consolidated Balance Sheet consist of:
Accrued liabilities		$	(25)		$	(27)
Postretirement benefit obligations other than pensions(1)		(171)			(202)
Net amount recognized		$	(196)		$	(229)

(1)Excludes non-U.S. plan of $37 million and $40 million as of December 31, 2021 and 2020.

Amounts recognized in Accumulated other comprehensive (income) loss associated with the Company's significant pension and other postretirement benefit plans at December 31, 2021 and 2020 are as follows:


	Pension Benefits
	U.S. Plans						Non-U.S. Plans
	2021			2020			2021			2020
Prior service (credit) cost		$	(92)		$	(134)		$	20		$	23
Net actuarial (gain) loss		492			505			397			629
Net amount recognized		$	400		$	371		$	417		$	652


	Other Postretirement Benefits
	2021			2020
Prior service (credit) cost		$	(92)		$	(165)
Net actuarial (gain) loss		(34)			(28)
Net amount recognized		$	(126)		$	(193)

The components of net periodic benefit (income) cost and other amounts recognized in Other comprehensive (income) loss for the Company's significant pension and other postretirement benefit plans include the following components:


Net Periodic Benefit Cost	Pension Benefits
	U.S. Plans									Non-U.S. Plans
	2021			2020			2019			2021			2020			2019
Service cost		$	105		$	99		$	82		$	26		$	23		$	22
Interest cost		306			461			613			77			106			142
Expected return on plan assets		(1,220)			(1,135)			(1,117)			(348)			(336)			(331)
Amortization of prior service (credit) cost		(42)			(42)			(42)			—			—			—
Recognition of actuarial losses		31			26			35			9			18			88
Settlements and curtailments		—			4			4			—			—			—
Net periodic benefit (income) cost		$	(820)		$	(587)		$	(425)		$	(236)		$	(189)		$	(79)


Other Changes in Plan Assets and Benefits Obligations Recognized in Other Comprehensive (Income) Loss	U.S. Plans									Non-U.S. Plans
	2021			2020			2019			2021			2020			2019
Actuarial (gains) losses		$	(14)		$	(9)		$	(277)		$	(221)		$	(73)		$	176
Prior service (credit) cost		—			—			—			(3)			2			—
Prior service credit recognized during year		43			42			42			(1)			—			—
Actuarial losses recognized during year		—			(30)			(39)			(9)			(18)			(88)
Foreign currency translation		—			—			—			(1)			19			14
Total recognized in other comprehensive (income) loss		$	29		$	3		$	(274)		$	(235)		$	(70)		$	102
Total recognized in net periodic benefit (income) cost and other comprehensive (income) loss		$	(791)		$	(584)		$	(699)		$	(471)		$	(259)		$	23


Net Periodic Benefit Cost	Other Postretirement Benefits
	Years Ended December 31,
	2021			2020			2019
Service cost		$	—		$	—		$	—
Interest cost		5			8			14
Amortization of prior service (credit) cost		(74)			(66)			(62)
Recognition of actuarial (gains) losses		(2)			—			—
Net periodic benefit (income) cost		$	(71)		$	(58)		$	(48)


Other Changes in Plan Assets and Benefits Obligations Recognized in Other Comprehensive (Income) Loss	Years Ended December 31,
	2021			2020			2019
Actuarial (gains) losses		$	(8)		$	(8)		$	(16)
Prior service (credit) cost		—			(65)			(2)
Prior service credit recognized during year		74			66			62
Actuarial (gains) losses recognized during year		2			—			—
Total recognized in other comprehensive (income) loss		$	68		$	(7)		$	44
Total recognized in net periodic benefit (income) cost and other comprehensive (income) loss		$	(3)		$	(65)		$	(4)

Major actuarial assumptions used in determining the benefit obligations and net periodic benefit (income) cost for the Company's significant benefit plans are presented in the following table as weighted averages.


	Pension Benefits
	U.S. Plans									Non-U.S. Plans
	2021			2020			2019			2021			2020			2019
Actuarial assumptions used to determine benefit obligations as of December 31:
Discount rate		2.87	%		2.50	%		3.22	%		1.79	%		1.23	%		1.81	%
Expected annual rate of compensation increase		3.25	%		3.25	%		3.25	%		2.56	%		2.43	%		2.47	%
Actuarial assumptions used to determine net periodic benefit (income) cost for years ended December 31:
Discount rate—benefit obligation		2.50	%		3.22	%		4.35	%		1.24	%		1.81	%		2.63	%
Discount rate—service cost		2.68	%		3.33	%		4.47	%		1.00	%		1.48	%		2.26	%
Discount rate—interest cost		1.76	%		2.76	%		3.94	%		1.00	%		1.56	%		2.34	%
Expected rate of return on plan assets		6.15	%		6.15	%		6.75	%		4.03	%		4.66	%		5.14	%
Expected annual rate of compensation increase		3.25	%		3.25	%		3.25	%		2.43	%		2.47	%		2.46	%


	Other Postretirement Benefits
	2021			2020			2019
Actuarial assumptions used to determine benefit obligations as of December 31:
Discount rate		2.66	%		2.20	%		3.03	%
Actuarial assumptions used to determine net periodic benefit cost for years ended December 31:
Discount rate(1)		2.20	%		2.36	%		4.07	%

(1)Discount rate was 3.03% for January 1, 2020 through September 30, 2020. The rate was changed to 2.36% for the remainder of 2020 due to a Plan remeasurement as of October 1, 2020.

The discount rate for the Company's U.S. pension and other postretirement benefits plans reflects the current rate at which the associated liabilities could be settled at the measurement date of December 31. To determine discount rates for the Company's U.S. pension and other postretirement benefit plans, the Company uses a modeling process that involves matching the expected cash outflows of the Company's benefit plans to a yield curve constructed from a portfolio of high quality, fixed-income debt instruments. The Company uses the single weighted-average yield of this hypothetical portfolio as a discount rate benchmark. The Company utilizes a full yield curve approach in the estimation of the service and interest cost components of net periodic pension benefit (income) for the Company's significant pension plans. This approach applies the specific spot rates along the yield curve used in the determination of the pension benefit obligation to their underlying projected cash flows and provides a more precise measurement of service and interest costs by improving the correlation between projected cash flows and their corresponding spot rates. For the Company's U.S. pension plans, the single weighted average spot rates used to determine service and interest costs for 2022 are 2.97% and 2.26%. The discount rate used to determine the other postretirement benefit obligation is lower principally due to a shorter expected duration of other postretirement plan obligations as compared to pension plan obligations.

The Company plans to use an expected rate of return on U.S. plan assets of 6.40% for 2022, which represents an increase from the 6.15% assumption used for 2021. The Company's asset return assumption is based on historical plan asset returns over varying long-term periods combined with current market conditions and broad asset mix considerations with a focus on long-term trends rather than short-term market conditions. The Company reviews the expected rate of return on an annual basis and revise it as appropriate.

For non-U.S. benefit plans actuarial assumptions reflect economic and market factors relevant to each country.

PENSION BENEFITS

The following amounts relate to the Company's significant pension plans with accumulated benefit obligations exceeding the fair value of plan assets:


	December 31,
	U.S. Plans						Non-U.S. Plans
	2021			2020			2021			2020
Projected benefit obligation		$	359		$	353		$	964		$	2,116
Accumulated benefit obligation		$	346		$	341		$	932		$	2,042
Fair value of plan assets		$	—		$	—		$	256		$	1,208

The accumulated benefit obligation for the Company's U.S. defined benefit pension plans was $17.3 billion and $17.9 billion and for the Company's Non-U.S. defined benefit pension plans was $6.9 billion and $7.6 billion at December 31, 2021 and 2020.

The Company's asset investment strategy for its U.S. pension plans focuses on maintaining a diversified portfolio using various asset classes in order to achieve the Company's long-term investment objectives on a risk adjusted basis. The Company's long-term target allocations are as follows: 55%-70% fixed income securities and cash, 25%-40% equity securities, 5%-10% real estate investments, and 10%-20% other types of investments. Equity securities include publicly-traded stock of companies located inside the United States. Fixed income securities include corporate bonds of companies from diversified industries, mortgage-backed securities, and U.S. Treasuries. Real estate investments include direct investments in commercial properties and investments in real estate funds. Other types of investments include investments in private equity that follow several different strategies. The Company reviews its assets on a regular basis to ensure that the Company is within the targeted asset allocation ranges and, if necessary, asset balances are adjusted back within target allocations.

The Company's non-U.S. pension assets are typically managed by decentralized fiduciary committees with the Honeywell Corporate Investments group providing funding and investment guidance. The Company's non-U.S. investment policies are different for each country as local regulations, funding requirements, and financial and tax considerations are part of the funding and investment allocation process in each country.

In accordance with ASU 2015-07, “Fair Value Measurement (Topic 820)”, certain investments that are measured at fair value using the net asset value (NAV) per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy. The fair value amounts presented in the following tables are intended to permit reconciliation of the fair value hierarchy to the amounts presented for the total pension benefits plan assets.

The fair values of both the Company's U.S. and non-U.S. pension plans assets by asset category are as follows:


	U.S. Plans
	December 31, 2021
	Total			Level 1			Level 2			Level 3
Equities:
Honeywell common stock		$	3,251		$	3,251		$	—		$	—
U.S. equities		—			—			—			—


Fixed income:
Short term investments		1,767			1,767			—			—
Government securities		1,373			—			1,373			—
Corporate bonds		9,588			—			9,588			—
Mortgage/Asset-backed securities		1,072			—			1,072			—
Insurance contracts		8			—			8			—
Direct investments:
Direct private investments		1,336			—			—			1,336
Real estate properties		843			—			—			843
Total		$	19,238		$	5,018		$	12,041		$	2,179
Investments measured at NAV:
Private funds		1,244
Real estate funds		14

Commingled Funds		64
Total assets at fair value		$	20,560


	U.S. Plans
	December 31, 2020
	Total			Level 1			Level 2			Level 3
Equities:
Honeywell common stock		$	3,319		$	3,319		$	—		$	—
U.S. equities		—			—			—			—


Fixed income:
Short term investments		1,314			1,314			—			—
Government securities		1,520			—			1,520			—
Corporate bonds		10,190			—			10,190			—
Mortgage/Asset-backed securities		982			—			982			—
Insurance contracts		7			—			7			—
Direct investments:
Direct private investments		1,220			—			—			1,220
Real estate properties		651			—			—			651
Total		$	19,203		$	4,633		$	12,699		$	1,871
Investments measured at NAV:
Private funds		1,105
Real estate funds		26

Commingled funds		62
Total assets at fair value		$	20,396


	Non-U.S. Plans
	December 31, 2021
	Total			Level 1			Level 2			Level 3
Equities:
U.S. equities		$	229		$	1		$	228		$	—
Non-U.S. equities		824			—			824			—
Fixed income:
Short-term investments		571			571			—			—
Government securities		3,893			—			3,893			—
Corporate bonds		1,681			—			1,681			—
Mortgage/Asset-backed securities		79			—			79			—
Insurance contracts		123			—			123			—
Insurance buy-in contracts		691			—			—			691
Investments in private funds:
Private funds		74			—			41			33
Real estate funds		163			—			—			163
Total		$	8,328		$	572		$	6,869		$	887
Investments measured at NAV:
Private funds		17
Real estate funds		51
Total assets at fair value		$	8,396


	Non-U.S. Plans
	December 31, 2020
	Total			Level 1			Level 2			Level 3
Equities:
U.S. equities		$	207		$	—		$	207		$	—
Non-U.S. equities		1,614			66			1,548			—
Fixed income:
Short-term investments		596			596			—			—
Government securities		3,105			—			3,105			—
Corporate bonds		1,649			—			1,649			—
Mortgage/Asset-backed securities		93			—			93			—
Insurance contracts		142			—			142			—
Insurance buy-in contracts		767			—			—			767
Investments in private funds:
Private funds		65			—			36			29
Real estate funds		147			—			—			147
Total		$	8,385		$	662		$	6,780		$	943
Investments measured at NAV:
Private funds		18
Real estate funds		47
Total assets at fair value		$	8,450

The following table summarizes changes in the fair value of Level 3 assets for both U.S. and Non-U.S. plans:


	U.S. Plans						Non-U.S. Plans
	Direct Private Investments			Real Estate Properties			Private Funds			Real Estate Funds			Insurance Buy-in Contracts
Balance at December 31, 2019		$	950		$	619		$	34		$	150		$	—
Actual return on plan assets:
Relating to assets still held at year-end		100			(4)			(5)			(3)			—
Relating to assets sold during the year		53			—			—			—			—
Purchases		221			59			—			—			767
Sales and settlements		(104)			(23)			—			—			—
Balance at December 31, 2020		1,220			651			29			147			767
Actual return on plan assets:
Relating to assets still held at year-end		11			96			4			23			(76)
Relating to assets sold during the year		174			—			—			4			—
Purchases		194			99			—			—			—
Sales and settlements		(263)			(3)			—			(11)			—
Balance at December 31, 2021		$	1,336		$	843		$	33		$	163		$	691

The Company enters into futures contracts to gain exposure to certain markets. Sufficient cash or cash equivalents are held by the Company's pension plans to cover the notional value of the futures contracts. At December 31, 2021 and 2020, the Company's U.S. plans had contracts with notional amounts of $4,415 million and $3,673 million. At December 31, 2021 and 2020, the Company's non-U.S. plans had contracts with notional amounts of $311 million and $564 million, respectively. In both the Company's U.S. and non-U.S. pension plans, the notional derivative exposure is related to outstanding equity and fixed income futures contracts.

Common stocks, preferred stocks, real estate investment trusts, and short-term investments are valued at the closing price reported in the active market in which the individual securities are traded. Corporate bonds, mortgages/asset-backed securities, and government securities are valued either by using pricing models, bids provided by brokers or dealers, quoted prices of securities with similar characteristics or discounted cash flows and as such include adjustments for certain risks that may not be observable such as credit and liquidity risks. Certain securities are held in collective trust funds which are valued using net asset values provided by the administrators of the funds. Investments in private equity, debt, real estate and hedge funds and direct private investments are valued at estimated fair value based on quarterly financial information received from the investment advisor and/or general partner. Investments in real estate properties are valued on a quarterly basis using the income approach. Valuation estimates are periodically supplemented by third party appraisals. The insurance buy-in contracts represent policies held by the Honeywell UK Pension Scheme, whereby the cost of providing pension benefits to plan participants is funded by the policies. The cash flows from the policies are intended to match the pension benefits. The fair value of these policies is based on an estimate of the policies' exit price.

The Company's funding policy for qualified defined benefit pension plans is to contribute amounts at least sufficient to satisfy regulatory funding standards. In 2021, 2020, and 2019, the Company was not required to make contributions to the U.S. pension plans and no contributions were made. The Company is not required to make any contributions to the U.S. pension plans in 2022. In 2021, contributions of $94 million were made to the non-U.S. pension plans to satisfy regulatory funding requirements. In 2022, the Company expects to make contributions of cash and/or marketable securities of approximately $11 million to the non-U.S. pension plans to satisfy regulatory funding standards. Contributions for both the U.S. and non-U.S. pension plans do not reflect benefits paid directly from Company assets.

Benefit payments, including amounts to be paid from Company assets, and reflecting expected future service, as appropriate, are expected to be paid as follows:


	U.S. Plans		Non-U.S. Plans
2022	$	1,135	$	261
2023	1,124		263
2024	1,115		268
2025	1,107		275
2026	1,097		284
2027-2031	5,152		1,455

OTHER POSTRETIREMENT BENEFITS


	December 31,
	2021			2020
Assumed health care cost trend rate:
Health care cost trend rate assumed for next year		6.50	%		7.00	%
Rate that the cost trend rate gradually declines to		5.00	%		5.00	%
Year that the rate reaches the rate it is assumed to remain at		2029			2029

Benefit payments reflecting expected future service, as appropriate, are expected to be paid as follows:


	Without Impact of Medicare Subsidy		Net of Medicare Subsidy
2022	$	27	$	25
2023	25		24
2024	14		14
2025	14		13
2026	13		12
2027-2031	57		53

- Definition

The entire disclosure for retirement benefits.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 55
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section S99
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(i)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (o)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (p)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 70
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-URI http://asc.fasb.org/topic&trid=2235017

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 60
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iv)(03)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (q)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (r)(1)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iii)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (l)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (r)(2)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

+ Details

REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS

12 Months Ended

Dec. 31, 2021

Revenue from Contract with Customer [Abstract]

Revenue from Contract with Customer [Text Block]

REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS

The Company has a comprehensive offering of products and services, including software and technologies, that are sold to a variety of customers in multiple end markets. See the following disaggregated revenue table and related discussions by operating segment for details.


	Years Ended December 31,
	2021			2020			2019
Aerospace
Commercial Aviation Original Equipment		$	1,720		$	1,940		$	2,999
Commercial Aviation Aftermarket		4,155			3,812			5,761
Defense and Space		5,151			5,792			5,294

		11,026			11,544			14,054
Honeywell Building Technologies


Products		3,243			2,971			3,293
Building Solutions		2,296			2,218			2,424
		5,539			5,189			5,717
Performance Materials and Technologies
UOP		2,348			2,177			2,890
Process Solutions		4,611			4,590			5,146
Advanced Materials		3,054			2,656			2,798
		10,013			9,423			10,834
Safety and Productivity Solutions
Safety and Retail		2,387			2,414			2,215
Productivity Solutions and Services		1,610			1,270			1,285
Warehouse and Workflow Solutions		2,944			1,965			1,719
Advanced Sensing Technologies		873			832			885
		7,814			6,481			6,104
Corporate and All Other		—			—			—
Net sales		$	34,392		$	32,637		$	36,709

Aerospace – A global supplier of products, software and services for aircrafts that it sells to OEM and other customers in a variety of end markets including: air transport, regional, business and general aviation aircraft, airlines, aircraft operators and defense and space contractors. Aerospace products and services include auxiliary power units, propulsion engines, environmental control systems, integrated avionics, wireless connectivity services, electric power systems, engine controls, flight safety, communications, navigation hardware, data and software applications, radar and surveillance systems, aircraft lighting, management and technical services, advanced systems and instruments, satellite and space components, aircraft wheels and brakes, repair, and overhaul services and thermal systems. Aerospace also provides spare parts, repair, overhaul and maintenance services (principally to aircraft operators) for the aftermarket. Honeywell Forge solutions are leveraged by the Company's customers as tools to turn data into predictive maintenance and predictive analytics to enable better fleet management and make flight operations more efficient.

Honeywell Building Technologies – A global provider of products, software, solutions, and technologies that enable building owners and occupants to ensure their facilities are safe, energy efficient, sustainable, and productive. Honeywell Building Technologies products and services include advanced software applications for building control and optimization; sensors, switches, control systems, and instruments for energy management; access control; video surveillance; fire products; and installation, maintenance and upgrades of systems. Honeywell Forge solutions enable the Company's customers to digitally manage buildings, connecting data from different assets to enable smart maintenance, improve building performance, and even protect from incoming security threats.

Performance Materials and Technologies – A global provider in developing and manufacturing high-quality performance chemicals and materials, process technologies, and automation solutions. The segment is comprised of Process Solutions, UOP, and Advanced Materials. Process Solutions provides automation control, instrumentation, advanced software, and related services for the oil and gas, refining, pulp and paper, industrial power generation, chemicals and petrochemicals, biofuels, life sciences, and metals, minerals, and mining industries. Through its smart energy products, Process Solutions enables utilities and distribution companies to deploy advanced capabilities to improve operations, reliability, and environmental sustainability. UOP provides process technology, products, including catalysts and adsorbents, equipment, and consulting services that enable customers to efficiently produce gasoline, diesel, jet fuel, petrochemicals and renewable fuels for the petroleum refining, gas processing, petrochemical, and other industries. Advanced Materials manufactures a wide variety of high-performance products, including materials used to manufacture end products such as bullet-resistant armor, nylon, computer chips, and pharmaceutical packaging, and provides reduced and low global-warming-potential materials based on hydrofluoro-olefin technology. In the industrial environment, Honeywell Forge solutions enable integration and connectivity to provide a holistic view of operations and turn data into clear actions to maximize productivity and efficiency. Honeywell Forge's cybersecurity capabilities help identify risks and act on cyber-related incidents, together enabling improved operations and protecting processes, people and assets.

Safety and Productivity Solutions – A global provider of products and software that improve productivity, workplace safety and asset performance to customers around the globe. Safety products include PPE, apparel, gear, and footwear; gas detection technology; and cloud-based notification and emergency messaging. Productivity Solutions products and services include mobile devices and software for computing, data collection, and thermal printing; supply chain and warehouse automation equipment, software and solutions; custom-engineered sensors, switches and controls for sensing and productivity solutions; and software-based data and asset management productivity solutions. Honeywell Forge solutions digitally automate processes to improve efficiency while reducing downtime and safety costs.

Corporate and All Other – Corporate and All Other includes revenue from Honeywell's majority-owned investment in Quantinuum. Through Quantinuum, Honeywell provides a wide range of service offerings of fully integrated quantum computing hardware and software solutions.

For a summary by disaggregated product and services sales for each segment, refer to Note 22 Segment Financial Data.

The Company recognizes revenue arising from performance obligations outlined in contracts with its customers that are satisfied at a point in time and over time. The disaggregation of the Company's revenue based off timing of recognition is as follows:


	Years Ended December 31,
	2021			2020			2019
Products, transferred point in time		58	%		61	%		61	%
Products, transferred over time		17			15			14
Net product sales		75			76			75
Services, transferred point in time		8			8			9
Services, transferred over time		17			16			16
Net service sales		25			24			25
Net sales		100	%		100	%		100	%

CONTRACT BALANCES

The Company records progress on satisfying performance obligations under contracts with customers and the related billings and cash collections are recorded on the Consolidated Balance Sheet in Accounts receivable—net and Other assets (unbilled receivables (contract assets) and billed receivables) and Accrued liabilities and Other liabilities (customer advances and deposits (contract liabilities)). Unbilled receivables (contract assets) arise when the timing of cash collected from customers differs from the timing of revenue recognition, such as when contract provisions require specific milestones to be met before a customer can be billed. Contract assets are recognized when the revenue associated with the contract is recognized prior to billing and derecognized when billed in accordance with the terms of the contract. Contract liabilities are recorded when customers remit contractual cash payments in advance of us satisfying performance obligations under contractual arrangements, including those with performance obligations to be satisfied over a period of time. Contract liabilities are derecognized when revenue is recorded, either when a milestone is met triggering the contractual right to bill or when the performance obligation is satisfied.

Contract balances are classified as assets or liabilities on a contract-by-contract basis at the end of each reporting period.

The following table summarizes the Company's contract assets and liabilities balances:


	2021			2020
Contract assets—January 1		$	1,618		$	1,602
Contract assets—December 31		2,060			1,618
Change in contract assets—increase (decrease)		$	442		$	16
Contract liabilities—January 1		$	(4,033)		$	(3,501)
Contract liabilities—December 31		(4,290)			(4,033)
Change in contract liabilities—(increase) decrease		$	(257)		$	(532)
Net change		$	185		$	(516)

The net change in 2021 and 2020 was primarily driven by the receipt of advance payments from customers exceeding recognition of revenue as performance obligations were satisfied prior to billing. For the years ended December 31, 2021 and 2020, the Company recognized revenue of $1,925 million and $1,709 million, respectively, that was previously included in the beginning balance of contract liabilities.

Contract assets include $2,035 million and $1,589 million of unbilled balances under long-term contracts as of December 31, 2021 and 2020, respectively. These amounts are billed in accordance with the terms of customer contracts to which they relate.

When contracts are modified to account for changes in contract specifications and requirements, the Company considers whether the modification either creates new or changes the existing enforceable rights and obligations. Contract modifications for goods or services and not distinct from the existing contract, due to the significant integration with the original good or service provided, are accounted for as if they were part of that existing contract. The effect of a contract modification on the transaction price and the Company's measure of progress for the performance obligation to which it relates, is recognized as an adjustment to revenue (either as an increase in or a reduction of revenue) on a cumulative catch-up basis. When the modifications include additional performance obligations that are distinct and at relative stand-alone selling price, they are accounted for as a new contract and performance obligation, which are recognized prospectively.

PERFORMANCE OBLIGATIONS

A performance obligation is a promise in a contract to transfer a distinct good or service to the customer, and is defined as the unit of account. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. When the Company's contracts with customers require highly complex integration or manufacturing services that are not separately identifiable from other promises in the contracts and, therefore, not distinct, then the entire contract is accounted for as a single performance obligation. In situations when the Company's contracts includes distinct goods or services that are substantially the same and have the same pattern of transfer to the customer over time, they are recognized as a series of distinct goods or services. For any contracts with multiple performance obligations, the Company allocates the contract’s transaction price to each performance obligation based on the estimated relative standalone selling price of each distinct good or service in the contract. For product sales, each product sold to a customer typically represents a distinct performance obligation. In such cases, the observable standalone sales are used to determine the stand alone selling price.

Performance obligations are satisfied as of a point in time or over time. Performance obligations are supported by contracts with customers, providing a framework for the nature of the distinct goods, services or bundle of goods and services. The timing of satisfying the performance obligation is typically indicated by the terms of the contract.

The following table outlines the Company's remaining performance obligations disaggregated by segment:


	December 31, 2021
Aerospace		$	9,423
Honeywell Building Technologies		6,871
Performance Materials and Technologies		7,243
Safety and Productivity Solutions		4,143
Corporate and All Other(1)		2
		$	27,682

(1) The remaining performance obligations within Corporate and All Other relate to the Quantinuum business.

Performance obligations recognized as of December 31, 2021 will be satisfied over the course of future periods. The Company's disclosure of the timing for satisfying the performance obligation is based on the requirements of contracts with customers. However, from time to time, these contracts may be subject to modifications, impacting the timing of satisfying the performance obligations. Performance obligations expected to be satisfied within one year and greater than one year are 59% and 41%, respectively.

The timing of satisfaction of the Company's performance obligations does not significantly vary from the typical timing of payment. Typical payment terms of the Company's fixed-price over time contracts include progress payments based on specified events or milestones, or based on project progress. For some contracts the Company may be entitled to receive an advance payment.

The Company has applied the practical expedient for certain revenue streams to exclude the value of remaining performance obligations for (i) contracts with an original expected term of one year or less or (ii) contracts for which the Company recognizes revenue in proportion to the amount the Company has the right to invoice for services performed.

- Definition

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI http://asc.fasb.org/topic&trid=49130388

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045

+ Details

REPOSITIONING AND OTHER CHARGES (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Component of Operating Other Cost and Expense [Abstract]
Total net repositioning charge	$ 318	$ 518	$ 433
Asbestos related litigation charges, net of insurance and reimbursements	129	50	42
Probable and reasonably estimable environmental liabilities, net of reimbursements	22	27	59
Other charges	100	(20)	12
Total net repositioning and other charges	569	575	546
Severance [Member]
Component of Operating Other Cost and Expense [Abstract]
Total net repositioning charge	80	475	260
Asset Impairments [Member]
Component of Operating Other Cost and Expense [Abstract]
Total net repositioning charge	117	21	95
Exit costs [Member]
Component of Operating Other Cost and Expense [Abstract]
Total net repositioning charge	134	69	83
Reserve Adjustments [Member]
Component of Operating Other Cost and Expense [Abstract]
Total net repositioning charge	$ (13)	$ (47)	$ (5)

DOCUMENT AND ENTITY INFORMATION - USD ($) $ in Billions	12 Months Ended
DOCUMENT AND ENTITY INFORMATION - USD ($) $ in Billions	Dec. 31, 2021	Jan. 28, 2022	Jun. 30, 2021
Entity Information [Line Items]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2021
Document Transition Report	false
Entity File Number	1-8974
Entity Registrant Name	Honeywell International Inc.
Entity Central Index Key	0000773840
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	FY
Amendment Flag	false
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	22-2640650
Entity Address, Address Line One	855 South Mint Street
Entity Address, City or Town	Charlotte,
Entity Address, State or Province	NC
Entity Address, Postal Zip Code	28202
City Area Code	704
Local Phone Number	627-6200
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Filer Category	Large Accelerated Filer
Icfr Auditor Attestation Flag	true
Entity Shell Company	false
Entity Public Float			$ 152.8
Entity Common Stock, Shares Outstanding		685,818,771
Documents Incorporated by Reference	Part III: Proxy Statement for Annual Meeting of Shareowners to be held April 25, 2022.
Common Stock [Member]
Entity Information [Line Items]
Title of 12(b) Security	Common Stock, par value $1 per share*
Trading Symbol	HON
Security Exchange Name	NASDAQ
Euro Notes 1.30% Due 2023 [Member]
Entity Information [Line Items]
Title of 12(b) Security	1.300% Senior Notes due 2023
Trading Symbol	HON 23A
Security Exchange Name	NASDAQ
0.000% Senior Notes due 2024 [Member]
Entity Information [Line Items]
Title of 12(b) Security	0.000% Senior Notes due 2024
Trading Symbol	HON 24A
Security Exchange Name	NASDAQ
Euro Notes 2.25% Due 2028 [Member]
Entity Information [Line Items]
Title of 12(b) Security	2.250% Senior Notes due 2028
Trading Symbol	HON 28A
Security Exchange Name	NASDAQ
0.750% Senior Notes due 2032 [Member]
Entity Information [Line Items]
Title of 12(b) Security	0.750% Senior Notes due 2032
Trading Symbol	HON 32
Security Exchange Name	NASDAQ

STOCK BASED COMPENSATION PLANS 3 (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
2016 Plan [Member] \| Share-based Payment Arrangement, Option [Member]
Share Based Compensation Arrangement By Share Based Payment Stock Options [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number	10,664,625	10,120,793	11,620,992
Weighted Average Exercise Price	$ 113.30	$ 103.89	$ 92.19
Shares of Honeywell common stock available for future grants	32,337,638
Unrecognized compensation on nonvested stock options	$ 100
Nonvested options recognized over weighted average period, years	2 years 5 months 15 days
Fair value of options vested	$ 52	$ 55	$ 61
Compensation expense	55	50	47
Future income tax benefit recognized	11	10	10
Financial Statement Impact From Stock Options Exercised [Abstract]
Intrinsic value	219	379	483
Tax benefit realized	48	84	117
2016 Plan [Member] \| Restricted Stock Units (RSUs) [Member]
Share Based Compensation Arrangement By Share Based Payment Stock Options [Line Items]
Unrecognized compensation on nonvested stock options	$ 273
Nonvested options recognized over weighted average period, years	2 years 2 months 23 days
Compensation expense	$ 162	118	106
Future income tax benefit recognized	$ 23	$ 24	$ 21
2016 Directors Plan \| Share-based Payment Arrangement, Option [Member]
Share Based Compensation Arrangement By Share Based Payment Stock Options [Line Items]
Shares of Honeywell common stock available for future grants	815,299

DERIVATIVE INSTRUMENTS AND HEDGING TRANSACTIONS (Tables)

12 Months Ended

Dec. 31, 2021

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]


	Notional						Fair Value Asset						Fair Value (Liability)
	December 31, 2021			December 31, 2020			December 31, 2021			December 31, 2020			December 31, 2021			December 31, 2020
Derivatives in Fair Value Hedging Relationships:
Interest rate swap agreements		$	3,150		$	3,950		$	60		$	194		$	—		$	—
Derivatives in Cash Flow Hedging Relationships:
Foreign currency exchange contracts		647			488			4			65			—			(58)
Derivatives in Net Investment Hedging Relationships:
Foreign currency exchange contracts		746			806			92			45			—			(1)
Cross currency swap agreements		1,200			1,200			39			—			—			(50)
Total Derivatives Designated as Hedging Instruments		5,743			6,444			195			304			—			(109)
Derivatives Not Designated as Hedging Instruments:
Foreign currency exchange contracts		11,278			14,829			278			92			(282)			(91)
Total Derivatives at Fair Value		$	17,021		$	21,273		$	473		$	396		$	(282)		$	(200)

All derivative assets are presented in Other current assets or Other assets. All derivative liabilities are presented in Accrued liabilities or Other liabilities.

Schedule of Derivative Instruments [Table Text Block]


Line in the Consolidated Balance Sheet of Hedged Item	Carrying Amount of the Hedged Item						Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Item
Line in the Consolidated Balance Sheet of Hedged Item	December 31, 2021			December 31, 2020			December 31, 2021			December 31, 2020
Long-term debt		$	3,210		$	4,144		$	60		$	194

Derivative Instruments, Gain (Loss) [Table Text Block]

The following tables summarize the location and impact to the Consolidated Statement of Operations related to derivative instruments:


	Year Ended December 31, 2021
	Net Sales			Cost of Products Sold			Cost of Services Sold			Selling, general and administrative expenses			Other (Income) Expense			Interest and Other Financial Charges
		$	34,392		$	18,344		$	5,050		$	4,798		$	(1,378)		$	343
Gain or (loss) on cash flow hedges:
Foreign Currency Exchange Contracts:
Amount reclassified from accumulated other comprehensive income into income		5			8			2			9			—			—

Gain or (loss) on fair value hedges:
Interest Rate Swap Agreements:
Hedged items		—			—			—			—			—			135
Derivatives designated as hedges		—			—			—			—			—			(135)
Gain or (loss) on net investment hedges:
Foreign Currency Exchange Contracts:
Amount excluded from effectiveness testing recognized in earnings using an amortization approach		—			—			—			—			—			16
Gain or (loss) on derivatives not designated as hedging instruments:
Foreign currency exchange contracts		—			—			—			—			195			—


	Year Ended December 31, 2020
	Net Sales			Cost of Products Sold			Cost of Services Sold			Selling, general and administrative expenses			Other (Income) Expense			Interest and Other Financial Charges
		$	32,637		$	17,638		$	4,531		$	4,772		$	(675)		$	359
Gain or (loss) on cash flow hedges:
Foreign Currency Exchange Contracts:
Amount reclassified from accumulated other comprehensive income into income		(3)			43			11			(4)			28			—
Amount excluded from effectiveness testing recognized in earnings using an amortization approach		—			10			3			—			29			—
Gain or (loss) on fair value hedges:
Interest Rate Swap Agreements:
Hedged items		—			—			—			—			—			(169)
Derivatives designated as hedges		—			—			—			—			—			169
Gain or (loss) on net investment hedges:
Foreign Currency Exchange Contracts:
Amount excluded from effectiveness testing recognized in earnings using an amortization approach		—			—			—			—			—			18
Gain or (loss) on derivatives not designated as hedging instruments:
Foreign currency exchange contracts		—			—			—			—			(166)			—


	Year Ended December 31, 2019
	Net Sales			Cost of Products Sold			Cost of Services Sold			Selling, general and administrative expenses			Other (Income) Expense			Interest and Other Financial Charges
		$	36,709		$	19,269		$	5,070		$	5,519		$	(1,065)		$	357
Gain or (loss) on cash flow hedges:
Foreign Currency Exchange Contracts:
Amount reclassified from accumulated other comprehensive income into income		3			35			9			1			73			—
Amount excluded from effectiveness testing recognized in earnings using an amortization approach		—			16			6			—			35			—
Gain or (loss) on fair value hedges:
Interest Rate Swap Agreements:
Hedged items		—			—			—			—			—			(70)
Derivatives designated as hedges		—			—			—			—			—			70
Gain or (loss) on net investment hedges:
Foreign Currency Exchange Contracts:
Amount excluded from effectiveness testing recognized in earnings using an amortization approach		—			—			—			—			—			19
Gain or (loss) on derivatives not designated as hedging instruments:
Foreign currency exchange contracts		—			—			—			—			106			—

Derivative Instruments Gain Loss Recognized In AOCI [Table Text Block]

The following table summarizes the amounts of gain or (loss) on net investment hedges recognized in Accumulated other comprehensive income (loss):


Derivatives Net Investment Hedging Relationships	Years Ended December 31,
	2021			2020
Euro-denominated long-term debt		$	284		$	(256)
Euro-denominated commercial paper		57			(8)
Cross currency swap		88			(109)
Foreign currency exchange contracts		40			(94)

- Definition

Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959

+ Details

REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS 3 (Details) $ in Millions	Dec. 31, 2021 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation - amount	$ 27,682
Within One Year [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Percentage	59.00%
Greater Than One Year [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Percentage	41.00%
Corporate and All Other [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation - amount	$ 2
Aerospace [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation - amount	9,423
Honeywell Building Technologies [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation - amount	6,871
Performance Materials And Technologies [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation - amount	7,243
Safety And Productivity Solutions [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation - amount	$ 4,143

FAIR VALUE MEASUREMENTS 2 (Details) - USD ($)	Dec. 31, 2021	Apr. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term investment		$ 577,000,000	$ 0	$ 0
Reported Value Measurement [Member] \| Fair Value, Inputs, Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term investment	$ 34,000,000		0
Long-term receivables	170,000,000		137,000,000
Long-term investment	366,000,000		0
Long-term debt and related current maturities	16,057,000,000		18,787,000,000
Estimate of Fair Value Measurement [Member] \| Fair Value, Inputs, Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term investment	34,000,000		0
Long-term receivables	152,000,000		132,000,000
Long-term investment	366,000,000		0
Long-term debt and related current maturities	$ 17,022,000,000		$ 20,176,000,000

INCOME TAX 2 (Details)	12 Months Ended
INCOME TAX 2 (Details)	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Effective Income Tax Rate Reconciliation, Percent [Abstract]
U.S. federal statutory income tax rate	21.00%	21.00%	21.00%
Taxes on non-U.S. earnings	(1.40%)	(0.80%)	(0.50%)
U.S. state income taxes	1.50%	1.30%	1.10%
Reserves for tax contingencies	2.20%	(2.60%)	2.00%
Employee share-based payments	(0.70%)	(1.20%)	(1.20%)
Reduction of certain receivables	0.00%	2.00%	0.00%
U.S. Tax Cuts and Jobs Act	0.00%	0.00%	(3.60%)
Restructuring	(1.40%)	0.00%	0.00%
U.S. Valuation Allowance	2.00%	0.10%	0.00%
All other items net	(0.70%)	(0.70%)	(1.20%)
Effective Income Tax Rate Reconciliation, Percent	22.50%	19.10%	17.60%
Tax Expense Paragraph Details [Abstract]
Net (decrease) increase in the effective tax rate from prior period	3.40%	1.50%
Net (decrease) increase in non-U.S. income tax rate	14.10%	(14.20%)
Non-U.S. effective income tax rate	26.00%	11.90%

LEASES (Tables)

12 Months Ended

Dec. 31, 2021

Leases [Abstract]

Lease, Cost [Table Text Block]


	Years Ended December 31,
	2021			2020
Operating lease cost		$	228		$	214
Variable lease cost		14			18
Short-term lease cost		15			17
Finance lease cost:
Amortization of right-of-use assets		65			69
Interest on lease liability		24			27
Total finance lease cost		89			96
Total lease cost		$	346		$	345

Supplemental cash flow information related to leases was as follows:


	Years Ended December 31,
	2021			2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for operating leases		$	215		$	206
Operating cash flows for finance leases		24			32
Financing cash flows for finance leases		67			65
Right-of-use assets obtained in exchange for lease obligations:
Operating leases		$	350		$	245
Finance leases		32			27

Supplemental balance sheet information related to leases was as follows:


	December 31,
	2021				2020
Operating leases:
Other assets		$	947			$	773
Accrued liabilities		185				187
Other liabilities		847				641
Total operating lease liabilities		$	1,032			$	828
Finance leases:
Property, plant and equipment		$	325			$	357
Accumulated depreciation		(177)				(180)
Property, plant and equipment—net		$	148			$	177
Current maturities of long-term debt		$	57			$	60
Long-term debt		99				124
Total finance lease liabilities		$	156			$	184
Weighted-average remaining lease term:
Operating leases	9 years				7 years
Finance leases	3 years				3 years
Weighted-average discount rate:
Operating leases		2.3		%		2.9		%
Finance leases		11.0		%		16.3		%

Finance Lease, Liability, Maturity [Table Text Block]

As of December 31, 2021, maturities of lease liabilities were as follows:


	Operating Leases			Finance Leases
2022		$	215		$	77
2023		188			59
2024		153			47
2025		113			14
2026		91			—
Thereafter		404			—
Total lease payments		1,164			197
Less-interest		(132)			(41)
Total		$	1,032		$	156

Lessee, Operating Lease, Liability, Maturity [Table Text Block]

As of December 31, 2021, maturities of lease liabilities were as follows:


	Operating Leases			Finance Leases
2022		$	215		$	77
2023		188			59
2024		153			47
2025		113			14
2026		91			—
Thereafter		404			—
Total lease payments		1,164			197
Less-interest		(132)			(41)
Total		$	1,032		$	156

COMMITMENTS AND CONTINGENCIES 9 (Details) - USD ($)	12 Months Ended
COMMITMENTS AND CONTINGENCIES 9 (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Other Matters [Line Items]
Expense Related To UOP Matters	$ 160,000,000	$ 0	$ 0
Petrobras [Member]
Other Matters [Line Items]
Expense Related To UOP Matters	$ 160,000,000

INCOME TAX 4 (Details)	Dec. 31, 2021 USD ($)
Operating Loss Carryforwards [Line Items]
Operating Loss Carryforwards	$ 3,725,000,000
Tax Credit Carryforward, Amount	168,000,000
U.S. Federal \| 2040 [Member]
Operating Loss Carryforwards [Line Items]
Operating Loss Carryforwards	684,000,000
Tax Credit Carryforward, Amount	97,000,000
Foreign Tax Authority [Member] \| Indefinite [Member]
Operating Loss Carryforwards [Line Items]
Operating Loss Carryforwards	2,185,000,000
Tax Credit Carryforward, Amount	0
Foreign Tax Authority [Member] \| Tax Year 2041 [Member]
Operating Loss Carryforwards [Line Items]
Operating Loss Carryforwards	466,000,000
Tax Credit Carryforward, Amount	50,000,000
U.S. State \| 2040 [Member]
Operating Loss Carryforwards [Line Items]
Operating Loss Carryforwards	390,000,000
Tax Credit Carryforward, Amount	$ 21,000,000

SUPPLEMENTAL CASH FLOW INFORMATION (Details) - USD ($) shares in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Apr. 30, 2021
Payments for repositioning and other charges [Abstract]
Severance and exit cost payments	$ (382,000,000)	$ (564,000,000)	$ (249,000,000)
Environmental payments	(210,000,000)	(216,000,000)	(256,000,000)
Reimbursement receipts	140,000,000	176,000,000	292,000,000
Insurance receipts for asbestos related liabilities	46,000,000	58,000,000	68,000,000
Asbestos related liability payments	(286,000,000)	(287,000,000)	(231,000,000)
Net payments for repositioning and other charges	(692,000,000)	(833,000,000)	(376,000,000)
Interest paid, net of amounts capitalized	339,000,000	329,000,000	344,000,000
Income taxes paid, net of refunds	1,202,000,000	1,173,000,000	1,564,000,000
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]
Common stock contributed to savings plans	191,000,000	211,000,000	159,000,000
Marketable securities contributed to non-U.S. pension plans	81,000,000	93,000,000	0
Non-cash adjustment to APIC	460,000,000	0	0
Noncontrolling interest non-cash contribution	419,000,000	0	0
Loan in exchange for prepaid assets	$ 25,000,000	0	0
Receipt of Garrett Series B Preferred Stock		$ 0	$ 0	$ 577,000,000
Investment Owned, Balance, Shares	834.8

INCOME TAXES

12 Months Ended

Dec. 31, 2021

Income Tax Disclosure [Abstract]

Income Taxes

INCOME BEFORE TAXES


	Years Ended December 31,
	2021			2020			2019
U.S.		$	3,955		$	3,318		$	4,178
Non-U.S.		3,280			2,694			3,381
		$	7,235		$	6,012		$	7,559

TAX EXPENSE (BENEFIT)


	Years Ended December 31,
	2021			2020			2019
Tax expense (benefit) consists of
Current:
U.S. Federal		$	415		$	475		$	8
U.S. State		146			79			43
Non-U.S.		886			768			1,099
		$	1,447		$	1,322		$	1,150
Deferred:
U.S. Federal		$	173		$	234		$	332
U.S. State		37			39			63
Non-U.S.		(32)			(448)			(216)
		178			(175)			179
		$	1,625		$	1,147		$	1,329


	Years Ended December 31,
	2021			2020			2019
The U.S. federal statutory income tax rate is reconciled to the effective income tax rate as follows:
U.S. federal statutory income tax rate		21.0	%		21.0	%		21.0	%
Taxes on non-U.S. earnings(1)(2)		(1.4)			(0.8)			(0.5)
U.S. state income taxes(1)		1.5			1.3			1.1
Reserves for tax contingencies		2.2			(2.6)			2.0
Employee share-based payments		(0.7)			(1.2)			(1.2)
Reduction of certain receivables		—			2.0			—
U.S. Tax Cuts and Jobs Act		—			—			(3.6)
Restructuring		(1.4)			—			—
U.S. Valuation Allowance		2.0			0.1			—
All other items—net		(0.7)			(0.7)			(1.2)
		22.5	%		19.1	%		17.6	%

(1)Net of changes in valuation allowance

(2)Includes U.S. taxes on non-U.S. earnings

The effective tax rate increased by 3.4 percentage points in 2021 compared to 2020. The increase was primarily due to the establishment of a valuation allowance for deferred tax assets not expected to be realized, incremental tax reserves, a lower tax benefit from restructuring and the absence of prior year items including tax benefits realized as a result of the favorable resolution of a foreign tax matter related to the spin-off transactions, tax law changes in India and the resolution of certain U.S. tax matters offset by a non-cash charge related to the reduction of the aggregate carrying value of certain receivables with no corresponding tax benefit. The Company’s non-U.S. effective tax rate was 26.0%, an increase of approximately 14.1 percentage points compared to 2020. The increase in the foreign effective tax rate was primarily attributable to incremental tax reserves, the tax impact of restructuring and the absence of prior year items including the favorable resolution of a foreign tax matter related to the previously completed spin-off transactions and tax law changes in India.

The effective tax rate increased by 1.5 percentage points in 2020 compared to 2019. The increase was primarily attributable to accrued withholding taxes related to unremitted foreign earnings and non-cash charges related to the reduction of the aggregate carrying value of certain receivables with no corresponding tax benefit, offset by the favorable resolution of a foreign tax matter related to the previously completed spin-off transactions, tax impact of restructuring, tax law changes in India, and the resolution of certain U.S. tax matters. The Company’s non-U.S. effective tax rate was 11.9%, a decrease of approximately 14.2 percentage points compared to 2019. The decrease in the foreign effective tax rate was primarily attributable to the favorable resolution of a foreign tax matter related to the previously completed spin-off transactions, tax impact of restructuring, and tax law changes in India offset by accrued withholding taxes related to unremitted foreign earnings.

DEFERRED TAX ASSETS (LIABILITIES)

The tax effects of temporary differences and tax carryforwards which give rise to future income tax benefits and payables are as follows:


Deferred tax assets:	December 31,
	2021			2020
Postretirement benefits other than pensions		$	77		$	85
Asbestos and environmental		468			508
Employee compensation and benefits		174			180
Lease liabilities		242			197
Other accruals and reserves		260			110
Net operating and capital losses		734			779
Capital loss limitation and carryover		151			—
Tax credit carryforwards		164			219
Gross deferred tax assets		2,270			2,078
Valuation allowance		(857)			(766)
Total deferred tax assets		$	1,413		$	1,312
Deferred tax liabilities:
Pension		$	(948)		$	(548)
Property, plant and equipment		(464)			(437)
Right-of-use asset		(230)			(184)
Intangibles		(883)			(898)
Unremitted earnings of foreign subsidiaries		(426)			(398)
Other asset basis differences		(334)			(169)
Other		(2)			(31)
Total deferred tax liabilities		(3,287)			(2,665)
Net deferred tax liability		$	(1,874)		$	(1,353)

The Company's gross deferred tax assets include $901 million related to non-U.S. operations comprised principally of net operating losses, capital loss and tax credit carryforwards, primarily in Canada, France, Germany, Luxembourg, and the United Kingdom, and deductible temporary differences. The Company maintains a valuation allowance of $703 million against a portion of the non-U.S. gross deferred tax assets. Additionally, a valuation allowance of $150 million was established against the U.S. gross deferred tax asset for capital losses generated from restructuring transactions during the year. The change in the valuation allowance resulted in an increase of $124 million, increase of $105 million, and a decrease of $23 million to income tax expense in 2021, 2020 and 2019, respectively. In the event the Company determines that it will not be able to realize its net deferred tax assets in the future, the Company will reduce such amounts through an increase to income tax expense in the period such determination is made. Conversely, if the Company determines that it will be able to realize net deferred tax assets in excess of the carrying amounts, the Company will decrease the recorded valuation allowance through a reduction to income tax expense in the period that such determination is made.

As of December 31, 2021, the Company recorded a $426 million deferred tax liability on all unremitted foreign earnings based on estimated earnings and profits of approximately $17.1 billion as of the balance sheet date.

As of December 31, 2021, the Company's net operating loss, capital loss and tax credit carryforwards were as follows:


Jurisdiction	Expiration Period	Net Operating and Capital Loss Carryforwards			Tax Credit Carryforwards
U.S. Federal	2040		$	684		$	97
U.S. State	2040		390			21
Non-U.S.	2041		466			50
Non-U.S.	Indefinite		2,185			—
			$	3,725		$	168

Many jurisdictions impose limitations on the timing and utilization of net operating loss and tax credit carryforwards. In those instances, whereby there is an expected permanent limitation on the utilization of the net operating loss or tax credit carryforward, the deferred tax asset and amount of the carryforward have been reduced.


	Years Ended December 31,
	2021			2020			2019
Change in unrecognized tax benefits:
Balance at beginning of year		$	991		$	1,164		$	1,089
Gross increases related to current period tax positions		93			94			51
Gross increases related to prior periods tax positions		39			68			83
Gross decreases related to prior periods tax positions		(27)			(256)			(34)
Decrease related to resolutions of audits with tax authorities		(1)			(35)			(3)
Expiration of the statute of limitations for the assessment of taxes		(12)			(76)			(13)
Foreign currency translation		(22)			32			(9)
Balance at end of year		$	1,061		$	991		$	1,164

As of December 31, 2021, 2020 and 2019, there were $1,061 million, $991 million, and $1,164 million, respectively, of unrecognized tax benefits that if recognized would be recorded as a component of Tax expense.

The following table summarizes tax years that remain subject to examination by major tax jurisdictions as of December 31, 2021:


Jurisdiction	Open Tax Years Based on Originally Filed Returns
	Examination in progress	Examination not yet initiated
U.S. Federal	2017-2018	2019-2021
U.S. State	2013-2019	2017-2021
Australia	n/a	2018-2021
Canada(1)	2015-2018	2019-2021
China	2011-2020	2021
France	2018-2020	2021
Germany(1)	2009-2018	2019-2021
India	1999-2020	2021
Italy	2012-2018	2019-2021
Netherlands	n/a	2018-2021
Switzerland(1)	2016-2018	2019-2021
United Kingdom	2013-2019	2020-2021

(1)Includes provincial or similar local jurisdictions, as applicable.

Based on the outcome of these examinations, or as a result of the expiration of statute of limitations for specific jurisdictions, it is reasonably possible that certain unrecognized tax benefits for tax positions taken on previously filed tax returns will materially change from those recorded as liabilities in the Company's financial statements. In addition, the outcome of these examinations may impact the valuation of certain deferred tax assets (such as net operating losses) in future periods.

Unrecognized tax benefits for examinations in progress were $592 million, $556 million, and $413 million, as of December 31, 2021, 2020 and 2019, respectively. Estimated interest and penalties related to the underpayment of income taxes are classified as a component of Tax expense in the Consolidated Statement of Operations and totaled $79 million, $80 million, and $73 million for the years ended December 31, 2021, 2020 and 2019, respectively. Accrued interest and penalties were $580 million, $507 million, and $487 million, as of December 31, 2021, 2020 and 2019, respectively.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-URI http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.5.Q1)
-URI http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 270
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI http://asc.fasb.org/topic&trid=2144680

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

+ Details

LONG-TERM DEBT AND CREDIT AGREEMENTS (Details) € in Millions	12 Months Ended
	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)	Dec. 31, 2020 EUR (€)
Debt Instrument [Line Items]
Total long-term debt, including current portion	$ 16,057,000,000	$ 18,787,000,000
Less-current portion	(1,803,000,000)	(2,445,000,000)
Total Long-term debt	14,254,000,000	16,342,000,000
Long-term Debt, Fiscal Year Maturity [Abstract]
2021	1,803,000,000
2022	1,810,000,000
2023	1,344,000,000
2024	1,258,000,000
2025	1,503,000,000
Thereafter	8,339,000,000
Total long-term debt, including current portion	16,057,000,000	18,787,000,000
Less-current portion	(1,803,000,000)	(2,445,000,000)
Total Long-term debt	14,254,000,000	$ 16,342,000,000
The $1.5 Billion 364 Day Credit Agreement [Member]
Line of Credit Facility [Line Items]
Line of credit facility, current borrowing capacity	1,500,000,000
Line of Credit Facility, Remaining Borrowing Capacity	1,500,000,000
Term Loan Agreement [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Remaining Borrowing Capacity	3,000,000,000
0.65% Euro notes due 2020 [Member]
Debt Instrument [Line Items]
Various interest rates		0.65%	0.65%
4.25% notes due 2021 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 0	$ 800,000,000
Various interest rates	4.25%
1.85% notes due 2021 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 0	1,500,000,000
Various interest rates	1.85%
0.483% notes due 2022 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 500,000,000	$ 2,500,000,000
Various interest rates		0.483%	0.483%
Repayments of Debt	2,000,000,000
2.15% notes due 2022 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 600,000,000	$ 600,000,000
Various interest rates	2.15%
Floating Rate Notes Due 2022 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 600,000,000	1,100,000,000
Repayments of Debt	500,000,000
Floating Rate Notes Due 2022 [Member] \| August 19, 2020 (Issuance date of additional Floating Rates Senior Notes due 2022) [Member]
Debt Instrument [Line Items]
Senior Notes		$ 500,000,000
Loans Receivable, Basis Spread on Variable Rate		0.23%	0.23%
1.30% Euro notes due 2023 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 1,416,000,000	$ 1,534,000,000
Various interest rates	1.30%
3.35% notes due 2023 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 300,000,000	300,000,000
Various interest rates	3.35%
0.00% Euro notes due 2024 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 566,000,000	$ 614,000,000	€ 500
Various interest rates		0.00%	0.00%
2.30% notes Due 2024 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 750,000,000	$ 750,000,000
Various interest rates	2.30%
1.350% notes due 2025 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 1,250,000,000	1,250,000,000
Various interest rates	1.35%
2.50% notes due 2026 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 1,500,000,000	1,500,000,000
Various interest rates	2.50%
1.10% notes due 2027 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 1,000,000,000	0
Various interest rates	1.10%
2.25% Euro notes due 2028 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 849,000,000	920,000,000
Various interest rates	2.25%
2.70% notes due 2029 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 750,000,000	750,000,000
Various interest rates	2.70%
1.95% notes due 2030 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 1,000,000,000	$ 1,000,000,000
Various interest rates		1.95%	1.95%
1.75% notes due 2031 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 1,500,000,000	$ 0
Various interest rates	1.75%
0.75% Euro notes due 2032 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 566,000,000	$ 614,000,000	€ 500
Various interest rates		0.75%	0.75%
5.70% notes due 2036 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 441,000,000	$ 441,000,000
Various interest rates	5.70%
5.70% notes due 2037 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 462,000,000	462,000,000
Various interest rates	5.70%
5.375% notes due 2041 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 417,000,000	417,000,000
Various interest rates	5.375%
3.812% notes due 2047 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 445,000,000	445,000,000
Various interest rates	3.812%
2.8% notes due 2050 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 750,000,000	$ 750,000,000
Various interest rates		2.80%	2.80%
Industrial development bond obligations, floating rate maturing at various dates through 2037 [Member]
Debt Instrument [Line Items]
Industrial development bond	22,000,000	$ 22,000,000
6.625% debentures due 2028 [Member]
Debt Instrument [Line Items]
Debentures	$ 201,000,000	201,000,000
Various interest rates	6.625%
9.065% debentures due 2033 [Member]
Debt Instrument [Line Items]
Debentures	$ 51,000,000	51,000,000
Various interest rates	9.065%
Other (including capitalized leases and debt issuance costs), 8.2% weighted average interest rate maturing at various dates through 2026 [Member]
Debt Instrument [Line Items]
Other long term debt	$ 121,000,000	266,000,000
Debt, Weighted Average Interest Rate	8.20%
Notes [Member]
Debt Instrument [Line Items]
Proceeds from Issuance of Long-term Debt	$ 2,500,000,000
Payments of Debt Issuance Costs	18,000,000
The 2022 Callable Notes [Member]
Debt Instrument [Line Items]
Proceeds from Issuance of Long-term Debt		3,000,000,000
Payments of Debt Issuance Costs		10,000,000
The 2020 Notes [Member]
Debt Instrument [Line Items]
Proceeds from Issuance of Long-term Debt		3,000,000,000
Payments of Debt Issuance Costs		27,000,000
The 2020 Euro Notes [Member]
Debt Instrument [Line Items]
Proceeds from Issuance of Long-term Debt		1,100,000,000
Payments of Debt Issuance Costs		9,000,000
Term Loan Due 2022 [Member]
Debt Instrument [Line Items]
Senior Notes		3,000,000,000
Proceeds from Issuance of Long-term Debt		3,000,000,000
Payments of Debt Issuance Costs		7,000,000
Repayments of Debt		$ 3,000,000,000
Loans Receivable, Basis Spread on Variable Rate		1.25%	1.25%
Syndicate Of Banks [Member] \| 5 Year Credit Agreement [Member]
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity	4,500,000,000
Line Of Credit Facility Borrowing Capacity Of Prior Agreement	4,000,000,000
Line of credit facility, current borrowing capacity	4,000,000,000
Line of Credit Facility, Remaining Borrowing Capacity	4,000,000,000
Syndicate Of Banks [Member] \| $1.5B Second 364-Day Credit Agreement [Member]
Line of Credit Facility [Line Items]
Line Of Credit Facility Borrowing Capacity Of Prior Agreement	$ 1,500,000,000
Syndicate Of Banks [Member] \| Term Loan Agreement [Member]
Line of Credit Facility [Line Items]
Line Of Credit Facility Borrowing Capacity Of Prior Agreement		$ 6,000,000,000
Amount of permanent reduction of the Unused Commitments		$ 3,000,000,000

GOODWILL AND OTHER INTANGIBLES-NET

12 Months Ended

Dec. 31, 2021

Goodwill And Other Intangible Assets Net [Abstract]

Goodwill and Other Intangible Assets, Net

The following table summarizes the change in the carrying amount of goodwill for the years ended December 31, 2021 and 2020 by segment.


	December 31, 2020			Acquisitions/ Divestitures			Currency Translation Adjustment			December 31, 2021
Aerospace		$	2,378		$	21		$	—		$	2,399
Honeywell Building Technologies		3,385			20			(88)			3,317
Performance Materials and Technologies		5,255			1,019			(136)			6,138
Safety and Productivity Solutions		5,040			(32)			(47)			4,961
Corporate and All Other		—			943			(2)			941
		$	16,058		$	1,971		$	(273)		$	17,756

Other intangible assets are comprised of:


	December 31, 2021									December 31, 2020
	Gross Carrying Amount			Accumulated Amortization			Net Carrying Amount			Gross Carrying Amount			Accumulated Amortization			Net Carrying Amount
Determinable life intangibles:
Patents and technology		$	2,345		$	(1,678)		$	667		$	2,159		$	(1,595)		$	564
Customer relationships		4,045			(2,235)			1,810			3,889			(2,050)			1,839
Trademarks		356			(261)			95			327			(247)			80
Other		298			(271)			27			298			(267)			31
		7,044			(4,445)			2,599			6,673			(4,159)			2,514
Indefinite life intangibles:
Trademarks		1,014			—			1,014			1,046			—			1,046
		$	8,058		$	(4,445)		$	3,613		$	7,719		$	(4,159)		$	3,560

Intangible assets amortization expense was $465 million, $358 million and $415 million for the years ended December 31, 2021, 2020 and 2019, respectively. Estimated intangible asset amortization expense for each of the next five years approximates $310 million in 2022, $273 million in 2023, $250 million in 2024, $241 million in 2025 and $203 million in 2026.

ACQUISITIONS AND DIVESTITURES	12 Months Ended
ACQUISITIONS AND DIVESTITURES	Dec. 31, 2021
Business Combinations [Abstract]
Acquisitions	ACQUISITIONS AND DIVESTITURES ACQUISITIONS On November 29, 2021, Honeywell Quantum Solutions, a wholly-owned subsidiary of Honeywell, and Cambridge Quantum Computing, a leading developer of quantum computing and quantum software, combined to form Quantinuum. Prior to closing the transaction, Honeywell held a 4.2% ownership interest in Cambridge Quantum Computing. At closing of the business combination, Honeywell contributed an additional $270 million of cash and is the controlling majority-owner of Quantinuum, with an overall 54% ownership in the business. Quantinuum is well positioned to lead the quantum computing industry by offering advanced, fully integrated hardware and software solutions at an unprecedented pace, scale and level of performance to large high-growth markets worldwide. Quantinuum supports customer needs for improved computation in cyber security, drug discovery and delivery, material science, finance, and optimization across all major industrial markets. The business is included within Corporate and All Other, which is not considered a reportable business segment. The combination was accounted for under the acquisition method of accounting; as such, assets and liabilities of Quantinuum are consolidated by Honeywell and included in the Consolidated Balance Sheet. Upon close of the transaction, Honeywell recorded a non-cash adjustment of $460 million in Additional paid-in-capital on the Consolidated Balance Sheet as the contribution of ownership interest in Honeywell Quantum Solutions and Cambridge Quantum Computing for the formation of Quantinuum. In addition, Honeywell recognized a gain of $22 million related to the fair value remeasurement of Honeywell's existing 4.2% ownership interest in Cambridge Quantum Computing, which was recorded in Other (income) expense on in the Consolidated Statement of Operations. At close of the transaction, the fair value of Cambridge Quantum Computing's noncontrolling interest in Quantinuum was $419 million. In December 2021, Cambridge Quantum Computing contributed cash of $12 million to Quantinuum, increasing their noncontrolling interest and decreasing Honeywell's additional-paid-in-capital. As of December 31, 2021, the assets and liabilities in Honeywell's Consolidated Balance Sheet includes $90 million of intangible assets and $943 million allocated to goodwill, which is non-deductible for tax purposes. The purchase accounting is subject to final adjustments, primarily for the valuation of intangible assets and goodwill. On February 12, 2021, the Company acquired 100% of the shares outstanding of Sparta Systems, a leading provider of enterprise quality management software for the life sciences industry, for $1,303 million. Sparta Systems is expected to further strengthen the Company's leadership in industrial automation, digital transformation solutions, and enterprise performance management software. The business is included within the Performance Materials and Technologies segment. The assets and liabilities acquired with Sparta Systems are included in the Consolidated Balance Sheet as of December 31, 2021, including $383 million of intangible assets and $1,011 million allocated to goodwill, which is nondeductible for tax purposes. The purchase accounting is subject to final adjustment, primarily for the valuation of intangible assets, amounts allocated to goodwill, tax balances, and certain pre-acquisition contingencies. During 2020, the Company acquired businesses for an aggregate cost (net of cash and debt assumed) of $261 million, which included the October 2020 acquisition of Rocky Research and the December 2020 acquisition of Sine Group. Rocky Research is a technology leader specializing in thermal, energy and power management solutions and is included within the Aerospace segment. Sine Group offers a Software-as-a-Service (SaaS) that handles visitor management, workplace and supply chain solutions and is included in the Honeywell Building Technologies segment. The acquisition of Rocky Research and Sine Group included approximately $167 million allocated to goodwill, which is non-deductible for tax purposes. During 2019, there were no significant acquisitions that closed individually or in the aggregate. DIVESTITURES On March 15, 2021, the Company completed the sale of its retail footwear business in exchange for gross cash consideration of $230 million. The Company recognized a pre-tax gain of $95 million for the twelve months ended December 31, 2021, which was recorded in Other (income) expense. The retail footwear business was previously included in the Safety and Productivity Solutions segment. During 2020 and 2019, there were no significant divestitures that closed individually or in the aggregate.

STOCK-BASED COMPENSATION PLANS

12 Months Ended

Dec. 31, 2021

Share-based Payment Arrangement [Abstract]

Share-based Payment Arrangement [Text Block]

The 2016 Stock Incentive Plan of Honeywell International Inc. and its Affiliates (2016 Plan) and 2016 Stock Plan for Non-Employee Directors of Honeywell International Inc. (2016 Directors Plan) were both approved by the shareowners at the Annual Meeting of Shareowners effective on April 25, 2016. At December 31, 2021, there were 32,337,638, and 815,299 shares of Honeywell common stock available for future grants under terms of the 2016 Plan and 2016 Directors Plan, respectively.

STOCK OPTIONS

The exercise price, term and other conditions applicable to each option granted under the Company's stock plans are generally determined by the Management Development and Compensation Committee of the Board of Directors. The exercise price of stock options is set on the grant date and may not be less than the fair market value per share of the Company's stock on that date. The fair value is recognized as an expense over the employee’s requisite service period (generally the vesting period of the award). Options generally vest over a four-year period and expire after ten years.

The fair value of each option award is estimated on the date of grant using the Black-Scholes option-pricing model. Expected volatility is based on implied volatilities from traded options on our common stock and historical volatility of the Company's common stock. The Company used a Monte Carlo simulation model to derive an expected term which represents an estimate of the time options are expected to remain outstanding. Such model uses historical data to estimate option exercise activity and post-vest termination behavior. The risk-free rate for periods within the contractual life of the option is based on the U.S. treasury yield curve in effect at the time of grant.

The following table summarizes the impact to the Consolidated Statement of Operations from stock options:


	Years Ended December 31,
	2021			2020			2019
Compensation expense		$	55		$	50		$	47
Future income tax benefit recognized		11			10			10

The following table sets forth fair value per share information, including related weighted-average assumptions, used to determine compensation cost.


	Years Ended December 31,
	2021				2020				2019
Weighted average fair value per share of options granted during the year(1)		$	32.42			$	21.30			$	21.57
Assumptions:
Expected annual dividend yield		2.31		%		2.59		%		2.65		%
Expected volatility		24.69		%		18.76		%		18.40		%
Risk-free rate of return		0.48		%		1.32		%		2.46		%
Expected option term (years)		4.54				4.62				4.87

(1)Estimated on date of grant using Black-Scholes option-pricing model.

The following table summarizes information about stock option activity for the three years ended December 31, 2021:


	Number of Options		Weighted Average Exercise Price
Outstanding at December 31, 2018		22,478,581		$	97.83
Granted		3,136,058		155.43
Exercised		(5,897,060)		84.31
Lapsed or canceled		(986,017)		136.15
Outstanding at December 31, 2019		18,731,562		109.87
Granted		3,192,693		176.93
Exercised		(4,424,754)		88.96
Lapsed or canceled		(930,972)		156.62
Outstanding at December 31, 2020		16,568,529		125.75
Granted		2,065,574		204.99
Exercised		(2,016,489)		113.01
Lapsed or canceled		(764,675)		175.42
Outstanding at December 31, 2021		15,852,939		$	135.31
Vested and expected to vest at December 31, 2021(1)		14,694,701		$	131.08
Exercisable at December 31, 2021		10,664,625		$	113.30

(1)Represents the sum of vested options of 10.7 million and expected to vest options of 4.0 million. Expected to vest options are derived by applying the pre-vesting forfeiture rate assumption to total outstanding unvested options of 5.2 million.

The following table summarizes information about stock options outstanding and exercisable at December 31, 2021:


Range of Exercise Prices	Options Outstanding										Options Exercisable
	Number Outstanding		Weighted Average Life(1)		Weighted Average Exercise Price per share			Aggregate Intrinsic Value			Number Exercisable		Weighted Average Exercise Price per share			Aggregate Intrinsic Value
$27.00–$64.99		90,181		0.17		$	56.97		$	14		90,181		$	56.97		$	14
$65.00–$89.99		2,293,585		1.68		79.39			296			2,293,585		79.39			296
$90.00–$99.99		3,341,048		3.44		98.80			367			3,341,048		98.80			366
$100.00–$134.99		2,435,321		5.04		119.69			216			2,314,755		119.19			214
$135.00–$232.99		7,692,804		7.55		173.71			271			2,625,056		158.14			232
		15,852,939		5.41		$	135.28		$	1,164		10,664,625		$	113.30		$	1,122

(1)Average remaining contractual life in years.

There were 10,120,793 and 11,620,992 options exercisable at weighted average exercise prices of $103.89 and $92.19 at December 31, 2020 and 2019, respectively.

The following table summarizes the financial statement impact from stock options exercised:


Options Exercised	Years Ended December 31,
	2021			2020			2019
Intrinsic value(1)		$	219		$	379		$	483
Tax benefit realized		48			84			117

(1)Represents the amount by which the stock price exceeded the exercise price of the options on the date of exercise.

At December 31, 2021, there was $100 million of total unrecognized compensation cost related to non-vested stock option awards which is expected to be recognized over a weighted-average period of 2.46 years. The total fair value of options vested for the years ended December 31, 2021, 2020 and 2019 was $52 million, $55 million and $61 million, respectively.

RESTRICTED STOCK UNITS

Restricted stock unit (RSU) awards entitle the holder to receive one share of common stock for each unit when the units vest. RSUs are issued to certain key employees and directors as compensation at fair market value at the date of grant. RSUs generally become fully vested over periods ranging from three to six years and are payable in Honeywell common stock upon vesting.

The following table summarizes information about RSU activity for the three years ended December 31, 2021:


	Number of Restricted Stock Units		Weighted Average Grant Date Fair Value Per Share
Non-vested at December 31, 2018		3,657,873		$	125.35
Granted		1,200,202		162.43
Vested		(1,160,333)		104.32
Forfeited		(457,677)		134.50
Non-vested at December 31, 2019		3,240,065		143.07
Granted		1,551,675		158.52
Vested		(1,001,101)		117.84
Forfeited		(394,116)		145.42
Non-vested at December 31, 2020		3,396,523		148.23
Granted		992,854		214.61
Vested		(1,123,547)		144.34
Forfeited		(308,293)		156.74
Non-vested at December 31, 2021		2,957,536		$	171.73

As of December 31, 2021, there was approximately $273 million of total unrecognized compensation cost related to non-vested RSUs granted under the Company's stock plans which is expected to be recognized over a weighted-average period of 2.23 years.

The following table summarizes the impact to the Consolidated Statement of Operations from RSUs:


	Years Ended December 31,
	2021			2020			2019
Compensation expense		$	162		$	118		$	106
Future income tax benefit recognized		23			24			21

OTHER LIABILITIES (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Other Liabilities Disclosure [Abstract]
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	Total other liabilities	Total other liabilities
Other Liabilities, Noncurrent [Abstract]
Income Taxes	$ 2,152	$ 2,009
Pension and other employee related	1,672	1,923
Deferred income	1,324	1,356
Operating lease liabilities	847	641
Environmental	393	435
Insurance	299	280
Product warranties and performance guarantees	43	60
Asset retirement obligations	26	31
Other	331	240
Total other liabilities	$ 7,087	$ 6,975

GEOGRAPHIC AREAS FINANCIAL DATA (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Geographic Areas [Line Items]
Revenue	$ 34,392	$ 32,637	$ 36,709
Long-Lived Assets	5,562	5,570	5,325
UNITED STATES
Geographic Areas [Line Items]
Revenue	20,662	19,665	21,910
Export sales included in United States net sales	4,037	4,000	5,415
Long-Lived Assets	3,964	3,823	3,649
Europe [Member]
Geographic Areas [Line Items]
Revenue	6,800	6,356	7,424
Long-Lived Assets	566	628	579
Other International [Member]
Geographic Areas [Line Items]
Revenue	6,930	6,616	7,375
Long-Lived Assets	$ 1,032	$ 1,119	$ 1,097

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

+ Details

OTHER (INCOME) EXPENSE (Details) - USD ($)	12 Months Ended
OTHER (INCOME) EXPENSE (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Other Income and Expenses [Line Items]
Interest Income	$ (102,000,000)	$ (107,000,000)	$ (255,000,000)
Equity income of affiliated companies	(67,000,000)	(66,000,000)	(52,000,000)
Loss (gain) on sale of non-strategic businesses and assets	(102,000,000)	3,000,000	1,000,000
Foreign exchange	25,000,000	(68,000,000)	(120,000,000)
Expense related to UOP matters	160,000,000	0	0
Reimbursement receivables charge	0	509,000,000	0
Other expense		12,000,000	14,000,000
Other income	(19,000,000)
Other (Income) Expense, Total	(1,378,000,000)	(675,000,000)	(1,065,000,000)
Pension Plan [Member]
Other Income and Expenses [Line Items]
Ongoing income - non-service	(1,202,000,000)	(901,000,000)	(606,000,000)
Other Postretirement Benefit Plans [Member]
Other Income and Expenses [Line Items]
Ongoing income - non-service	$ (71,000,000)	$ (57,000,000)	$ (47,000,000)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Other Assets With Determinable Lives [Line Items]
Research and development expense	$ 1,333	$ 1,334	$ 1,556
Customer-sponsored research and development	1,284	1,200	1,079
Capitalized contract fulfillment costs	1,300	1,300
Capitalized Contract amounts recognized as Cost of products and services sold	100	100	$ 100
Lease liabilities	242	197
Right-of-use-assets	$ 230	$ 184
Minimum [Member]
Other Assets With Determinable Lives [Line Items]
Finite Lived Intangible Assets Estimated Useful Lives	2 years
Maximum [Member]
Other Assets With Determinable Lives [Line Items]
Finite Lived Intangible Assets Estimated Useful Lives	22 years
Building and Building Improvements [Member] \| Minimum [Member]
Property Plant And Equipment Details [Line Items]
Property, plant and equipment, estimated useful lives	10
Building and Building Improvements [Member] \| Maximum [Member]
Property Plant And Equipment Details [Line Items]
Property, plant and equipment, estimated useful lives	50
Machinery and Equipment [Member] \| Minimum [Member]
Property Plant And Equipment Details [Line Items]
Property, plant and equipment, estimated useful lives	3
Machinery and Equipment [Member] \| Maximum [Member]
Property Plant And Equipment Details [Line Items]
Property, plant and equipment, estimated useful lives	16

GOODWILL AND OTHER INTANGIBLES-NET (Tables)

12 Months Ended

Dec. 31, 2021

Goodwill And Other Intangible Assets, Net (Tables) [Abstract]

Schedule of Goodwill [Table Text Block]


	December 31, 2020			Acquisitions/ Divestitures			Currency Translation Adjustment			December 31, 2021
Aerospace		$	2,378		$	21		$	—		$	2,399
Honeywell Building Technologies		3,385			20			(88)			3,317
Performance Materials and Technologies		5,255			1,019			(136)			6,138
Safety and Productivity Solutions		5,040			(32)			(47)			4,961
Corporate and All Other		—			943			(2)			941
		$	16,058		$	1,971		$	(273)		$	17,756

Acquired Finite-Lived Intangible Assets [Table Text Block]


	December 31, 2021									December 31, 2020
	Gross Carrying Amount			Accumulated Amortization			Net Carrying Amount			Gross Carrying Amount			Accumulated Amortization			Net Carrying Amount
Determinable life intangibles:
Patents and technology		$	2,345		$	(1,678)		$	667		$	2,159		$	(1,595)		$	564
Customer relationships		4,045			(2,235)			1,810			3,889			(2,050)			1,839
Trademarks		356			(261)			95			327			(247)			80
Other		298			(271)			27			298			(267)			31
		7,044			(4,445)			2,599			6,673			(4,159)			2,514
Indefinite life intangibles:
Trademarks		1,014			—			1,014			1,046			—			1,046
		$	8,058		$	(4,445)		$	3,613		$	7,719		$	(4,159)		$	3,560

Acquired Indefinite-Lived Intangible Assets [Table Text Block]

Other intangible assets are comprised of:


	December 31, 2021									December 31, 2020
	Gross Carrying Amount			Accumulated Amortization			Net Carrying Amount			Gross Carrying Amount			Accumulated Amortization			Net Carrying Amount
Determinable life intangibles:
Patents and technology		$	2,345		$	(1,678)		$	667		$	2,159		$	(1,595)		$	564
Customer relationships		4,045			(2,235)			1,810			3,889			(2,050)			1,839
Trademarks		356			(261)			95			327			(247)			80
Other		298			(271)			27			298			(267)			31
		7,044			(4,445)			2,599			6,673			(4,159)			2,514
Indefinite life intangibles:
Trademarks		1,014			—			1,014			1,046			—			1,046
		$	8,058		$	(4,445)		$	3,613		$	7,719		$	(4,159)		$	3,560

REPOSITIONING AND OTHER CHARGES 5 (Details) - USD ($)	12 Months Ended
REPOSITIONING AND OTHER CHARGES 5 (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Restructuring Reserve Disclosures [Line Items]
Balance at beginning of period,	$ 601,000,000	$ 651,000,000	$ 566,000,000
Repositioning Charges	331,000,000	565,000,000	438,000,000
Severance and exit cost payments	(382,000,000)	(564,000,000)	(249,000,000)
Usage - noncash	(119,000,000)	(21,000,000)	(100,000,000)
Divestitures	0	0	0
Adjustments	(13,000,000)	(47,000,000)	(5,000,000)
Foreign currency translation	(7,000,000)	17,000,000	1,000,000
Balance at end of period,	411,000,000	601,000,000	651,000,000
Other charges	100,000,000	(20,000,000)	12,000,000
Severance [Member]
Restructuring Reserve Disclosures [Line Items]
Balance at beginning of period,	527,000,000	555,000,000	489,000,000
Repositioning Charges	80,000,000	475,000,000	260,000,000
Severance and exit cost payments	(299,000,000)	(474,000,000)	(186,000,000)
Usage - noncash	0	0	0
Divestitures	0	0	0
Adjustments	(14,000,000)	(44,000,000)	(8,000,000)
Foreign currency translation	(5,000,000)	15,000,000	0
Balance at end of period,	289,000,000	527,000,000	555,000,000
Asset Impairments [Member]
Restructuring Reserve Disclosures [Line Items]
Balance at beginning of period,	0	0	0
Repositioning Charges	117,000,000	21,000,000	95,000,000
Severance and exit cost payments	0	0	0
Usage - noncash	(119,000,000)	(21,000,000)	(100,000,000)
Divestitures	0	0	0
Adjustments	2,000,000	0	5,000,000
Foreign currency translation	0	0	0
Balance at end of period,	0	0	0
Exit costs [Member]
Restructuring Reserve Disclosures [Line Items]
Balance at beginning of period,	74,000,000	96,000,000	77,000,000
Repositioning Charges	134,000,000	69,000,000	83,000,000
Severance and exit cost payments	(83,000,000)	(90,000,000)	(63,000,000)
Usage - noncash	0	0	0
Divestitures	0	0	0
Adjustments	(1,000,000)	(3,000,000)	(2,000,000)
Foreign currency translation	(2,000,000)	2,000,000	1,000,000
Balance at end of period,	$ 122,000,000	$ 74,000,000	$ 96,000,000

CONSOLIDATED BALANCE SHEET - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Assets, Current [Abstract]
Cash and cash equivalents	$ 10,959	$ 14,275
Short-term investments	564	945
Accounts receivable, less allowances	6,830	6,827
Inventories	5,138	4,489
Other current assets	1,881	1,639
Total current assets	25,372	28,175
Investments and long-term receivables	1,222	685
Property, plant and equipment - net	5,562	5,570
Goodwill	17,756	16,058
Other intangible assets - net	3,613	3,560
Insurance recoveries for asbestos related liabilities	322	366
Deferred income taxes	489	760
Other assets	10,134	9,412
Total assets	64,470	64,586
Liabilities, Current [Abstract]
Accounts payable	6,484	5,750
Commercial paper and other short-term borrowings	3,542	3,597
Current maturities of long-term debt	1,803	2,445
Accrued liabilities	7,679	7,405
Total current liabilities	19,508	19,197
Long-term debt	14,254	16,342
Deferred income taxes	2,364	2,113
Postretirement benefit obligations other than pensions	208	242
Asbestos related liabilities	1,800	1,920
Other liabilities	7,087	6,975
Redeemable noncontrolling interest	7	7
SHAREOWNERS' EQUITY [Abstract]
Capital - common stock issued	958	958
Capital - additional paid in capital	8,141	7,292
Common stock held in treasury, at cost	(30,462)	(27,229)
Accumulated other comprehensive income (loss)	(2,895)	(3,377)
Retained earnings	42,827	39,905
Total Honeywell shareowners' equity	18,569	17,549
Noncontrolling interest	673	241
Total shareowners' equity	19,242	17,790
Total liabilities, redeemable noncontrolling interest, and shareowners' equity	$ 64,470	$ 64,586

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) 3 (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Product Sales	$ (34,392,000,000)	$ (32,637,000,000)	$ (36,709,000,000)
Cost of Products and Services Sold	23,394,000,000	22,169,000,000	24,339,000,000
Selling, General and Administrative Expenses	4,798,000,000	4,772,000,000	5,519,000,000
Other (Income) Expense	(1,378,000,000)	(675,000,000)	(1,065,000,000)
Interest and other financial charges	343,000,000	359,000,000	357,000,000
Tax expense (benefit)	1,625,000,000	1,147,000,000	1,329,000,000
Products [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Product Sales	(25,643,000,000)	(24,737,000,000)	(27,629,000,000)
Cost of Products and Services Sold	18,344,000,000	17,638,000,000	19,269,000,000
Services [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Product Sales	(8,749,000,000)	(7,900,000,000)	(9,080,000,000)
Cost of Products and Services Sold	5,050,000,000	4,531,000,000	5,070,000,000
Reclassification out of Accumulated Other Comprehensive Income [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Product Sales	(5,000,000)	3,000,000	(3,000,000)
Selling, General and Administrative Expenses	(9,000,000)	4,000,000	(1,000,000)
Other (Income) Expense	(109,000,000)	(79,000,000)	(42,000,000)
Interest and other financial charges	(16,000,000)	(18,000,000)	(19,000,000)
Total	(149,000,000)	(144,000,000)	(109,000,000)
Tax expense (benefit)	35,000,000	36,000,000	(59,000,000)
Total reclassifications for the period, net of tax	(114,000,000)	(108,000,000)	(168,000,000)
Reclassification out of Accumulated Other Comprehensive Income [Member] \| Products [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of Products and Services Sold	(8,000,000)	(43,000,000)	(35,000,000)
Reclassification out of Accumulated Other Comprehensive Income [Member] \| Services [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of Products and Services Sold	(2,000,000)	(11,000,000)	(9,000,000)
Reclassification out of Accumulated Other Comprehensive Income [Member] \| Losses (gains) on cash flow hedges
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Product Sales	(5,000,000)	3,000,000	(3,000,000)
Selling, General and Administrative Expenses	(9,000,000)	4,000,000	(1,000,000)
Other (Income) Expense	0	(28,000,000)	(73,000,000)
Interest and other financial charges	0	0	0
Total	(24,000,000)	(75,000,000)	(121,000,000)
Reclassification out of Accumulated Other Comprehensive Income [Member] \| Losses (gains) on cash flow hedges \| Products [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of Products and Services Sold	(8,000,000)	(43,000,000)	(35,000,000)
Reclassification out of Accumulated Other Comprehensive Income [Member] \| Losses (gains) on cash flow hedges \| Services [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of Products and Services Sold	(2,000,000)	(11,000,000)	(9,000,000)
Reclassification out of Accumulated Other Comprehensive Income [Member] \| Losses (gains) on excluded component of net investment hedges
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Product Sales	0	0	0
Selling, General and Administrative Expenses	0	0	0
Other (Income) Expense	0	0	0
Interest and other financial charges	(16,000,000)	(18,000,000)	(19,000,000)
Total	(16,000,000)	(18,000,000)	(19,000,000)
Reclassification out of Accumulated Other Comprehensive Income [Member] \| Losses (gains) on excluded component of net investment hedges \| Products [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of Products and Services Sold	0	0	0
Reclassification out of Accumulated Other Comprehensive Income [Member] \| Losses (gains) on excluded component of net investment hedges \| Services [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of Products and Services Sold	0	0	0
Reclassification out of Accumulated Other Comprehensive Income [Member] \| Actuarial losses recognized [Member] \| Amortization of Pension and Other Postretirement Items [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Product Sales	0	0	0
Selling, General and Administrative Expenses	0	0	0
Other (Income) Expense	7,000,000	57,000,000	135,000,000
Interest and other financial charges	0	0	0
Total	7,000,000	57,000,000	135,000,000
Reclassification out of Accumulated Other Comprehensive Income [Member] \| Actuarial losses recognized [Member] \| Amortization of Pension and Other Postretirement Items [Member] \| Products [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of Products and Services Sold	0	0	0
Reclassification out of Accumulated Other Comprehensive Income [Member] \| Actuarial losses recognized [Member] \| Amortization of Pension and Other Postretirement Items [Member] \| Services [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of Products and Services Sold	0	0	0
Reclassification out of Accumulated Other Comprehensive Income [Member] \| Prior service (credit) recognized [Member] \| Amortization of Pension and Other Postretirement Items [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Product Sales	0	0	0
Selling, General and Administrative Expenses	0	0	0
Other (Income) Expense	(116,000,000)	(108,000,000)	(104,000,000)
Interest and other financial charges	0	0	0
Total	(116,000,000)	(108,000,000)	(104,000,000)
Reclassification out of Accumulated Other Comprehensive Income [Member] \| Prior service (credit) recognized [Member] \| Amortization of Pension and Other Postretirement Items [Member] \| Products [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of Products and Services Sold	0	0	0
Reclassification out of Accumulated Other Comprehensive Income [Member] \| Prior service (credit) recognized [Member] \| Amortization of Pension and Other Postretirement Items [Member] \| Services [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of Products and Services Sold	$ 0	$ 0	$ 0

COMMITMENTS AND CONTINGENCIES 8 (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Movement in Standard Product Warranty Accrual [Roll Forward]
Beginning of year	$ 243	$ 269	$ 310
Accruals for warranties/guarantees issued during the year	146	164	173
Adjustment of pre-existing warranties/guarantees	(7)	(18)	(34)
Settlement of warranty/guarantee claims	(159)	(172)	(180)
End of year	223	243	269
Standard Product Warranty Accrual, Balance Sheet Classification [Abstract]
Accrued liabilities	180	183
Other liabilities	43	60
Total Product Warranties and Guarantees Liabilities	$ 223	$ 243	$ 269

SUPPLEMENTAL CASH FLOW INFORMATION

12 Months Ended

Dec. 31, 2021

Supplemental Cash Flow Information [Abstract]

Cash Flow, Supplemental Disclosures [Text Block]


	Years Ended December 31,
	2021			2020			2019
Net payments for repositioning and other charges:
Severance and exit cost payments		$	(382)		$	(564)		$	(249)
Environmental payments		(210)			(216)			(256)
Reimbursement receipts		140			176			292
Insurance receipts for asbestos related liabilities		46			58			68
Asbestos related liability payments		(286)			(287)			(231)
		$	(692)		$	(833)		$	(376)
Interest paid, net of amounts capitalized		$	339		$	329		$	344
Income taxes paid, net of refunds		1,202			1,173			1,564
Non-cash investing and financing activities:
Common stock contributed to savings plans		191			211			159
Marketable securities contributed to non-U.S. pension plans		81			93			—
Impact of Quantinuum contribution(1)		460			—			—
Noncontrolling interest non-cash contribution(1)		419			—			—
Loan in exchange for prepaid assets		25			—			—
Receipt of Garrett Series B Preferred Stock(2)		577			—			—

(1)See Note 2 Acquisitions and Divestitures for additional information for non-cash amounts recognized related to the combination of Honeywell Quantum Solutions and Cambridge Quantum Computing to form Quantinuum, a newly formed entity, Honeywell consolidates as the controlling majority-owner.

(2)See Note 19 Commitments and Contingencies for additional information for non-cash amounts recognized related to the receipt of 834.8 million shares of Garrett Series B Preferred Stock in exchange for the full and final satisfaction of the Garrett Indemnity, Tax Matters Agreement and pending litigation between the Company and Garrett. The non-cash amount reflects the fair value of the Garrett Series B Preferred Stock as of April 30, 2021, the date Garrett issued the Series B Preferred Stock to the Company. See Note 12 for additional information for the fair value determination of the Garrett Series B Preferred Stock.

COMMITMENTS AND CONTINGENCIES 3 (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Loss Contingencies [Line Items]
Insurance recoveries for asbestos related liabilities	$ 322	$ 366
Total assets	363	402	$ 434	$ 477
Accrued liabilities	261	300
Asbestos related liabilities	1,800	1,920
Total liabilities	2,061	2,220	$ 2,357	$ 2,514
NARCO And Bendix Asbestos Related Loss Contingency [Member]
Loss Contingencies [Line Items]
Other current assets	41	36
Insurance recoveries for asbestos related liabilities	322	366
Total assets	363	402
Accrued liabilities	261	300
Asbestos related liabilities	1,800	1,920
Total liabilities	$ 2,061	$ 2,220

LONG-TERM DEBT AND CREDIT AGREEMENTS (Tables)

12 Months Ended

Dec. 31, 2021

Long Term Debt And Credit Agreements Tables [Abstract]

Long-Term Debt and Credit Agreements


	December 31,
	2021			2020

4.25% notes due 2021		$	—	$	800
1.85% notes due 2021		—		1,500
0.483% notes due 2022		500		2,500
2.15% notes due 2022		600		600
Floating rate notes due 2022		600		1,100
1.30% Euro notes due 2023		1,416		1,534
3.35% notes due 2023		300		300
0.00% Euro notes due 2024		566		614
2.30% notes due 2024		750		750
1.35% notes due 2025		1,250		1,250
2.50% notes due 2026		1,500		1,500
1.10% notes due 2027		1,000		—
2.25% Euro notes due 2028		849		920
2.70% notes due 2029		750		750
1.95% notes due 2030		1,000		1,000
1.75% notes due 2031		1,500		—
0.75% Euro notes due 2032		566		614
5.70% notes due 2036		441		441
5.70% notes due 2037		462		462
5.375% notes due 2041		417		417
3.812% notes due 2047		445		445
2.80% notes due 2050		750		750
Industrial development bond obligations, floating rate maturing at various dates through 2037		22		22
6.625% debentures due 2028		201		201
9.065% debentures due 2033		51		51
Other (including capitalized leases and debt issuance costs), 8.2% weighted average interest rate maturing at various dates through 2026		121		266
		16,057		18,787
Less-current portion		(1,803)		(2,445)
		$	14,254	$	16,342

Principal Payments on Long-Term Debt

The schedule of principal payments on long-term debt is as follows:


	December 31, 2021
2022		$	1,803
2023		1,810
2024		1,344
2025		1,258
2026		1,503
Thereafter		8,339
		16,057
Less-current portion		(1,803)
		$	14,254

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 55
-Paragraph 69B
-URI http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 55
-Paragraph 69E
-URI http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644

+ Details

EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Earnings Per Share [Abstract]
Net income attributable to Honeywell	$ 5,542	$ 4,779	$ 6,143
Weighted average shares outstanding	692.3	704.1	721.0
Earnings per share of common stock - basic	$ 8.01	$ 6.79	$ 8.52
Earnings Per Share, Diluted [Abstract]
Net income attributable to Honeywell	$ 5,542	$ 4,779	$ 6,143
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Weighted average shares outstanding	692.3	704.1	721.0
Dilutive securities issuable - stock plans	8.1	7.1	9.3
Total weighted average diluted shares outstanding	700.4	711.2	730.3
Earnings per share of common stock - assuming dilution	$ 7.91	$ 6.72	$ 8.41
Earnings Per Share Paragraph Details [Abstract]
Stock options excluded from diluted computations	1.7	5.5	2.5

LEASES 4 (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Assets and Liabilities [Abstract]
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Accrued Liabilities, Current	Accrued Liabilities, Current
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Other assets	Other assets
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Property, plant and equipment - net	Property, plant and equipment - net
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	Other liabilities	Other liabilities
Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]	Total Long-term debt, Long-term Debt and Lease Obligation, Current	Total Long-term debt, Long-term Debt and Lease Obligation, Current
Operating Lease, Liability, Statement of Financial Position [Extensible List]	Accrued Liabilities, Current, Other liabilities	Accrued Liabilities, Current, Other liabilities
Other assets	$ 947	$ 773
Accrued liabilities	185	187
Other liabilities	847	641
Total operating lease liabilities	1,032	828
Property, plant and equipment	325	357
Accumulated depreciation	(177)	(180)
Property, plant and equipment - net	148	177
Current maturities of long-term debt	57	60
Long-term debt	99	124
Total finance lease liabilities	$ 156	$ 184
Operating Lease, Weighted Average Remaining Lease Term	9 years	7 years
Finance Lease, Weighted Average Remaining Lease Term	3 years	3 years
Lease, Cost [Abstract]
Operating Lease, Weighted Average Discount Rate, Percent	2.30%	2.90%
Finance Lease, Weighted Average Discount Rate, Percent	11.00%	16.30%

SEGMENT FINANCIAL DATA 2 (Details) - USD ($) $ in Millions	12 Months Ended
SEGMENT FINANCIAL DATA 2 (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]
Segment Reporting Segment Profit Loss	$ 7,212	$ 6,665	$ 7,739
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Interest and other financial charges	(343)	(359)	(357)
Repositioning and other charges	(569)	(575)	(546)
Income before taxes	7,235	6,012	7,559
Other Postretirement Benefits [Member]
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Benefit plans income/(expense)	71	58	48
Corporate and All Other [Member]
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]
Segment Reporting Segment Profit Loss	(226)	(96)	(256)
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Repositioning and other charges	(202)	(110)	(241)
Segment Reconciling Items [Member]
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Pension mark-to-market expense	(40)	(44)	(123)
Other income (expense)	38	(349)	360
Interest and other financial charges	(343)	(359)	(357)
Stock compensation expense	(217)	(168)	(153)
Repositioning and other charges	(569)	(575)	(546)
Income before taxes	7,235	6,012	7,559
Segment Reconciling Items [Member] \| Pension Plan [Member]
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Benefit plans income/(expense)	1,083	785	592
Segment Reconciling Items [Member] \| Other Postretirement Benefits [Member]
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Benefit plans income/(expense)	$ 71	$ 57	$ 47

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)

12 Months Ended

Dec. 31, 2021

Accumulated Other Comprehensive Income (Loss) [Abstract]

Accumulated other comprehensive income (loss)


	Pre-tax			Tax			After-Tax
Year Ended December 31, 2021
Foreign exchange translation adjustment		$	302		$	—		$	302
Pensions and other postretirement benefit adjustments		245			(59)			186
Changes in fair value of available for sale investments		(3)			—			(3)
Changes in fair value of designated cash flow hedges		(4)			1			(3)
		$	540		$	(58)		$	482
Year Ended December 31, 2020
Foreign exchange translation adjustment		$	(214)		$	—		$	(214)
Pensions and other postretirement benefit adjustments		76			(2)			74
Changes in fair value of available for sale investments		4			—			4
Changes in fair value of designated cash flow hedges		(61)			17			(44)
		$	(195)		$	15		$	(180)
Year Ended December 31, 2019
Foreign exchange translation adjustment		$	143		$	—		$	143
Pensions and other postretirement benefit adjustments		115			(29)			86
Changes in fair value of designated cash flow hedges		20			(9)			11
		$	278		$	(38)		$	240

COMPONENTS OF ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)


	December 31,
	2021			2020
Cumulative foreign exchange translation adjustment		$	(2,478)		$	(2,780)
Pensions and other postretirement benefit adjustments		(415)			(601)
Fair value adjustments of available for sale investments		1			4
Fair value adjustments of designated cash flow hedges		(3)			—
		$	(2,895)		$	(3,377)

CHANGES IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) BY COMPONENT


	Foreign Exchange Translation Adjustment			Pension and Other Postretirement Adjustments			Changes in Fair Value of Available for Sale Investments			Changes in Fair Value of Cash Flow Hedges			Total
Balance at December 31, 2018		$	(2,709)		$	(761)		$	—		$	33		$	(3,437)
Other comprehensive income (loss) before reclassifications		156			149			—			103			408
Amounts reclassified from accumulated other comprehensive income		(13)			(63)			—			(92)			(168)
Net current period other comprehensive income (loss)		143			86			—			11			240
Balance at December 31, 2019		$	(2,566)		$	(675)		$	—		$	44		$	(3,197)
Other comprehensive income (loss) before reclassifications		(201)			115			4			10			(72)
Amounts reclassified from accumulated other comprehensive income		(13)			(41)			—			(54)			(108)

Net current period other comprehensive income (loss)		(214)			74			4			(44)			(180)
Balance at December 31, 2020		$	(2,780)		$	(601)		$	4		$	—		$	(3,377)
Other comprehensive income (loss) before reclassifications		314			268			(3)			17			596
Amounts reclassified from accumulated other comprehensive income		(12)			(82)			—			(20)			(114)
Net current period other comprehensive income (loss)		302			186			(3)			(3)			482
Balance at December 31, 2021		$	(2,478)		$	(415)		$	1		$	(3)		$	(2,895)

Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]


	Year Ended December 31, 2021
	Affected Line in the Consolidated Statement of Operations
	Net Sales			Cost of Products Sold			Cost of Services Sold			Selling, general and administrative expenses			Other (Income) Expense			Interest and Other Financial Charges			Total
Amortization of Pension and Other Postretirement Items:
Actuarial losses recognized		$	—		$	—		$	—		$	—		$	7		$	—		$	7
Prior service (credit) recognized		—			—			—			—			(116)			—			(116)

Losses (gains) on cash flow hedges		(5)			(8)			(2)			(9)			—			—			(24)
Losses (gains) on excluded component of net investment hedges		—			—			—			—			—			(16)			(16)
Total before tax		$	(5)		$	(8)		$	(2)		$	(9)		$	(109)		$	(16)		$	(149)
Tax expense (benefit)																				35
Total reclassifications for the period, net of tax																				$	(114)


	Year Ended December 31, 2020
	Affected Line in the Consolidated Statement of Operations
	Net Sales			Cost of Products Sold			Cost of Services Sold			Selling, general and administrative expenses			Other (Income) Expense			Interest and Other Financial Charges			Total
Amortization of Pension and Other Postretirement Items:
Actuarial losses recognized		$	—		$	—		$	—		$	—		$	57		$	—		$	57
Prior service (credit) recognized		—			—			—			—			(108)			—			(108)

Losses (gains) on cash flow hedges		3			(43)			(11)			4			(28)			—			(75)
Losses (gains) on excluded component of net investment hedges		—			—			—			—			—			(18)			(18)
Total before tax		$	3		$	(43)		$	(11)		$	4		$	(79)		$	(18)		$	(144)
Tax expense (benefit)																				36
Total reclassifications for the period, net of tax																				$	(108)

PENSION AND OTHER POSTRETIREMENT BENEFITS (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Amounts recognized in Consolidated Balance Sheet [Abstract]
Postretirement benefit obligations other than pensions	$ (208,000,000)	$ (242,000,000)
Other Postretirement Benefits [Member]
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]
Benefit obligation at beginning of year	229,000,000	325,000,000
Service cost	0	0	$ 0
Interest cost	5,000,000	8,000,000	14,000,000
Plan amendments	0	(65,000,000)
Actuarial (gains) losses	(8,000,000)	(8,000,000)
Benefits paid - OPEB	(30,000,000)	(31,000,000)
Benefit obligation at end of year	196,000,000	229,000,000	325,000,000
Defined Benefit Plan, Change in Plan Assets [Roll Forward]
Fair value of plan assets at beginning of year	0	0
Actual return on plan assets	0	0
Company contributions	0	0
Benefits paid - OPEB	0	0
Fair value of plan assets at end of year	0	0	0
Funded status of plans	(196,000,000)	(229,000,000)
Amounts recognized in Consolidated Balance Sheet [Abstract]
Accrued Liabilities - Current	(25,000,000)	(27,000,000)
Postretirement benefit obligations other than pensions	(171,000,000)	(202,000,000)
Net amount recognized	(196,000,000)	(229,000,000)
Foreign plans excluded from postretirement benefits other than pensions	37,000,000	40,000,000
Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract]
Prior service (credit) cost	(92,000,000)	(165,000,000)
Net actuarial (gain) loss	(34,000,000)	(28,000,000)
Net amount recognized	(126,000,000)	(193,000,000)
Defined Benefit Plan Disclosure [Abstract]
Service cost	0	0	0
Interest cost	5,000,000	8,000,000	14,000,000
Amortization of prior service (credit) cost	(74,000,000)	(66,000,000)	(62,000,000)
Recognition of actuarial losses	(2,000,000)	0	0
Net periodic benefit (income) cost	(71,000,000)	(58,000,000)	(48,000,000)
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Income) Loss [Abstract]
Actuarial (gains) losses	(8,000,000)	(8,000,000)	(16,000,000)
Prior service (credit) cost	0	(65,000,000)	(2,000,000)
Prior service credit recognized during year	74,000,000	66,000,000	62,000,000
Actuarial (gains) losses recognized during year	2,000,000	0	0
Total recognized in other comprehensive (income) loss	68,000,000	(7,000,000)	44,000,000
Total recognized in net periodic benefit (income) cost and other comprehensive (income) loss	(3,000,000)	(65,000,000)	(4,000,000)
UNITED STATES
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]
Benefit obligation at beginning of year	18,054,000,000	17,283,000,000
Service cost	105,000,000	99,000,000	82,000,000
Interest cost	306,000,000	461,000,000	613,000,000
Plan amendments	0	0
Actuarial (gains) losses	141,000,000	1,331,000,000
Benefits paid	(1,221,000,000)	(1,100,000,000)
Settlements and curtailments	0	(21,000,000)
Foreign currency translation	0	0
Other	6,000,000	1,000,000
Benefit obligation at end of year	17,391,000,000	18,054,000,000	17,283,000,000
Defined Benefit Plan, Change in Plan Assets [Roll Forward]
Fair value of plan assets at beginning of year	20,396,000,000	18,995,000,000
Actual return on plan assets	1,344,000,000	2,475,000,000
Company contributions	35,000,000	46,000,000
Benefits paid	(1,221,000,000)	(1,100,000,000)
Settlements and curtailments	0	(21,000,000)
Foreign currency translation	0	0
Other	6,000,000	1,000,000
Fair value of plan assets at end of year	20,560,000,000	20,396,000,000	18,995,000,000
Funded status of plans	3,169,000,000	2,342,000,000
Amounts recognized in Consolidated Balance Sheet [Abstract]
Other Assets	3,528,000,000	2,695,000,000
Accrued Liabilities - Current	(33,000,000)	(29,000,000)
Other Liabilities - Noncurrent	(326,000,000)	(324,000,000)
Net amount recognized	3,169,000,000	2,342,000,000
Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract]
Prior service (credit) cost	(92,000,000)	(134,000,000)
Net actuarial (gain) loss	492,000,000	505,000,000
Net amount recognized	400,000,000	371,000,000
Defined Benefit Plan Disclosure [Abstract]
Service cost	105,000,000	99,000,000	82,000,000
Interest cost	306,000,000	461,000,000	613,000,000
Expected return on plan assets	(1,220,000,000)	(1,135,000,000)	(1,117,000,000)
Amortization of prior service (credit) cost	(42,000,000)	(42,000,000)	(42,000,000)
Recognition of actuarial losses	31,000,000	26,000,000	35,000,000
Settlements and curtailments	0	4,000,000	4,000,000
Net periodic benefit (income) cost	(820,000,000)	(587,000,000)	(425,000,000)
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Income) Loss [Abstract]
Actuarial (gains) losses	(14,000,000)	(9,000,000)	(277,000,000)
Prior service (credit) cost	0	0	0
Prior service credit recognized during year	43,000,000	42,000,000	42,000,000
Actuarial (gains) losses recognized during year	0	(30,000,000)	(39,000,000)
Foreign currency translation	0	0	0
Total recognized in other comprehensive (income) loss	29,000,000	3,000,000	(274,000,000)
Total recognized in net periodic benefit (income) cost and other comprehensive (income) loss	(791,000,000)	(584,000,000)	(699,000,000)
Foreign Plan [Member]
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]
Benefit obligation at beginning of year	7,670,000,000	6,897,000,000
Service cost	26,000,000	23,000,000	22,000,000
Interest cost	77,000,000	106,000,000	142,000,000
Plan amendments	(3,000,000)	2,000,000
Actuarial (gains) losses	(403,000,000)	509,000,000
Benefits paid	(249,000,000)	(246,000,000)
Settlements and curtailments	0	0
Foreign currency translation	(121,000,000)	291,000,000
Other	2,000,000	88,000,000
Benefit obligation at end of year	6,999,000,000	7,670,000,000	6,897,000,000
Defined Benefit Plan, Change in Plan Assets [Roll Forward]
Fair value of plan assets at beginning of year	8,450,000,000	7,307,000,000
Actual return on plan assets	166,000,000	918,000,000
Company contributions	101,000,000	116,000,000
Benefits paid	(249,000,000)	(246,000,000)
Settlements and curtailments	0	0
Foreign currency translation	(74,000,000)	253,000,000
Other	2,000,000	102,000,000
Fair value of plan assets at end of year	8,396,000,000	8,450,000,000	7,307,000,000
Funded status of plans	1,397,000,000	780,000,000
Amounts recognized in Consolidated Balance Sheet [Abstract]
Other Assets	2,105,000,000	1,688,000,000
Accrued Liabilities - Current	(14,000,000)	(14,000,000)
Other Liabilities - Noncurrent	(694,000,000)	(894,000,000)
Net amount recognized	1,397,000,000	780,000,000
Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract]
Prior service (credit) cost	20,000,000	23,000,000
Net actuarial (gain) loss	397,000,000	629,000,000
Net amount recognized	417,000,000	652,000,000
Defined Benefit Plan Disclosure [Abstract]
Service cost	26,000,000	23,000,000	22,000,000
Interest cost	77,000,000	106,000,000	142,000,000
Expected return on plan assets	(348,000,000)	(336,000,000)	(331,000,000)
Amortization of prior service (credit) cost	0	0	0
Recognition of actuarial losses	9,000,000	18,000,000	88,000,000
Settlements and curtailments	0	0	0
Net periodic benefit (income) cost	(236,000,000)	(189,000,000)	(79,000,000)
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Income) Loss [Abstract]
Actuarial (gains) losses	(221,000,000)	(73,000,000)	176,000,000
Prior service (credit) cost	(3,000,000)	2,000,000	0
Prior service credit recognized during year	(1,000,000)	0	0
Actuarial (gains) losses recognized during year	(9,000,000)	(18,000,000)	(88,000,000)
Foreign currency translation	(1,000,000)	19,000,000	14,000,000
Total recognized in other comprehensive (income) loss	(235,000,000)	(70,000,000)	102,000,000
Total recognized in net periodic benefit (income) cost and other comprehensive (income) loss	$ (471,000,000)	$ (259,000,000)	$ 23,000,000

GOODWILL AND OTHER INTANGIBLE ASSETS - NET (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Future Amortization Expense - 2021	$ 310,000,000
Future Amortization Expense - 2022	273,000,000
Future Amortization Expense - 2023	250,000,000
Future Amortization Expense - 2024	241,000,000
Future Amortization Expense - 2025	203,000,000
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	7,044,000,000	$ 6,673,000,000
Accumulated Amortization	(4,445,000,000)	(4,159,000,000)
Net Carrying Amount	2,599,000,000	2,514,000,000
Goodwill [Line Items]
Balance at beginning of period,	16,058,000,000
Acquisitions/Divestitures	1,971,000,000
Currency Translation Adjustment	(273,000,000)
Balance at end of period,	17,756,000,000	16,058,000,000
Finite And Indefinite Other Intangible Assets [Abstract]
Trademarks with indefinite lives	1,014,000,000	1,046,000,000
Gross carrying amount	8,058,000,000	7,719,000,000
Accumulated Amortization	(4,445,000,000)	(4,159,000,000)
Net carrying amount	3,613,000,000	3,560,000,000
Goodwill and Intangible Assets Paragraph Details [Abstract]
Amortization of Intangible Assets	465,000,000	358,000,000	$ 415,000,000
Corporate and All Other [Member]
Goodwill [Line Items]
Balance at beginning of period,	0
Acquisitions/Divestitures	943,000,000
Currency Translation Adjustment	(2,000,000)
Balance at end of period,	941,000,000	0
Aerospace [Member]
Goodwill [Line Items]
Balance at beginning of period,	2,378,000,000
Acquisitions/Divestitures	21,000,000
Currency Translation Adjustment	0
Balance at end of period,	2,399,000,000	2,378,000,000
Honeywell Building Technologies [Member]
Goodwill [Line Items]
Balance at beginning of period,	3,385,000,000
Acquisitions/Divestitures	20,000,000
Currency Translation Adjustment	(88,000,000)
Balance at end of period,	3,317,000,000	3,385,000,000
Performance Materials And Technologies [Member]
Goodwill [Line Items]
Balance at beginning of period,	5,255,000,000
Acquisitions/Divestitures	1,019,000,000
Currency Translation Adjustment	(136,000,000)
Balance at end of period,	6,138,000,000	5,255,000,000
Safety And Productivity Solutions [Member]
Goodwill [Line Items]
Balance at beginning of period,	5,040,000,000
Acquisitions/Divestitures	(32,000,000)
Currency Translation Adjustment	(47,000,000)
Balance at end of period,	4,961,000,000	5,040,000,000
Patents and Technology [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	2,345,000,000	2,159,000,000
Accumulated Amortization	(1,678,000,000)	(1,595,000,000)
Net Carrying Amount	667,000,000	564,000,000
Finite And Indefinite Other Intangible Assets [Abstract]
Accumulated Amortization	(1,678,000,000)	(1,595,000,000)
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	4,045,000,000	3,889,000,000
Accumulated Amortization	(2,235,000,000)	(2,050,000,000)
Net Carrying Amount	1,810,000,000	1,839,000,000
Finite And Indefinite Other Intangible Assets [Abstract]
Accumulated Amortization	(2,235,000,000)	(2,050,000,000)
Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	356,000,000	327,000,000
Accumulated Amortization	(261,000,000)	(247,000,000)
Net Carrying Amount	95,000,000	80,000,000
Finite And Indefinite Other Intangible Assets [Abstract]
Accumulated Amortization	(261,000,000)	(247,000,000)
Other Intangible Assets [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	298,000,000	298,000,000
Accumulated Amortization	(271,000,000)	(267,000,000)
Net Carrying Amount	27,000,000	31,000,000
Finite And Indefinite Other Intangible Assets [Abstract]
Accumulated Amortization	$ (271,000,000)	$ (267,000,000)

Statement of Financial Position, Classified (Parentheticals) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Allowance for credit loss	$ 177	$ 202

SUPPLEMENTAL CASH FLOW INFORMATION (Tables)

12 Months Ended

Dec. 31, 2021

Supplemental Cash Flow Information [Abstract]

Supplemental Cash Flow Information


	Years Ended December 31,
	2021			2020			2019
Net payments for repositioning and other charges:
Severance and exit cost payments		$	(382)		$	(564)		$	(249)
Environmental payments		(210)			(216)			(256)
Reimbursement receipts		140			176			292
Insurance receipts for asbestos related liabilities		46			58			68
Asbestos related liability payments		(286)			(287)			(231)
		$	(692)		$	(833)		$	(376)
Interest paid, net of amounts capitalized		$	339		$	329		$	344
Income taxes paid, net of refunds		1,202			1,173			1,564
Non-cash investing and financing activities:
Common stock contributed to savings plans		191			211			159
Marketable securities contributed to non-U.S. pension plans		81			93			—
Impact of Quantinuum contribution(1)		460			—			—
Noncontrolling interest non-cash contribution(1)		419			—			—
Loan in exchange for prepaid assets		25			—			—
Receipt of Garrett Series B Preferred Stock(2)		577			—			—

LEASES

12 Months Ended

Dec. 31, 2021

Leases [Abstract]

Lessee, Operating Leases [Text Block]

A significant portion of the Company's operating and finance lease portfolio includes corporate offices, research and development facilities, manufacturing sites, information technology equipment, and automobiles. The majority of the Company's leases have remaining lease terms of 1 year to 20 years, some of which include options to extend the leases for 5 years or more. Operating lease ROU assets are included in Other assets. The current portion of operating lease liabilities are included in Accrued liabilities, and the non-current portion of operating lease liabilities are included in Other liabilities on the Consolidated Balance Sheet. Finance lease ROU assets are included in Property, plant and equipment—net. The current portion of finance lease liabilities are included in Current maturities of long-term debt, and the non-current portion of finance lease liabilities are included in Long-term debt on the Consolidated Balance Sheet.

A portion of the Company's real estate leases is generally subject to annual changes in the Consumer Price Index (CPI). The changes to the CPI are treated as variable lease payments and recognized in the period in which the obligation for those payments was incurred. In addition, a subset of the Company's automobile leases are considered variable. The variable lease payments for such automobiles leases are based on actual mileage incurred at the stated contractual rate and recognized in the period in which the obligation for those payments was incurred.


	Years Ended December 31,
	2021			2020
Operating lease cost		$	228		$	214
Variable lease cost		14			18
Short-term lease cost		15			17
Finance lease cost:
Amortization of right-of-use assets		65			69
Interest on lease liability		24			27
Total finance lease cost		89			96
Total lease cost		$	346		$	345

Supplemental cash flow information related to leases was as follows:


	Years Ended December 31,
	2021			2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for operating leases		$	215		$	206
Operating cash flows for finance leases		24			32
Financing cash flows for finance leases		67			65
Right-of-use assets obtained in exchange for lease obligations:
Operating leases		$	350		$	245
Finance leases		32			27

Supplemental balance sheet information related to leases was as follows:


	December 31,
	2021				2020
Operating leases:
Other assets		$	947			$	773
Accrued liabilities		185				187
Other liabilities		847				641
Total operating lease liabilities		$	1,032			$	828
Finance leases:
Property, plant and equipment		$	325			$	357
Accumulated depreciation		(177)				(180)
Property, plant and equipment—net		$	148			$	177
Current maturities of long-term debt		$	57			$	60
Long-term debt		99				124
Total finance lease liabilities		$	156			$	184
Weighted-average remaining lease term:
Operating leases	9 years				7 years
Finance leases	3 years				3 years
Weighted-average discount rate:
Operating leases		2.3		%		2.9		%
Finance leases		11.0		%		16.3		%

As of December 31, 2021, maturities of lease liabilities were as follows:


	Operating Leases			Finance Leases
2022		$	215		$	77
2023		188			59
2024		153			47
2025		113			14
2026		91			—
Thereafter		404			—
Total lease payments		1,164			197
Less-interest		(132)			(41)
Total		$	1,032		$	156

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement of Comprehensive Income [Abstract]
Net income	$ 5,610,000,000	$ 4,865,000,000	$ 6,230,000,000
Other Comprehensive Income (Loss), Net Of Tax [Abstract]
Foreign exchange translation adjustment	302,000,000	(211,000,000)	143,000,000
Actuarial gains (losses) recognized	256,000,000	91,000,000	162,000,000
Prior service credit (cost) recognized	7,000,000	47,000,000	1,000,000
Prior service credit recognized during year	(87,000,000)	(82,000,000)	(79,000,000)
Actuarial (gains) losses recognized during year	5,000,000	41,000,000	16,000,000
Foreign exchange translation and other	5,000,000	(23,000,000)	(14,000,000)
Pensions and other postretirement benefit adjustments	186,000,000	74,000,000	86,000,000
Changes in fair value of available for sale investments	(3,000,000)	4,000,000	0
Cash flow hedges recognized in other comprehensive income	17,000,000	10,000,000	103,000,000
Less: Reclassification adjustment for gains (losses) included in net income	20,000,000	54,000,000	92,000,000
Changes in fair value of cash flow hedges	(3,000,000)	(44,000,000)	11,000,000
Other comprehensive income (loss), net of tax	482,000,000	(177,000,000)	240,000,000
Comprehensive income	6,092,000,000	4,688,000,000	6,470,000,000
Less: Comprehensive income attributable to the noncontrolling interest	64,000,000	89,000,000	82,000,000
Comprehensive income attributable to Honeywell	$ 6,028,000,000	$ 4,599,000,000	$ 6,388,000,000

REPOSITIONING AND OTHER CHARGES (Tables)

12 Months Ended

Dec. 31, 2021

Restructuring and Related Activities [Abstract]

Repositioning and other charges text block

A summary of repositioning and other charges follows:


	Years Ended December 31,
	2021			2020			2019
Severance		$	80		$	475		$	260
Asset impairments		117			21			95
Exit costs		134			69			83
Reserve adjustments		(13)			(47)			(5)
Total net repositioning charge		318			518			433
Asbestos related litigation charges, net of insurance and reimbursements		129			50			42
Probable and reasonably estimable environmental liabilities, net of reimbursements		22			27			59
Other charges		100			(20)			12
Total net repositioning and other charges		$	569		$	575		$	546

Pretax distribution of total net repositioning and other charges by income statement classification

The following table summarizes the pre-tax distribution of total net repositioning and other charges by classification in the Consolidated Statement of Operations:


	Years Ended December 31,
	2021			2020			2019
Cost of products and services sold		$	457		$	308		$	276
Selling, general and administrative expenses		112			267			270
Other (income) expense		—			—			—
		$	569		$	575		$	546

Pretax Impact of Total Net Repositioning and Other Charges by Segment

The following table summarizes the pre-tax amount of total net repositioning and other charges by segment. These amounts are excluded from segment profit as described in Note 22 Segment Financial Data.


	Years Ended December 31,
	2021			2020			2019
Aerospace		$	62		$	157		$	33
Honeywell Building Technologies		13			100			108
Performance Materials and Technologies		24			167			93
Safety and Productivity Solutions		268			41			71
Corporate and All Other		202			110			241
		$	569		$	575		$	546

Total Repositioning Reserves

The following table summarizes the status of the Company's total repositioning reserves:


	Severance Costs			Asset Impairments			Exit Costs			Total
Balance at December 31, 2018		$	489		$	—		$	77		$	566
Charges		260			95			83			438
Usage—cash		(186)			—			(63)			(249)
Usage—noncash		—			(100)			—			(100)
Divestitures		—			—			—			—
Adjustments		(8)			5			(2)			(5)
Foreign currency translation		—			—			1			1
Balance at December 31, 2019		555			—			96			651
Charges		475			21			69			565
Usage—cash		(474)			—			(90)			(564)
Usage—noncash		—			(21)			—			(21)
Divestitures		—			—			—			—
Adjustments		(44)			—			(3)			(47)
Foreign currency translation		15			—			2			17
Balance at December 31, 2020		527			—			74			601
Charges		80			117			134			331
Usage—cash		(299)			—			(83)			(382)
Usage—noncash		—			(119)			—			(119)
Divestitures		—			—			—			—
Adjustments		(14)			2			(1)			(13)
Foreign currency translation		(5)			—			(2)			(7)
Balance at December 31, 2021		$	289		$	—		$	122		$	411

INVENTORIES

12 Months Ended

Dec. 31, 2021

Inventory Disclosure [Abstract]

Inventories


	December 31,
	2021			2020
Raw materials		$	1,352		$	1,079
Work in process		861			798
Finished products		2,925			2,612
		$	5,138		$	4,489

LONG-TERM DEBT AND CREDIT AGREEMENTS

12 Months Ended

Dec. 31, 2021

Long Term Debt And Credit Agreements [Abstract]

Long-term Debt and Credit Agreements

LONG-TERM DEBT AND CREDIT AGREEMENTS


	December 31,
	2021			2020

4.25% notes due 2021		$	—	$	800
1.85% notes due 2021		—		1,500
0.483% notes due 2022		500		2,500
2.15% notes due 2022		600		600
Floating rate notes due 2022		600		1,100
1.30% Euro notes due 2023		1,416		1,534
3.35% notes due 2023		300		300
0.00% Euro notes due 2024		566		614
2.30% notes due 2024		750		750
1.35% notes due 2025		1,250		1,250
2.50% notes due 2026		1,500		1,500
1.10% notes due 2027		1,000		—
2.25% Euro notes due 2028		849		920
2.70% notes due 2029		750		750
1.95% notes due 2030		1,000		1,000
1.75% notes due 2031		1,500		—
0.75% Euro notes due 2032		566		614
5.70% notes due 2036		441		441
5.70% notes due 2037		462		462
5.375% notes due 2041		417		417
3.812% notes due 2047		445		445
2.80% notes due 2050		750		750
Industrial development bond obligations, floating rate maturing at various dates through 2037		22		22
6.625% debentures due 2028		201		201
9.065% debentures due 2033		51		51
Other (including capitalized leases and debt issuance costs), 8.2% weighted average interest rate maturing at various dates through 2026		121		266
		16,057		18,787
Less-current portion		(1,803)		(2,445)
		$	14,254	$	16,342

The schedule of principal payments on long-term debt is as follows:


	December 31, 2021
2022		$	1,803
2023		1,810
2024		1,344
2025		1,258
2026		1,503
Thereafter		8,339
		16,057
Less-current portion		(1,803)
		$	14,254

On November 1, 2021, the Company repaid its 1.85% notes due 2021.

On August 16, 2021 the Company issued $1.0 billion 1.10% Senior Notes due 2027 and $1.5 billion 1.75% Senior Notes due 2031 (collectively, the Notes). The Company may redeem the Notes at any time, and from time to time, in whole or in part, at the Company's option at the applicable make-whole redemption price. The Notes are senior unsecured and unsubordinated obligations of the Company and rank equally with each other and with all of the Company's existing and future senior unsecured debt and senior to all of the Company's subordinated debt. The offering provided gross proceeds of $2.5 billion, offset by $18.0 million in discount and closing costs related to the offering. The Company used the proceeds of the offering to redeem at par $2 billion of the $2.5 billion in outstanding principal amount of the callable 0.483% Senior Notes due 2022 and to redeem in full and at par $500 million callable Floating rate Senior Notes due 2022 that the Company issued in August 2020.

On March 31, 2021, the Company entered into a $4.0 billion Amended and Restated Five Year Credit Agreement (the 5-Year Credit Agreement) and a $1.5 billion 364-Day Credit Agreement (the 364-Day Credit Agreement). The 5-Year Credit Agreement amended and restated the previously reported $4.0 billion amended and restated five-year credit agreement dated as of April 26, 2019. Commitments under the 5-Year Credit Agreement can be increased pursuant to the terms of the 5-Year Credit Agreement to an aggregate amount not to exceed $4.5 billion. The 364-Day Credit Agreement replaced the $1.5 billion 364-day credit agreement dated as of April 10, 2020, which was terminated in accordance with its terms effective March 31, 2021. Amounts borrowed under the 364-Day Credit Agreement are required to be repaid no later than March 30, 2022, unless (i) Honeywell elects to convert all then outstanding amounts into a term loan, upon which such amounts shall be repaid in full on March 30, 2023, or (ii) the 364-Day Credit Agreement is terminated earlier pursuant to its terms. The 5-Year Credit Agreement and the 364-Day Credit Agreement are maintained for general corporate purposes. On November 18, 2021, the Company amended the 364-Day Credit Agreement and the 5-Year Credit Agreement to transition from LIBOR-based benchmark rates to the appropriate replacement rates.

On March 1, 2021, the Company repaid its 4.25% notes due 2021.

As of December 31, 2021, there were no outstanding borrowings under the 364-Day Credit Agreement or 5-Year Credit Agreement.

On August 19, 2020, the Company issued $2.5 billion 0.483% Senior Notes due 2022 and $500 million Floating Rate Senior Notes due 2022 (collectively, the 2022 Callable Notes). The $500 million Floating Rate Senior Notes due 2022 were issued at a variable interest rate equal to the three-month LIBOR plus the applicable margin of 0.23%. The Company may redeem the 2022 fixed rate notes at any time, in whole or in part, at the Company's option. The Company may redeem the 2022 floating rate notes at any time, in whole or in part, on or after August 19, 2021. The 2022 Callable Notes resulted in gross proceeds of $3.0 billion, offset by $10 million in discount and closing costs related to the offering. The Company used the proceeds of the offering to repay $3.0 billion of borrowings under the Term Loan Agreement (defined below).

On May 18, 2020, the Company issued $1.25 billion 1.35% Senior Notes due 2025, $1.0 billion 1.95% Senior Notes due 2030, and $750 million 2.80% Senior Notes due 2050 (collectively, the 2020 Notes) to replace and, accordingly, permanently reduce $3.0 billion of undrawn commitments under the Term Loan Agreement, referenced below. The Company may redeem the 2020 Notes at any time, in whole or in part, at the Company's option. The offering provided gross proceeds of $3.0 billion, offset by $27 million in discount and closing costs related to the offering.

On March 10, 2020, the Company issued €500 million 0.00% Senior Notes due 2024 and €500 million 0.75% Senior Notes due 2032 (collectively, the 2020 Euro Notes). The offering provided gross proceeds of $1.1 billion, offset by $9 million in discount and closing costs related to the offering.

The 2022 Callable Notes, 2020 Notes, and 2020 Euro Notes are senior unsecured and unsubordinated obligations of the Company and rank equally with each other and with all of the Company's existing and future senior unsecured debt and senior to all of the Company's subordinated debt.

On March 26, 2020, the Company entered into a Delayed Draw Term Loan Agreement (the Term Loan Agreement) with a syndicate of banks. The Term Loan Agreement provided for a two-year, delayed draw term loan facility in the aggregate principal amount of $6.0 billion. Effective May 22, 2020, the Company permanently reduced the undrawn commitments under the Term Loan Agreement by an aggregate amount of $3.0 billion. On June 24, 2020, the Company drew on the remaining $3.0 billion of commitments under the Term Loan Agreement at a variable interest rate equal to the one-month LIBOR plus the applicable margin of 1.25%. The draw provided gross proceeds of $3.0 billion, offset by $7 million in closing costs related to the borrowing. On August 20, 2020, the Company prepaid the outstanding principal amount of $3.0 billion, using the proceeds from the offering of the 2022 Callable Notes.On February 21, 2020, the Company paid its 0.65% Euro notes due 2020.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-URI http://asc.fasb.org/topic&trid=2208564

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1E
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

+ Details

SEGMENT FINANCIAL DATA

12 Months Ended

Dec. 31, 2021

Segment Reporting [Abstract]

Segment Financial Data

Honeywell globally manages its business operations through four reportable operating segments. Segment information is consistent with how management reviews the businesses, makes investing and resource allocation decisions, and assesses operating performance.

Honeywell’s senior management evaluates segment performance based on segment profit. Each segment’s profit is measured as segment income (loss) before taxes excluding general corporate unallocated expense, interest and other financial charges, stock compensation expense, pension and other postretirement income (expense), repositioning and other charges, and other items within Other (income) expense.


	Years Ended December 31,
	2021			2020			2019
Net Sales
Aerospace
Products		$	6,158		$	7,194		$	8,766
Services		4,868			4,350			5,288
Total		11,026			11,544			14,054
Honeywell Building Technologies
Products		4,098			3,868			4,395
Services		1,441			1,321			1,322
Total		5,539			5,189			5,717
Performance Materials and Technologies
Products		8,008			7,548			8,732
Services		2,005			1,875			2,102
Total		10,013			9,423			10,834
Safety and Productivity Solutions
Products		7,379			6,127			5,736
Services		435			354			368
Total		7,814			6,481			6,104
Corporate and All Other
Services		—			—			—
Total		—			—			—
		$	34,392		$	32,637		$	36,709
Depreciation and amortization
Aerospace		$	278		$	241		$	234
Honeywell Building Technologies		67			55			63
Performance Materials and Technologies		454			440			493
Safety and Productivity Solutions		237			223			222
Corporate and All Other		102			44			76
		$	1,138		$	1,003		$	1,088
Segment Profit
Aerospace		$	3,051		$	2,904		$	3,607
Honeywell Building Technologies		1,238			1,099			1,165
Performance Materials and Technologies		2,120			1,851			2,433
Safety and Productivity Solutions		1,029			907			790
Corporate and All Other		(226)			(96)			(256)
		$	7,212		$	6,665		$	7,739


	Years Ended December 31,
	2021			2020			2019
Capital expenditures
Aerospace		$	284		$	248		$	272
Honeywell Building Technologies		62			66			43
Performance Materials and Technologies		265			252			314
Safety and Productivity Solutions		190			288			82
Corporate and All Other		94			52			128
		$	895		$	906		$	839
Total Assets
Aerospace		$	11,490		$	11,035		$	11,378
Honeywell Building Technologies		6,543			6,351			5,968
Performance Materials and Technologies		18,021			16,772			16,888
Safety and Productivity Solutions		11,242			10,640			9,888
Corporate and All Other		17,174			19,788			14,557
		$	64,470		$	64,586		$	58,679

A reconciliation of segment profit to consolidated income before taxes are as follows:


	Years Ended December 31,
	2021			2020			2019
Segment Profit		$	7,212		$	6,665		$	7,739
Interest and other financial charges		(343)			(359)			(357)
Stock compensation expense(1)		(217)			(168)			(153)
Pension ongoing income (expense)(2)		1,083			785			592
Pension mark-to-market expense		(40)			(44)			(123)
Other postretirement income(2)		71			57			47
Repositioning and other charges(3)		(569)			(575)			(546)
Other(4)		38			(349)			360
Income before taxes		$	7,235		$	6,012		$	7,559

(1)Amounts included in Selling, general and administrative expenses.

(2)Amounts included in Cost of products and services sold and Selling, general and administrative expenses (service cost component) and Other (income) expense (non-service cost component).

(3)Amounts included in Cost of products and services sold, Selling, general and administrative expenses, and Other (income) expense.

(4)Amounts include the other components of Other (income) expense not included within other categories in this reconciliation. Equity income of affiliated companies is included in segment profit.

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI http://asc.fasb.org/topic&trid=2134510

+ Details

DERIVATIVE INSTRUMENTS AND HEDGING TRANSACTIONS (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Derivative [Line Items]
Notional		$ 17,021,000,000	$ 21,273,000,000
Fair Value Asset		473,000,000	396,000,000
Fair value (Liability)		(282,000,000)	(200,000,000)
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax		(114,000,000)	(108,000,000)	$ (168,000,000)
Foreign Exchange Forward [Member]
Derivative [Line Items]
Notional		12,671,000,000	16,123,000,000
Amount of hedged item		4,074,000,000	4,414,000,000
Foreign Exchange Forward [Member] \| Forecast [Member]
Derivative [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	$ 10,000,000
Designated as Hedging Instrument [Member]
Derivative [Line Items]
Notional		5,743,000,000	6,444,000,000
Fair Value Asset		195,000,000	304,000,000
Fair value (Liability)		0	(109,000,000)
Designated as Hedging Instrument [Member] \| Derivatives in Fair Value Hedging Relationships [Member] \| Interest rate swap agreements [Member]
Derivative [Line Items]
Notional		3,150,000,000	3,950,000,000
Fair Value Asset		60,000,000	194,000,000
Fair value (Liability)		0	0
Designated as Hedging Instrument [Member] \| Derivatives in Cash Flow Hedging Relationships [Member] \| Foreign Currency Exchange Contracts [Member]
Derivative [Line Items]
Notional		647,000,000	488,000,000
Fair Value Asset		4,000,000	65,000,000
Fair value (Liability)		0	(58,000,000)
Designated as Hedging Instrument [Member] \| Derivatives in Net Investment Hedging Relationships [Member] \| Foreign Currency Exchange Contracts [Member]
Derivative [Line Items]
Notional		746,000,000	806,000,000
Fair Value Asset		92,000,000	45,000,000
Fair value (Liability)		0	(1,000,000)
Designated as Hedging Instrument [Member] \| Derivatives in Net Investment Hedging Relationships [Member] \| Cross currency swap agreements [Member]
Derivative [Line Items]
Notional		1,200,000,000	1,200,000,000
Fair Value Asset		39,000,000	0
Fair value (Liability)		0	(50,000,000)
Derivatives Not Designated as Hedging Instruments [Member] \| Foreign Currency Exchange Contracts [Member]
Derivative [Line Items]
Notional		11,278,000,000	14,829,000,000
Fair Value Asset		278,000,000	92,000,000
Fair value (Liability)		$ (282,000,000)	$ (91,000,000)

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

12 Months Ended

Dec. 31, 2021

Accumulated Other Comprehensive Income (Loss) [Abstract]

Comprehensive Income (Loss) Note [Text Block]

The changes in Accumulated other comprehensive income (loss) are provided in the tables below. Comprehensive income (loss) attributable to noncontrolling interest consists predominantly of net income.


	Pre-tax			Tax			After-Tax
Year Ended December 31, 2021
Foreign exchange translation adjustment		$	302		$	—		$	302
Pensions and other postretirement benefit adjustments		245			(59)			186
Changes in fair value of available for sale investments		(3)			—			(3)
Changes in fair value of designated cash flow hedges		(4)			1			(3)
		$	540		$	(58)		$	482
Year Ended December 31, 2020
Foreign exchange translation adjustment		$	(214)		$	—		$	(214)
Pensions and other postretirement benefit adjustments		76			(2)			74
Changes in fair value of available for sale investments		4			—			4
Changes in fair value of designated cash flow hedges		(61)			17			(44)
		$	(195)		$	15		$	(180)
Year Ended December 31, 2019
Foreign exchange translation adjustment		$	143		$	—		$	143
Pensions and other postretirement benefit adjustments		115			(29)			86
Changes in fair value of designated cash flow hedges		20			(9)			11
		$	278		$	(38)		$	240

COMPONENTS OF ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)


	December 31,
	2021			2020
Cumulative foreign exchange translation adjustment		$	(2,478)		$	(2,780)
Pensions and other postretirement benefit adjustments		(415)			(601)
Fair value adjustments of available for sale investments		1			4
Fair value adjustments of designated cash flow hedges		(3)			—
		$	(2,895)		$	(3,377)

CHANGES IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) BY COMPONENT


	Foreign Exchange Translation Adjustment			Pension and Other Postretirement Adjustments			Changes in Fair Value of Available for Sale Investments			Changes in Fair Value of Cash Flow Hedges			Total
Balance at December 31, 2018		$	(2,709)		$	(761)		$	—		$	33		$	(3,437)
Other comprehensive income (loss) before reclassifications		156			149			—			103			408
Amounts reclassified from accumulated other comprehensive income		(13)			(63)			—			(92)			(168)
Net current period other comprehensive income (loss)		143			86			—			11			240
Balance at December 31, 2019		$	(2,566)		$	(675)		$	—		$	44		$	(3,197)
Other comprehensive income (loss) before reclassifications		(201)			115			4			10			(72)
Amounts reclassified from accumulated other comprehensive income		(13)			(41)			—			(54)			(108)

Net current period other comprehensive income (loss)		(214)			74			4			(44)			(180)
Balance at December 31, 2020		$	(2,780)		$	(601)		$	4		$	—		$	(3,377)
Other comprehensive income (loss) before reclassifications		314			268			(3)			17			596
Amounts reclassified from accumulated other comprehensive income		(12)			(82)			—			(20)			(114)
Net current period other comprehensive income (loss)		302			186			(3)			(3)			482
Balance at December 31, 2021		$	(2,478)		$	(415)		$	1		$	(3)		$	(2,895)

RECLASSIFICATIONS OUT OF ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)


	Year Ended December 31, 2021
	Affected Line in the Consolidated Statement of Operations
	Net Sales			Cost of Products Sold			Cost of Services Sold			Selling, general and administrative expenses			Other (Income) Expense			Interest and Other Financial Charges			Total
Amortization of Pension and Other Postretirement Items:
Actuarial losses recognized		$	—		$	—		$	—		$	—		$	7		$	—		$	7
Prior service (credit) recognized		—			—			—			—			(116)			—			(116)

Losses (gains) on cash flow hedges		(5)			(8)			(2)			(9)			—			—			(24)
Losses (gains) on excluded component of net investment hedges		—			—			—			—			—			(16)			(16)
Total before tax		$	(5)		$	(8)		$	(2)		$	(9)		$	(109)		$	(16)		$	(149)
Tax expense (benefit)																				35
Total reclassifications for the period, net of tax																				$	(114)


	Year Ended December 31, 2020
	Affected Line in the Consolidated Statement of Operations
	Net Sales			Cost of Products Sold			Cost of Services Sold			Selling, general and administrative expenses			Other (Income) Expense			Interest and Other Financial Charges			Total
Amortization of Pension and Other Postretirement Items:
Actuarial losses recognized		$	—		$	—		$	—		$	—		$	57		$	—		$	57
Prior service (credit) recognized		—			—			—			—			(108)			—			(108)

Losses (gains) on cash flow hedges		3			(43)			(11)			4			(28)			—			(75)
Losses (gains) on excluded component of net investment hedges		—			—			—			—			—			(18)			(18)
Total before tax		$	3		$	(43)		$	(11)		$	4		$	(79)		$	(18)		$	(144)
Tax expense (benefit)																				36
Total reclassifications for the period, net of tax																				$	(108)

STOCK-BASED COMPENSATION PLANS (Details) - 2016 Plan [Member] - Share-based Payment Arrangement, Option [Member] - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Weighted average fair value per share of options granted during the year	$ 32.42	$ 21.30	$ 21.57
Expected annual dividend yield	2.31%	2.59%	2.65%
Expected volatility	24.69%	18.76%	18.40%
Risk-free rate of return	0.48%	1.32%	2.46%
Expected option term (years)	4 years 6 months 14 days	4 years 7 months 13 days	4 years 10 months 13 days
Stock Options Number of Options [Abstract]
Outstanding at beginning of period,	16,568,529	18,731,562	22,478,581
Granted	2,065,574	3,192,693	3,136,058
Exercised	(2,016,489)	(4,424,754)	(5,897,060)
Lapsed or Canceled	(764,675)	(930,972)	(986,017)
Outstanding at end of period,	15,852,939	16,568,529	18,731,562
Vested and Expected to Vest at December 31,	14,694,701
Exercisable at December 31,	10,664,625	10,120,793	11,620,992
Options Activity Footnote [Abstract]
Vested options	10,700,000
Options expected to vest	4,000,000
Outstanding unvested options	5,200,000
Stock Options Weighted Average Exercise Price [Abstract]
Outstanding at beginning of period,	$ 125.75	$ 109.87	$ 97.83
Granted	204.99	176.93	155.43
Exercised	113.01	88.96	84.31
Lapsed or Canceled	175.42	156.62	136.15
Outstanding at end of period,	135.31	125.75	109.87
Vested and Expected to Vest at December 31,	131.08
Exercisable at December 31,	$ 113.30	$ 103.89	$ 92.19
Income Statement Impact From Stock Options [Abstract]
Compensation expense	$ 55	$ 50	$ 47
Future income tax benefit recognized	$ 11	$ 10	$ 10

SEGMENT FINANCIAL DATA (Tables)

12 Months Ended

Dec. 31, 2021

Segment Reporting [Abstract]

Segment Financial Data


	Years Ended December 31,
	2021			2020			2019
Net Sales
Aerospace
Products		$	6,158		$	7,194		$	8,766
Services		4,868			4,350			5,288
Total		11,026			11,544			14,054
Honeywell Building Technologies
Products		4,098			3,868			4,395
Services		1,441			1,321			1,322
Total		5,539			5,189			5,717
Performance Materials and Technologies
Products		8,008			7,548			8,732
Services		2,005			1,875			2,102
Total		10,013			9,423			10,834
Safety and Productivity Solutions
Products		7,379			6,127			5,736
Services		435			354			368
Total		7,814			6,481			6,104
Corporate and All Other
Services		—			—			—
Total		—			—			—
		$	34,392		$	32,637		$	36,709
Depreciation and amortization
Aerospace		$	278		$	241		$	234
Honeywell Building Technologies		67			55			63
Performance Materials and Technologies		454			440			493
Safety and Productivity Solutions		237			223			222
Corporate and All Other		102			44			76
		$	1,138		$	1,003		$	1,088
Segment Profit
Aerospace		$	3,051		$	2,904		$	3,607
Honeywell Building Technologies		1,238			1,099			1,165
Performance Materials and Technologies		2,120			1,851			2,433
Safety and Productivity Solutions		1,029			907			790
Corporate and All Other		(226)			(96)			(256)
		$	7,212		$	6,665		$	7,739


	Years Ended December 31,
	2021			2020			2019
Capital expenditures
Aerospace		$	284		$	248		$	272
Honeywell Building Technologies		62			66			43
Performance Materials and Technologies		265			252			314
Safety and Productivity Solutions		190			288			82
Corporate and All Other		94			52			128
		$	895		$	906		$	839
Total Assets
Aerospace		$	11,490		$	11,035		$	11,378
Honeywell Building Technologies		6,543			6,351			5,968
Performance Materials and Technologies		18,021			16,772			16,888
Safety and Productivity Solutions		11,242			10,640			9,888
Corporate and All Other		17,174			19,788			14,557
		$	64,470		$	64,586		$	58,679

Reconciliation of Operating Profit Loss From Segments to Consolidated

A reconciliation of segment profit to consolidated income before taxes are as follows:


	Years Ended December 31,
	2021			2020			2019
Segment Profit		$	7,212		$	6,665		$	7,739
Interest and other financial charges		(343)			(359)			(357)
Stock compensation expense(1)		(217)			(168)			(153)
Pension ongoing income (expense)(2)		1,083			785			592
Pension mark-to-market expense		(40)			(44)			(123)
Other postretirement income(2)		71			57			47
Repositioning and other charges(3)		(569)			(575)			(546)
Other(4)		38			(349)			360
Income before taxes		$	7,235		$	6,012		$	7,559

(1)Amounts included in Selling, general and administrative expenses.

(2)Amounts included in Cost of products and services sold and Selling, general and administrative expenses (service cost component) and Other (income) expense (non-service cost component).

(3)Amounts included in Cost of products and services sold, Selling, general and administrative expenses, and Other (income) expense.

(4)Amounts include the other components of Other (income) expense not included within other categories in this reconciliation. Equity income of affiliated companies is included in segment profit.

FAIR VALUE MEASUREMENTS (Tables)

12 Months Ended

Dec. 31, 2021

Fair Value Disclosures [Abstract]

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

The following table sets forth the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis:


	December 31,
	2021			2020
Assets:
Foreign currency exchange contracts		$	374		$	202
Available for sale investments		742			1,118
Interest rate swap agreements		60			194
Cross currency swap agreements		39			—
Investments in equity securities		57			11
Liabilities:
Foreign currency exchange contracts		$	282		$	150

Cross currency swap agreements		—			50

Fair Value, by Balance Sheet Grouping [Table Text Block]

The following table sets forth the Company’s financial assets and liabilities that were not carried at fair value:


	December 31, 2021						December 31, 2020
	Carrying Value			Fair Value			Carrying Value			Fair Value
Assets:
Short-term investment		$	34		$	34		$	—		$	—
Long-term receivables		170			152			137			132
Long-term investment		366			366			—			—
Liabilities:
Long-term debt and related current maturities		$	16,057		$	17,022		$	18,787		$	20,176

INVENTORIES (Tables)

12 Months Ended

Dec. 31, 2021

Inventory Disclosure [Abstract]

Inventories


	December 31,
	2021			2020
Raw materials		$	1,352		$	1,079
Work in process		861			798
Finished products		2,925			2,612
		$	5,138		$	4,489

CAPITAL STOCK (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021
Capital Stock Paragraph Details [Abstract]
Preferred Stock, Shares Authorized		40,000,000
Common Stock [Member]
Equity, Class of Treasury Stock [Line Items]
Common Stock, Shares Authorized		2,000,000,000
Common Shares par value		$ 1
Treasury Stock [Member]
Equity, Class of Treasury Stock [Line Items]
Stock Repurchase Program Remaining Authorized Repurchase Amount	$ 3,300	$ 7,100
Stock Repurchased During Period Shares	(20,700,000)
Reacquired stock or repurchases of common stock	$ 3,714
Treasury Stock [Member] \| April 2019 [Member]
Equity, Class of Treasury Stock [Line Items]
Authorized Amount Of Common Stock Value Of Share Repurchase Program		10,000
Stock Repurchase Program Remaining Authorized Repurchase Amount		2,800
Treasury Stock [Member] \| February 12 2021 [Member]
Equity, Class of Treasury Stock [Line Items]
Authorized Amount Of Common Stock Value Of Share Repurchase Program		$ 10,000

OTHER (INCOME) EXPENSE (Tables)

12 Months Ended

Dec. 31, 2021

Other Income and Expenses [Abstract]

Other (income) expense


	Years Ended December 31,
	2021			2020			2019
Interest income		$	(102)		$	(107)		$	(255)
Pension ongoing income—non-service		(1,202)			(901)			(606)
Other postretirement income—non-service		(71)			(57)			(47)
Equity income of affiliated companies		(67)			(66)			(52)
Loss (gain) on sale of non-strategic business and assets		(102)			3			1
Foreign exchange		25			(68)			(120)
Expense related to UOP Matters		160			—			—
Reimbursement receivables charge		—			509			—
Other (net)		(19)			12			14
		$	(1,378)		$	(675)		$	(1,065)

CAPITAL STOCK	12 Months Ended
CAPITAL STOCK	Dec. 31, 2021
Capital Stock [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	The Company is authorized to issue up to 2,000,000,000 shares of common stock, with a par value of $1. Common shareowners are entitled to receive such dividends as may be declared by the Board of Directors, are entitled to one vote per share, and are entitled, in the event of liquidation, to share ratably in all the assets of the Company which are available for distribution to the common shareowners. Common shareowners do not have preemptive or conversion rights. Shares of common stock issued and outstanding or held in the treasury are not liable to further calls or assessments. There are no restrictions on the Company relative to dividends or the repurchase or redemption of common stock. In April 2019, the Board of Directors authorized the repurchase of up to a total of $10 billion of Honeywell common stock. On February 12, 2021 the Board of Directors authorized another repurchase of up to a total of $10 billion of Honeywell common stock, which included $2.8 billion remaining under, and replaced, the previously approved share repurchase authorization. Approximately $7.1 billion and $3.3 billion remained available as of December 31, 2021 and 2020, respectively, for additional share repurchases. Honeywell repurchased approximately 15.8 million and 20.7 million shares of its common stock during the years ended December 31, 2021 and 2020, for $3,380 million and $3,714 million. The Company is authorized to issue up to 40,000,000 shares of preferred stock, without par value, and can determine the number of shares of each series, and the rights, preferences and limitations of each series. At December 31, 2021, there was no preferred stock outstanding.

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI http://asc.fasb.org/topic&trid=2208762

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 16
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

+ Details

DERIVATIVE INSTRUMENTS AND HEDGING TRANSACTIONS 2 (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Derivative Instruments And Hedging Activity Paragragh [Abstract]
Gain (Loss) on interest rate swap agreements	$ (135)	$ 169	$ (70)

COMMITMENTS AND CONTINGENCIES (Tables)

12 Months Ended

Dec. 31, 2021

Commitments and Contingencies Disclosure [Abstract]

Loss Contingency


	Years Ended December 31,
	2021			2020			2019
Beginning of year		$	660		$	709		$	755
Accruals for environmental matters deemed probable and reasonably estimable		168			173			213
Environmental liability payments		(210)			(216)			(256)
Other		—			(6)			(3)
End of year		$	618		$	660		$	709

Environmental liabilities are included in the following balance sheet accounts:


	December 31,
	2021			2020
Accrued liabilities		$	225		$	225
Other liabilities		393			435
		$	618		$	660

Asbestos Related Liabilities


	Year Ended December 31, 2021									Year Ended December 31, 2020									Year Ended December 31, 2019
	Bendix			NARCO			Total			Bendix			NARCO			Total			Bendix			NARCO			Total
Beginning of year		$	1,441		$	779		$	2,220		$	1,499		$	858		$	2,357		$	1,623		$	891		$	2,514
Accrual for update to estimated liability		64			31			95			80			18			98			78			22			100
Change in estimated cost of future claims		29			—			29			42			—			42			(22)			—			(22)
Update of expected resolution values for pending claims		3			—			3			10			—			10			(4)			—			(4)
Asbestos related liability payments		(165)			(121)			(286)			(190)			(97)			(287)			(176)			(55)			(231)
End of year		$	1,372		$	689		$	2,061		$	1,441		$	779		$	2,220		$	1,499		$	858		$	2,357

Insurance Recoveries for Asbestos Related Liabilities


	Year Ended December 31, 2021									Year Ended December 31, 2020									Year Ended December 31, 2019
	Bendix			NARCO			Total			Bendix			NARCO			Total			Bendix			NARCO			Total
Beginning of year		$	148		$	254		$	402		$	153		$	281		$	434		$	170		$	307		$	477
Probable insurance recoveries related to estimated liability		7			—			7			10			—			10			3			—			3
Insurance receipts for asbestos related liabilities		(13)			(33)			(46)			(33)			(25)			(58)			(39)			(29)			(68)
Insurance receivables settlements and write offs		—			—			—			18			(2)			16			19			3			22

End of year		$	142		$	221		$	363		$	148		$	254		$	402		$	153		$	281		$	434

NARCO and Bendix asbestos related balances are included in the following balance sheet accounts

NARCO and Bendix asbestos related balances are included in the following balance sheet accounts:


	December 31,
	2021			2020
Other current assets		$	41		$	36
Insurance recoveries for asbestos related liabilities		322			366
		$	363		$	402
Accrued liabilities		$	261		$	300
Asbestos related liabilities		1,800			1,920
		$	2,061		$	2,220

Schedule Of Bendix Loss Contingencies Litigation Claims Activity [Table Text Block]


Claims Activity	Years Ended December 31,
	2021		2020
Claims Unresolved at the beginning of year		6,242		6,480
Claims Filed		2,611		2,233
Claims Resolved		(2,452)		(2,471)
Claims Unresolved at the end of year		6,401		6,242


Disease Distribution of Unresolved Claims	Years Ended December 31,
	2021		2020
Mesothelioma and Other Cancer Claims		3,760		3,422
Nonmalignant Claims		2,641		2,820
Total Claims		6,401		6,242

Honeywell has experienced average resolution values per claim excluding legal costs as follows:


	Years Ended December 31,
	2021			2020			2019			2018			2017
		(in whole dollars)
Malignant claims		$	56,000		$	61,500		$	50,200		$	55,300		$	56,000
Nonmalignant claims		$	400		$	550		$	3,900		$	4,700		$	2,800

Movement In Standard Product Warranty Rollforward And Balances


	Years Ended December 31,
	2021			2020			2019
Beginning of year		$	243		$	269		$	310
Accruals for warranties/guarantees issued during the year		146			164			173
Adjustment of pre-existing warranties/guarantees		(7)			(18)			(34)
Settlement of warranty/guarantee claims		(159)			(172)			(180)
End of year		$	223		$	243		$	269

Product warranties and product performance guarantees are included in the following balance sheet accounts:


	December 31,
	2021			2020
Accrued liabilities		$	180		$	183
Other liabilities		43			60
		$	223		$	243

LEASES 5 (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Operating Leases
2022	$ 215,000,000
2023	188,000,000
2024	153,000,000
2025	113,000,000
2026	91,000,000
Thereafter	404,000,000
Total lease payments	1,164,000,000
Less: interest	(132,000,000)
Total	1,032,000,000	$ 828,000,000
Financing Leases
2022	77,000,000
2023	59,000,000
2024	47,000,000
2025	14,000,000
2026	0
Thereafter	0
Total lease payments	197,000,000
Less: Interest	(41,000,000)
Total	$ 156,000,000	$ 184,000,000

PENSOION AND OTHER POSTRETIREMENT BENEFITS 4 (Details)	Dec. 31, 2021
Fixed Income Securities [Member] \| Minimum [Member]
Defined Benefit Plan Plans With Benefit Obligations In Excess of Plan Assets Paragraph Details [Line Items]
Target allocations percentage	55.00%
Fixed Income Securities [Member] \| Maximum [Member]
Defined Benefit Plan Plans With Benefit Obligations In Excess of Plan Assets Paragraph Details [Line Items]
Target allocations percentage	70.00%
Equity Securities [Member] \| Minimum [Member]
Defined Benefit Plan Plans With Benefit Obligations In Excess of Plan Assets Paragraph Details [Line Items]
Target allocations percentage	25.00%
Equity Securities [Member] \| Maximum [Member]
Defined Benefit Plan Plans With Benefit Obligations In Excess of Plan Assets Paragraph Details [Line Items]
Target allocations percentage	40.00%
Real Estate [Member] \| Minimum [Member]
Defined Benefit Plan Plans With Benefit Obligations In Excess of Plan Assets Paragraph Details [Line Items]
Target allocations percentage	5.00%
Real Estate [Member] \| Maximum [Member]
Defined Benefit Plan Plans With Benefit Obligations In Excess of Plan Assets Paragraph Details [Line Items]
Target allocations percentage	10.00%
Other than Securities Investment [Member] \| Minimum [Member]
Defined Benefit Plan Plans With Benefit Obligations In Excess of Plan Assets Paragraph Details [Line Items]
Target allocations percentage	10.00%
Other than Securities Investment [Member] \| Maximum [Member]
Defined Benefit Plan Plans With Benefit Obligations In Excess of Plan Assets Paragraph Details [Line Items]
Target allocations percentage	20.00%

COMMITMENTS AND CONTINGENCIES 5 (Details) - Bendix Asbestos Loss Contingency Liability [Member]	12 Months Ended
	Dec. 31, 2021 claims $ / claims	Dec. 31, 2020 claims $ / claims	Dec. 31, 2019 claims $ / claims	Dec. 31, 2018 $ / claims	Dec. 31, 2017 $ / claims
Loss Contingency Claims [Abstract]
Claims unresolved at the beginning of period	6,242	6,480
Claims Filed	2,611	2,233
Claims Resolved	(2,452)	(2,471)
Claims unresolved at the end of period	6,401	6,242	6,480
Loss Contingency, Disease Distribution of Unresolved Claims [Abstract]
Mesothelioma and Other Cancer Claims	3,760	3,422
Nonmalignant Claims	2,641	2,820
Claims unresolved at the end of period	6,401	6,242	6,480
Resolution Values Per Claim [Abstract]
Malignant claims \| $ / claims	56,000	61,500	50,200	55,300	56,000
Nonmalignant claims \| $ / claims	400	550	3,900	4,700	2,800

OTHER (INCOME) EXPENSE

12 Months Ended

Dec. 31, 2021

Other Income and Expenses [Abstract]

Other (income) expense Text Block


	Years Ended December 31,
	2021			2020			2019
Interest income		$	(102)		$	(107)		$	(255)
Pension ongoing income—non-service		(1,202)			(901)			(606)
Other postretirement income—non-service		(71)			(57)			(47)
Equity income of affiliated companies		(67)			(66)			(52)
Loss (gain) on sale of non-strategic business and assets		(102)			3			1
Foreign exchange		25			(68)			(120)
Expense related to UOP Matters		160			—			—
Reimbursement receivables charge		—			509			—
Other (net)		(19)			12			14
		$	(1,378)		$	(675)		$	(1,065)

For more information on the UOP Matters and reimbursement receivables related to Garrett, see Note 19 Commitments and Contingencies.

REPOSITIONING AND OTHER CHARGES 4 (Details)	12 Months Ended
REPOSITIONING AND OTHER CHARGES 4 (Details)	Dec. 31, 2021 USD ($) Employees	Dec. 31, 2020 USD ($) Employees	Dec. 31, 2019 USD ($) Employees	Dec. 31, 2018 USD ($)
Net Repositioning And Other Charges [Line Items]
Restructuring Reserve	$ 411,000,000	$ 601,000,000	$ 651,000,000	$ 566,000,000
Repositioning Charges	331,000,000	565,000,000	438,000,000
Severance and exit cost payments	(382,000,000)	(564,000,000)	(249,000,000)
Usage - noncash	(119,000,000)	(21,000,000)	(100,000,000)
Divestitures	0	0	0
Adjustments	(13,000,000)	(47,000,000)	(5,000,000)
Foreign currency translation	(7,000,000)	17,000,000	1,000,000
Restructuring and Related Cost, Incurred Cost	318,000,000	518,000,000	433,000,000
Other charges	(100,000,000)	20,000,000	(12,000,000)
Net repositioning and other charges Paragraph Details [Abstract]
Repositioning Charges	$ 331,000,000	$ 565,000,000	$ 438,000,000
Number Of Employees Severed \| Employees	6,432	14,159	5,336
Severance [Member]
Net Repositioning And Other Charges [Line Items]
Restructuring Reserve	$ 289,000,000	$ 527,000,000	$ 555,000,000	489,000,000
Repositioning Charges	80,000,000	475,000,000	260,000,000
Severance and exit cost payments	(299,000,000)	(474,000,000)	(186,000,000)
Usage - noncash	0	0	0
Divestitures	0	0	0
Adjustments	(14,000,000)	(44,000,000)	(8,000,000)
Foreign currency translation	(5,000,000)	15,000,000	0
Restructuring and Related Cost, Incurred Cost	80,000,000	475,000,000	260,000,000
Net repositioning and other charges Paragraph Details [Abstract]
Repositioning Charges	80,000,000	475,000,000	260,000,000
Asset Impairments [Member]
Net Repositioning And Other Charges [Line Items]
Restructuring Reserve	0	0	0	0
Repositioning Charges	117,000,000	21,000,000	95,000,000
Severance and exit cost payments	0	0	0
Usage - noncash	(119,000,000)	(21,000,000)	(100,000,000)
Divestitures	0	0	0
Adjustments	2,000,000	0	5,000,000
Foreign currency translation	0	0	0
Restructuring and Related Cost, Incurred Cost	117,000,000	21,000,000	95,000,000
Net repositioning and other charges Paragraph Details [Abstract]
Repositioning Charges	117,000,000	21,000,000	95,000,000
Exit costs [Member]
Net Repositioning And Other Charges [Line Items]
Restructuring Reserve	122,000,000	74,000,000	96,000,000	$ 77,000,000
Repositioning Charges	134,000,000	69,000,000	83,000,000
Severance and exit cost payments	(83,000,000)	(90,000,000)	(63,000,000)
Usage - noncash	0	0	0
Divestitures	0	0	0
Adjustments	(1,000,000)	(3,000,000)	(2,000,000)
Foreign currency translation	(2,000,000)	2,000,000	1,000,000
Restructuring and Related Cost, Incurred Cost	134,000,000	69,000,000	83,000,000
Net repositioning and other charges Paragraph Details [Abstract]
Repositioning Charges	134,000,000	69,000,000	83,000,000
Reserve Adjustments [Member]
Net Repositioning And Other Charges [Line Items]
Restructuring and Related Cost, Incurred Cost	(13,000,000)	$ (47,000,000)	$ (5,000,000)
COVID-19 Related [Member]
Net Repositioning And Other Charges [Line Items]
Other charges	$ 105,000,000

ACCRUED LIABILITIES (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Accrued Liabilities, Current [Abstract]
Customer advances and deferred income	$ 3,163	$ 2,932
Compensation, benefit and other employee related	1,273	1,244
Repositioning	411	601
Asbestos related liabilities	261	300
Income taxes	393	307
Other taxes	269	281
Environmental costs	225	225
Operating lease liabilities	185	187
Product warranties and performance guarantees	180	183
Insurance	101	140
Accrued interest	100	102
Other (primarily operating expenses)	1,118	903
Accrued Liabilities	$ 7,679	$ 7,405
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Accrued Liabilities	Accrued Liabilities

FAIR VALUE MEASUREMENTS (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, Notional Amount	$ 17,021,000,000	$ 21,273,000,000
Derivative Fair Value Of Derivative Asset	473,000,000	396,000,000
Derivative Fair Value Of Derivative Liability	282,000,000	200,000,000
Foreign currency exchange contracts [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, Notional Amount	12,671,000,000	16,123,000,000
Fair Value, Inputs, Level 2 [Member] \| Fair Value, Recurring [Member] \| Foreign currency exchange contracts [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Fair Value Of Derivative Asset	374,000,000	202,000,000
Derivative Fair Value Of Derivative Liability	282,000,000	150,000,000
Fair Value, Inputs, Level 2 [Member] \| Fair Value, Recurring [Member] \| Interest Rate Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Fair Value Of Derivative Asset	60,000,000	194,000,000
Fair Value, Inputs, Level 2 [Member] \| Fair Value, Recurring [Member] \| Currency Swap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Fair Value Of Derivative Asset	39,000,000	0
Derivative Fair Value Of Derivative Liability	0	50,000,000
Fair Value, Inputs, Level 2 [Member] \| Fair Value, Recurring [Member] \| Series B Preferred Stock, Series A Preferred Stock and Common Stock investments in Garrett [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments in equity securities	57,000,000	11,000,000
Fair Value Inputs Level 1 And Level 2 [Member] \| Fair Value, Recurring [Member] \| Available for sale investments [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale investments	$ 742,000,000	$ 1,118,000,000

STOCK-BASED COMPENSATION PLANS 2 (Details) - 2016 Plan [Member] - Share-based Payment Arrangement, Option [Member] - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Share-based Payment Arrangement, Option, Exercise Price Range, Beginning of Period [Abstract]
Options Outstanding, Number of Options	15,852,939
Options Outstanding, Weighted Average Life	5 years 4 months 27 days
Options Outstanding, Weighted Average Exercise Price	135.28
Options Outstanding Aggregate Intrinsic Value	$ 1,164
Options Exercisable Number of Options	10,664,625
Weighted Average Exercise Price	$ 113.30	$ 103.89	$ 92.19
Options Exercisable Aggregate Intrinsic Value	$ 1,122
Minimum [Member]
Share-based Payment Arrangement, Option, Exercise Price Range, Beginning of Period [Abstract]
Vesting periods	4 years
Maximum [Member]
Share-based Payment Arrangement, Option, Exercise Price Range, Beginning of Period [Abstract]
Vesting periods	10 years
Exercise Price Range $27.00-64.99 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range, Beginning of Period [Abstract]
Options Outstanding, Number of Options	90,181
Options Outstanding, Weighted Average Life	2 months 1 day
Options Outstanding, Weighted Average Exercise Price	56.97
Options Outstanding Aggregate Intrinsic Value	$ 14
Options Exercisable Number of Options	90,181
Weighted Average Exercise Price	$ 56.97
Options Exercisable Aggregate Intrinsic Value	$ 14
Exercise Price Range $65.00-$89.99 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range, Beginning of Period [Abstract]
Options Outstanding, Number of Options	2,293,585
Options Outstanding, Weighted Average Life	1 year 8 months 4 days
Options Outstanding, Weighted Average Exercise Price	79.39
Options Outstanding Aggregate Intrinsic Value	$ 296
Options Exercisable Number of Options	2,293,585
Weighted Average Exercise Price	$ 79.39
Options Exercisable Aggregate Intrinsic Value	$ 296
Exercise Price Range $90.00-$99.99 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range, Beginning of Period [Abstract]
Options Outstanding, Number of Options	3,341,048
Options Outstanding, Weighted Average Life	3 years 5 months 8 days
Options Outstanding, Weighted Average Exercise Price	98.80
Options Outstanding Aggregate Intrinsic Value	$ 367
Options Exercisable Number of Options	3,341,048
Weighted Average Exercise Price	$ 98.80
Options Exercisable Aggregate Intrinsic Value	$ 366
Exercise Price Range $100.00-$134.99 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range, Beginning of Period [Abstract]
Options Outstanding, Number of Options	2,435,321
Options Outstanding, Weighted Average Life	5 years 14 days
Options Outstanding, Weighted Average Exercise Price	119.69
Options Outstanding Aggregate Intrinsic Value	$ 216
Options Exercisable Number of Options	2,314,755
Weighted Average Exercise Price	$ 119.19
Options Exercisable Aggregate Intrinsic Value	$ 214
Exercise Price Range $135.00-$180.99 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range, Beginning of Period [Abstract]
Options Outstanding, Number of Options	7,692,804
Options Outstanding, Weighted Average Life	7 years 6 months 18 days
Options Outstanding, Weighted Average Exercise Price	173.71
Options Outstanding Aggregate Intrinsic Value	$ 271
Options Exercisable Number of Options	2,625,056
Weighted Average Exercise Price	$ 158.14
Options Exercisable Aggregate Intrinsic Value	$ 232

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	Dec. 31, 2021
Accounting Policies [Abstract]
Accounting Principles	ACCOUNTING PRINCIPLES The financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America. The following is a description of Honeywell’s significant accounting policies.
Principles of Consolidation	PRINCIPLES OF CONSOLIDATION The Consolidated Financial Statements include the accounts of Honeywell International Inc. and all of its subsidiaries and entities in which a controlling interest is maintained. The Company's consolidation policy requires equity investments that the Company exercises significant influence over but do not control the investee and are not the primary beneficiary of the investee’s activities to be accounted for using the equity method. Investments through which the Company is not able to exercise significant influence over the investee and which the Company does not have readily determinable fair values are accounted for under the cost method. All intercompany transactions and balances are eliminated in consolidation.
Reclassifications	RECLASSIFICATIONS Certain prior year amounts have been reclassified to conform to the current year presentation.
Recent Accounting Pronouncements	RECENT ACCOUNTING PRONOUNCEMENTS The Company considers the applicability and impact of all Accounting Standards Updates (ASUs) issued by the Financial Accounting Standards Board (FASB). ASUs not listed below were assessed and determined to be either not applicable or are expected to have minimal impact on the Company's consolidated statement of operations, balance sheet and cash flows (Consolidated Financial Statements). In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes. The standard’s amendments include changes in various subtopics of accounting for income taxes including, but not limited to, accounting for “hybrid” tax regimes, tax basis step-up in goodwill obtained in a transaction that is not a business combination, intraperiod tax allocation exception to incremental approach, ownership changes in investments, interim-period accounting for enacted changes in tax law, and year-to-date loss limitation in interim-period tax accounting. Effective January 1, 2021, the Company adopted this standard. The adoption of this standard did not have a material impact on the Company's Consolidated Financial Statements. In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying generally accepted accounted principles to contracts, hedging relationships, and other transactions affected by the transition away from reference rates expected to be discontinued to alternative reference rates. In January 2021, the FASB issued ASU 2021-01, Reference Rate Reform (Topic 848): Scope, to expand the scope of this guidance to include derivatives. The guidance was effective upon issuance and may be applied prospectively to contract modifications made and hedging relationships entered into on or before December 31, 2022. The Company will apply the guidance to impacted transactions during the transition period. The Company does not expect the adoption of this standard to have a material impact on the Company’s Consolidated Financial Statements. In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805) - Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers. This ASU should be applied prospectively to acquisitions occurring on or after the effective date of December 15, 2022, and early adoption is permitted. The Company is currently evaluating the impacts of this guidance on the Company’s Consolidated Financial Statements. The Company does not expect the adoption of this standard to have a material impact on the Company’s Consolidated Financial Statements.
Research and Development	RESEARCH AND DEVELOPMENT Research and development costs for projects are expensed as incurred, unless these costs relate to contracts with customers where the Company receives reimbursements. Amounts expensed as incurred for Company-sponsored research and development projects are included in Cost of products and services sold and were $1,333 million, $1,334 million and $1,556 million for the years ended December 31, 2021, 2020 and 2019, respectively. Costs related to contracts with customers for customer-sponsored research and development projects are included as a contract cost and included in Cost of products and services sold when revenue from such contracts is recognized, consistent with the Company's sales recognition policies. This revenue was $1,284 million, $1,200 million and $1,079 million for the years ended December 31, 2021, 2020 and 2019, respectively.
Cash And Cash Equivalents	CASH AND CASH EQUIVALENTS Cash and cash equivalents include cash on hand and highly liquid investments having an original maturity of three months or less.
Inventories	INVENTORIES Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out (FIFO) basis. Carrying value adjustments for inventory obsolescence is equal to the difference between the cost and net realizable value. Net realizable value is the estimate selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.
Property, Plant and Equipment	PROPERTY, PLANT AND EQUIPMENT Property, plant and equipment are recorded at cost, including any asset retirement obligations, less accumulated depreciation. For financial reporting, the straight-line method of depreciation is used over the estimated useful lives of 10 to 50 years for buildings and improvements and 3 to 16 years for machinery and equipment. Recognition of the fair value of obligations associated with the retirement of tangible long-lived assets is required when there is a legal obligation to incur such costs. Upon initial recognition of a liability, the cost is capitalized as part of the related long-lived asset and depreciated over the corresponding asset’s useful life.
Goodwill and Indefinite-Lived Intangible Assets	GOODWILL AND INDEFINITE-LIVED INTANGIBLE ASSETSGoodwill and indefinite-lived intangible assets are subject to impairment testing annually as of March 31, or if a triggering event occurs or changes in circumstances indicate that the carrying amount may not be fully recoverable. This testing compares carrying values to fair values and, when appropriate, the carrying value of these assets is reduced to fair value. The Company completed its annual goodwill impairment test as of March 31, 2021, and determined that there was no impairment as of that date. The Company is not aware of any additional triggering events.
Finite-Lived Intangible Assets	FINITE-LIVED INTANGIBLE ASSETS Other intangible assets with determinable lives consist of customer lists, technology, patents and trademarks and other intangibles and are amortized over their estimated useful lives, ranging from 2 to 22 years.
Foreign Currency Translation	FOREIGN CURRENCY TRANSLATION Assets and liabilities of subsidiaries operating outside the United States with a functional currency other than U.S. Dollars are translated into U.S. Dollars using year-end exchange rates. Sales, costs and expenses are translated at the average exchange rates in effect during the year. Foreign currency translation gains and losses are included as a component of Accumulated other comprehensive income (loss). For subsidiaries operating in highly inflationary environments, inventories and property, plant and equipment, including related expenses, are remeasured at the exchange rate in effect on the date the assets were acquired, while monetary assets and liabilities are remeasured at year-end exchange rates. Remeasurement adjustments for these subsidiaries are included in earnings.
Derivative Financial Instruments	DERIVATIVE FINANCIAL INSTRUMENTS All derivative financial instruments are recorded on the balance sheet as assets or liabilities and measured at fair value. For derivatives designated as hedges of the fair value of assets or liabilities, the changes in fair values of both the derivatives and the hedged items are recorded in current earnings. For derivatives designated as cash flow hedges, the changes in fair value of the derivatives are recorded in Accumulated other comprehensive income (loss) and subsequently recognized in earnings when the hedged items impact earnings. Derivative financial instruments designated as hedges must be designated and effective as a hedge of the identified risk exposure at the inception of the contract. Changes in fair value of the derivative contract must be highly correlated with changes in fair value of the underlying hedged item at inception and over the life of the hedge contract. Cash flows of such derivative financial instruments are classified consistent with the underlying hedged item. The Company elected to exclude the time value of the derivatives (i.e., the forward points) from the assessment of hedge effectiveness and recognize the initial value of the excluded component in earnings using the amortization approach. For derivative instruments that are designated and qualify as a net investment hedge, the gain or loss is reported as a component of Other comprehensive income (loss) and recorded in Accumulated other comprehensive income (loss). The gain or loss will be subsequently reclassified into net earnings when the hedged net investment is either sold or substantially liquidated.
Leases	LEASES At the inception of a contract, the Company assesses whether the contract is, or contains, a lease. The assessment is based on (1) whether the contract involves the use of a distinct identified asset, (2) whether the Company obtains the right to substantially all the economic benefit from the use of the asset throughout the period, and (3) whether the Company has the right to direct the use of the asset. All significant lease arrangements are generally recognized at lease commencement. Operating lease right-of-use (ROU) assets and lease liabilities are recognized at commencement. An ROU asset and corresponding lease liability are not recorded for leases with an initial term of 12 months or less (short-term leases), and we recognize lease expense for these leases as incurred over the lease term. ROU assets represent the Company's right to use an underlying asset during the reasonably certain lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. The Company's lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Lease payments may be fixed or variable, however, only fixed payments or in-substance fixed payments are included in determining the lease liability. Variable lease payments are recognized in operating expenses in the period in which the obligation for those payments are incurred. The operating lease ROU asset also includes any lease payments related to initial direct cost and prepayments and excludes lease incentives. Lease expense is recognized on a straight-line basis over the lease term. The Company has lease agreements with lease and non-lease components, which are generally accounted for separately. The Company primarily uses its incremental borrowing rate, which is based on the information available at the lease commencement date, in determining the present value of the lease payments. In determining the borrowing rate, the Company considers the lease term, secured incremental borrowing rate, and for leases denominated in a currency different than U.S. dollar, the collateralized borrowing rate in the foreign currency using the U.S. dollar and foreign currency swap spread, when available.
Pension Benefits	PENSION BENEFITS The Company presents net periodic pensions costs by disaggregating the service cost component of such costs and reports those costs in the same line item or items in the Consolidated Statement of Operations as other compensation costs arising from services rendered by the pertinent employees during the period. The other non-service components of such costs are required to be presented separately from the service cost component. The Company records the service cost component of Pension ongoing (income) expense in Costs of products and services sold and Selling, general and administrative expenses. The remaining components of costs within Pension ongoing (income) expense, primarily interest costs and assumed return on plan assets, are recorded in Other (income) expense. The Company recognizes net actuarial gains or losses in excess of 10% of the greater of the fair value of plan assets or the plan's projected benefit obligation (the corridor) annually in the fourth quarter each year (MTM Adjustment). The MTM Adjustment is also reported in Other (income) expense. See Note 22 Segment Financial Data for a definition of Pension ongoing (income) expense.
Sales Recognition	SALES RECOGNITION Product and service sales are recognized when or as the Company transfers control of the promised products or services to its customers. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods or providing services. Service sales, principally representing repair, maintenance and engineering activities, are recognized over the contractual period or as services are rendered. Sales under long-term contracts with performance obligations satisfied over time are recognized using either an input or output method. The Company recognizes revenue over time as the Company performs on these contracts because of the continuous transfer of control to the customer. With control transferring over time, revenue is recognized based on the extent of progress towards completion of the performance obligation. The Company generally uses the cost-to-cost input method of progress for contracts because it best depicts the transfer of control to the customer that occurs as the Company incurs costs. Under the cost-to-cost input method, the extent of progress towards completion is measured based on the proportion of costs incurred to date to the total estimated costs at completion of the performance obligation. The Company reviews its cost estimates on significant contracts on a periodic basis, or when circumstances change and warrant a modification to a previous estimate. Cost estimates are largely based on negotiated or estimated purchase contract terms, historical performance trends and other economic projections. Significant factors that influence these estimates include inflationary trends, technical and schedule risk, internal and subcontractor performance trends, business volume assumptions, asset utilization, and anticipated labor agreements. Provisions for anticipated losses on long-term contracts are recorded in full when such losses become evident, to the extent required. The customer funding for costs incurred for nonrecurring engineering and development activities of the Company's products under agreements with commercial customers is deferred and subsequently recognized as revenue as products are delivered to the customers. Additionally, expenses incurred, up to the customer agreed funded amount, are deferred as an asset and recognized as cost of sales when products are delivered to the customer. The deferred customer funding and costs result in recognition of deferred costs (asset) and deferred revenue (liability) on the Company's Consolidated Balance Sheet. Capitalized contract fulfillment costs were approximately $1.3 billion as of December 31, 2021 and 2020. The amounts recognized as Cost of products and services sold were approximately $0.1 billion for the years ended December 31, 2021, 2020 and 2019. Revenues for the Company's mechanical service programs are recognized as performance obligations that are satisfied over time, with recognition reflecting a series of distinct services using the output method. The terms of a contract or the historical business practice can give rise to variable consideration due to, but not limited to, cash-based incentives, rebates, performance awards, or credits. The Company estimates variable consideration at the most likely amount the Company will receive from customers. The Company includes estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized for such transaction will not occur, or when the uncertainty associated with the variable consideration is resolved. The Company's estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely on an assessment of the Company's anticipated performance and all information (historical, current and forecasted) that is reasonably available to the Company.
Stock-Based Compensation Plans	STOCK-BASED COMPENSATION PLANS The principal awards issued under the Company's stock-based compensation plans, which are described in Note 15 Stock-Based Compensation Plans, are non-qualified stock options and restricted stock units. The cost for such awards is measured at the grant date based on the fair value of the award. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods (generally the vesting period of the equity award) and is included in Selling, general and administrative expenses. Forfeitures are estimated at the time of grant to recognize expense for those awards that are expected to vest and are based on the Company's historical forfeiture rates.
Income Taxes	INCOME TAXES Significant judgment is required in evaluating tax positions. The Company establishes reserves for income taxes when, despite the belief that tax positions are fully supportable, there remain certain positions that do not meet the minimum recognition threshold. The approach for evaluating certain and uncertain tax positions is defined by the authoritative guidance which determines when a tax position is more likely than not to be sustained upon examination by the applicable taxing authority. In the normal course of business, the Company and its subsidiaries are examined by various federal, state and foreign tax authorities. The Company regularly assesses the potential outcomes of these examinations and any future examinations for the current or prior years in determining the adequacy of the Company's provision for income taxes. The Company continually assesses the likelihood and amount of potential adjustments and adjust the income tax provision, the current tax liability and deferred taxes in the period in which the facts that give rise to a change in estimate become known. For additional information, see Note 5 Income Taxes.
Earnings Per Share	EARNINGS PER SHARE Basic earnings per share is based on the weighted average number of common shares outstanding. Diluted earnings per share is based on the weighted average number of common shares outstanding and all dilutive potential common shares outstanding.
Environmental	ENVIRONMENTAL The Company accrues costs related to environmental matters when it is probable that it has incurred a liability related to a contaminated site and the amount can be reasonably estimated. For additional information, see Note 19 Commitments and Contingencies.
Asbestos Related Liabilities and Insurance Recoveries	ASBESTOS RELATED LIABILITIES AND INSURANCE RECOVERIES The Company recognizes a liability for any asbestos related contingency that is probable of occurrence and reasonably estimable. In connection with the recognition of liabilities for asbestos related matters, the Company records asbestos related insurance recoveries that are deemed probable. For additional information, see Note 19 Commitments and Contingencies.
Reimbursement Receivables [Policy Text Block]	REIMBURSEMENT RECEIVABLES In conjunction with the Resideo Technologies, Inc. (Resideo) spin-off, the Company entered into a reimbursement agreement under which Honeywell receives cash payments as reimbursement primarily related to net spending for environmental matters at certain sites as defined in the reimbursement agreement. Accordingly, the Company recorded receivables based on estimates of the underlying reimbursable Honeywell environmental spend, and the Company monitors the recoverability of such receivables, which are subject to the terms of applicable credit agreements and general ability to pay.

COMMITMENTS AND CONTINGENCIES

12 Months Ended

Dec. 31, 2021

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

ENVIRONMENTAL MATTERS

The Company is subject to various federal, state, local and foreign government requirements relating to the protection of the environment. The Company believes that, as a general matter, the Company's policies, practices, and procedures are properly designed to prevent unreasonable risk of environmental damage and personal injury and that the handling, manufacture, use, and disposal of hazardous substances are in accordance with environmental and safety laws and regulations. However, mainly because of past operations and operations of predecessor companies, the Company, like other companies engaged in similar businesses, have incurred remedial response and voluntary cleanup costs for site contamination and are a party to lawsuits and claims associated with environmental and safety matters, including past production of products containing hazardous substances. Additional lawsuits, claims, and costs involving environmental matters are likely to continue to arise in the future.

With respect to environmental matters involving site contamination, the Company continually conducts studies, individually or jointly with other potentially responsible parties, to determine the feasibility of various remedial techniques. It is the Company's policy to record appropriate liabilities for environmental matters when remedial efforts or damage claim payments are probable and the costs can be reasonably estimated. Such liabilities are based on our best estimate of the undiscounted future costs required to complete the remedial work. The recorded liabilities are adjusted periodically as remediation efforts progress or as additional technical, regulatory, or legal information becomes available. Given the uncertainties regarding the status of laws, regulations, enforcement policies, the impact of other potentially responsible parties, technology, and information related to individual sites, the Company does not believe it is possible to develop an estimate of the range of reasonably possible environmental loss in excess of the Company's recorded liabilities. The Company expects to fund expenditures for these matters from operating cash flow. The timing of cash expenditures depends on a number of factors, including the timing of remedial investigations and feasibility studies, the timing of litigation and settlements of remediation liability, personal injury and property damage claims, regulatory approval of cleanup projects, remedial techniques to be utilized, and agreements with other parties.

The following table summarizes information concerning our recorded liabilities for environmental costs:


	Years Ended December 31,
	2021			2020			2019
Beginning of year		$	660		$	709		$	755
Accruals for environmental matters deemed probable and reasonably estimable		168			173			213
Environmental liability payments		(210)			(216)			(256)
Other		—			(6)			(3)
End of year		$	618		$	660		$	709

Environmental liabilities are included in the following balance sheet accounts:


	December 31,
	2021			2020
Accrued liabilities		$	225		$	225
Other liabilities		393			435
		$	618		$	660

The Company does not currently possess sufficient information to reasonably estimate the amounts of environmental liabilities to be recorded upon future completion of studies, litigation or settlements, and neither the timing nor the amount of the ultimate costs associated with environmental matters can be determined, although they could be material to the Company's consolidated results of operations and operating cash flows in the periods recognized or paid. However, considering the Company's past experience and existing reserves, the Company does not expect that environmental matters will have a material adverse effect on its consolidated financial position.

In conjunction with the Resideo spin-off, the Company entered into an indemnification and reimbursement agreement with a Resideo subsidiary, pursuant to which Resideo’s subsidiary has an ongoing obligation to make cash payments to Honeywell in amounts equal to 90% of Honeywell’s annual net spending for environmental matters at certain sites as defined in the agreement. The amount payable to Honeywell in any given year is subject to a cap of $140 million, and the obligation will continue until the earlier of December 31, 2043, or December 31 of the third consecutive year during which the annual payment obligation is less than $25 million.

Reimbursements associated with this agreement are collected from Resideo quarterly and were $140 million in both 2021 and 2020 and offset operating cash outflows incurred by the Company. As the Company incurs costs for environmental matters deemed probable and reasonably estimable related to the sites covered by the indemnification and reimbursement agreement, a corresponding receivable from Resideo for 90% of such costs is also recorded. This receivable amount recorded in 2021 and 2020 was $146 million and $146 million, respectively. As of December 31, 2021, Other current assets and Other assets included $140 million and $457 million, respectively, for the short-term and long-term portion of the receivable amount due from Resideo under the indemnification and reimbursement agreement. As of December 31, 2020, Other current assets and Other assets included $140 million and $451 million, respectively, for the short-term and long-term portion of the receivable amount due from Resideo under the indemnification and reimbursement agreement.

ASBESTOS RELATED LIABILITIES

Honeywell is named in asbestos-related personal injury claims related to North American Refractories Company (NARCO), which was sold in 1986, and the Bendix Friction Materials (Bendix) business, which was sold in 2014.

The following tables summarize information concerning NARCO and Bendix asbestos-related balances:


	Year Ended December 31, 2021									Year Ended December 31, 2020									Year Ended December 31, 2019
	Bendix			NARCO			Total			Bendix			NARCO			Total			Bendix			NARCO			Total
Beginning of year		$	1,441		$	779		$	2,220		$	1,499		$	858		$	2,357		$	1,623		$	891		$	2,514
Accrual for update to estimated liability		64			31			95			80			18			98			78			22			100
Change in estimated cost of future claims		29			—			29			42			—			42			(22)			—			(22)
Update of expected resolution values for pending claims		3			—			3			10			—			10			(4)			—			(4)
Asbestos related liability payments		(165)			(121)			(286)			(190)			(97)			(287)			(176)			(55)			(231)
End of year		$	1,372		$	689		$	2,061		$	1,441		$	779		$	2,220		$	1,499		$	858		$	2,357

INSURANCE RECOVERIES FOR ASBESTOS RELATED LIABILITIES


	Year Ended December 31, 2021									Year Ended December 31, 2020									Year Ended December 31, 2019
	Bendix			NARCO			Total			Bendix			NARCO			Total			Bendix			NARCO			Total
Beginning of year		$	148		$	254		$	402		$	153		$	281		$	434		$	170		$	307		$	477
Probable insurance recoveries related to estimated liability		7			—			7			10			—			10			3			—			3
Insurance receipts for asbestos related liabilities		(13)			(33)			(46)			(33)			(25)			(58)			(39)			(29)			(68)
Insurance receivables settlements and write offs		—			—			—			18			(2)			16			19			3			22

End of year		$	142		$	221		$	363		$	148		$	254		$	402		$	153		$	281		$	434

NARCO and Bendix asbestos related balances are included in the following balance sheet accounts:


	December 31,
	2021			2020
Other current assets		$	41		$	36
Insurance recoveries for asbestos related liabilities		322			366
		$	363		$	402
Accrued liabilities		$	261		$	300
Asbestos related liabilities		1,800			1,920
		$	2,061		$	2,220

NARCO Products – NARCO manufactured high-grade, heat-resistant, refractory products for various industries. Honeywell’s predecessor, Allied Corporation, owned NARCO from 1979 to 1986. Allied Corporation sold the NARCO business in 1986 and entered into a cross-indemnity agreement which included an obligation to indemnify the purchaser for asbestos claims, arising primarily from alleged occupational exposure to asbestos-containing refractory brick and mortar for high-temperature applications. NARCO ceased manufacturing these products in 1980 and filed for bankruptcy in January 2002, at which point in time all then current and future NARCO asbestos claims were stayed against both NARCO and Honeywell pending the reorganization of NARCO. The Company established its initial liability for NARCO asbestos claims in 2002.

NARCO emerged from bankruptcy in April 2013, at which time a federally authorized 524(g) trust was established to evaluate and resolve all existing NARCO asbestos claims (the Trust). Both Honeywell and NARCO are protected by a permanent channeling injunction barring all present and future individual actions in state or federal courts and requiring all asbestos-related claims based on exposure to NARCO asbestos-containing products to be made against the Trust. The NARCO Trust Agreement (TA) and the NARCO Trust Distribution Procedures (TDP) set forth the structure and operating rules of the Trust, and established Honeywell’s evergreen funding obligations.

In accordance with the TA, the Trust is eligible to receive cash dividends from Harbison-Walker International Inc. (HWI), the reorganized and renamed entity that emerged from the NARCO bankruptcy. HWI cash dividends are required to be used to pay asbestos-related claims which qualify for payment under the TDP (Annual Contribution Claims) until those funds are exhausted, at which point Honeywell’s funding obligation, subject to an annual cap of $145 million, is triggered. The Trust received dividend payments from HWI in 2021. The Company is also required to fund amounts owed pursuant to settlement agreements reached during the pendency of the NARCO bankruptcy proceedings that provide for the right to submit claims to the Trust subject to qualification under the terms of the settlement agreements and TDP (Pre-Established Unliquidated Claims), as well as fund the annual operating costs of the Trust. There is no annual funding cap relative to Pre-Established Unliquidated Claims.

The operating rules per the TDP define criteria claimants must meet for a claim to be considered valid and paid, which include adequate medical evidence of the claimant’s asbestos-related condition and credible evidence of exposure to a specific NARCO asbestos-containing product. The TDP allows Honeywell to audit claim support documents against these criteria. Once operational in 2014, the Trust began to receive, process and pay claims. The Company identified several issues with the way the Trust was adhering to the TDP in audits subsequent to the Trust becoming operational. The Company consistently raised with the Trust concern that the Trust adopted an improper practice of paying claimants who have not demonstrated the requisite exposure. The Trust refused to alter its practices for payment of claims, and in September 2021, Honeywell filed suit against the Trust in the United States Bankruptcy Court for the Western District of Pennsylvania (Bankruptcy Court) alleging that the Trust has breached its duties in managing the Trust, including breaches of certain provisions of the TA and TDP. Honeywell's lawsuit seeks appropriate relief preventing the Trust from continuing these practices. The Trust also filed suit against Honeywell, alleging Honeywell has breached its obligations under the Trust's governing documents. Honeywell moved to dismiss the Trust’s suit, and on December 15, 2021, the Bankruptcy Court granted Honeywell’s motion to dismiss subject to granting the Trust leave to file an amended complaint. On December 28, 2021, the Trust filed an answer with counterclaims in response to Honeywell’s complaint and in lieu of filing an amended complaint. At this time, the Company cannot predict the outcome of these matters, or the potential impact on the asbestos-related liabilities.

Due to the bankruptcy filing in 2002, claimants were not permitted to file additional claims until the Trust became operative in 2014. As a consequence, there was a large backlog of claims filed with the Trust upon it becoming operative in 2014 through December 31, 2017, the date by which these claims had to be filed or else be barred by the expiration of the statute of limitations. Therefore, the claims filing rate did not start to normalize until 2018 and thereafter. As a result, between 2002 and 2018, the Company lacked a history of sufficiently reliable claims data to derive a reasonable estimate of its NARCO asbestos-related liability, and the Company continued to update its original estimate, as appropriate, using all available information.

Beginning in 2020, with three years of sufficiently reliable claims data, the Company updated its estimate of the NARCO asbestos-related liability. The estimate for the resolution of asserted Annual Contribution Claims and Pre-Established Unliquidated Claims uses average payment values for the relevant historical period. The estimate for unasserted claims is based on historic and anticipated claims filing experience and payment rates, disease classifications and type of claim, and average payment values by the Trust for the relevant historical period. The Company utilizes an asbestos liability valuation specialist to support the preparation of the NARCO asbestos-related liability estimates during the fourth quarter each year. The Company's estimates, which involve significant management judgment, and consider multiple scenarios, include all years of epidemiological disease projection through 2059.

The NARCO asbestos-related liability reflects an estimate for the resolution of Annual Contribution Claims and Pre-Established Unliquidated Claims filed with the Trust, as well as for unasserted Annual Contribution Claims and Pre-Established Unliquidated Claims. The NARCO asbestos-related liability excludes the annual operating expenses of the Trust which are expensed as they are incurred.

The Company's NARCO-related insurance receivable reflects coverage which reimburses Honeywell for portions of NARCO-related claims and defense costs. This coverage is provided by a large number of insurance policies written by dozens of insurance companies in both the domestic insurance market and the London excess market. Honeywell's NARCO-related insurance receivable is an estimate of the probable amount of insurance that is recoverable for asbestos claims. The Company's judgments related to the Company's insurance carriers and insurance coverages are reasonable and consistent with Honeywell's historical dealings and Honeywell's knowledge of any pertinent solvency issues surrounding insurers.

Bendix Products – Bendix manufactured automotive brake linings that contained chrysotile asbestos in an encapsulated form. Claimants consist largely of individuals who allege exposure to asbestos from brakes from either performing or being in the vicinity of individuals who performed brake replacements. The following tables present information regarding Bendix related asbestos claims activity:


Claims Activity	Years Ended December 31,
	2021		2020
Claims Unresolved at the beginning of year		6,242		6,480
Claims Filed		2,611		2,233
Claims Resolved		(2,452)		(2,471)
Claims Unresolved at the end of year		6,401		6,242


Disease Distribution of Unresolved Claims	Years Ended December 31,
	2021		2020
Mesothelioma and Other Cancer Claims		3,760		3,422
Nonmalignant Claims		2,641		2,820
Total Claims		6,401		6,242

Honeywell has experienced average resolution values per claim excluding legal costs as follows:


	Years Ended December 31,
	2021			2020			2019			2018			2017
		(in whole dollars)
Malignant claims		$	56,000		$	61,500		$	50,200		$	55,300		$	56,000
Nonmalignant claims		$	400		$	550		$	3,900		$	4,700		$	2,800

It is not possible to predict whether resolution values for Bendix-related asbestos claims will increase, decrease or stabilize in the future.

The Consolidated Financial Statements reflect an estimated liability for resolution of asserted (claims filed as of the financial statement date) and unasserted Bendix-related asbestos claims, which exclude the Company’s ongoing legal fees to defend such asbestos claims which will continue to be expensed as they are incurred.

The Company reflects the inclusion of all years of epidemiological disease projection through 2059 when estimating the liability for unasserted Bendix-related asbestos claims. Such liability for unasserted Bendix-related asbestos claims is based on historic and anticipated claims filing experience and dismissal rates, disease classifications, and resolution values in the tort system for the previous five years. The Company has valued Bendix asserted and unasserted claims using average resolution values for the previous five years. The Company updates the resolution values used to estimate the cost of Bendix asserted and unasserted claims during the fourth quarter each year.

The Company's insurance receivable corresponding to the liability for settlement of asserted and unasserted Bendix asbestos claims reflects coverage which is provided by a large number of insurance policies written by dozens of insurance companies in both the domestic insurance market and the London excess market. Based on the Company's ongoing analysis of the probable insurance recovery, insurance receivables are recorded in the financial statements simultaneous with the recording of the estimated liability for the underlying asbestos claims. This determination is based on the Company's analysis of the underlying insurance policies, historical experience with insurers, ongoing review of the solvency of insurers, judicial determinations relevant to insurance programs, and consideration of the impacts of any settlements reached with the Company's insurers.

On October 31, 2018, David Kanefsky (Plaintiff), a Honeywell shareholder, filed a putative class action complaint in the U.S. District Court for the District of New Jersey (the Court) alleging violations of the Securities Exchange Act of 1934 and Rule 10b-5 related to the prior accounting for Bendix asbestos claims. An Amended Complaint was filed on December 30, 2019, and on February 7, 2020, the Company filed a Motion to Dismiss. On May 18, 2020, the Court denied the Motion to Dismiss. On December 7, 2021, the parties filed a Stipulation of Settlement (Settlement Agreement) and Plaintiff filed a motion for preliminary approval of the Settlement Agreement, which includes payment by Honeywell of $10 million to settle the claims in dispute. Honeywell continues to believe the claims lack merit and denies wrongdoing as well as any liability for the claims made against Honeywell in the action. The Settlement Agreement remains subject to final court approval and other conditions.

GARRETT LITIGATION AND BANKRUPTCY PROCEEDINGS

In conjunction with the Garrett spin-off, the Company entered into a binding indemnification and reimbursement agreement (Garrett Indemnity) and a binding tax matters agreement (Tax Matters Agreement) with Garrett and a Garrett subsidiary. On December 2, 2019, Garrett and Garrett ASASCO Inc. filed a Summons with Notice and commenced a lawsuit in the Commercial Division of the Supreme Court of the State of New York, County of New York (the State Court), seeking to invalidate the Garrett Indemnity. Garrett sought damages and a declaratory judgment based on various claims set forth in the Summons with Notice. On July 17, 2020, the Company received a notice from Garrett asserting that the Company had caused material breaches of the Tax Matters Agreement and that the Tax Matters Agreement was unenforceable.

On September 20, 2020, Garrett and 36 of its affiliates filed voluntary petitions for relief under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the Southern District of New York (the Bankruptcy Court). On September 24, 2020, Garrett moved the existing State Court litigation against Honeywell to the Bankruptcy Court. For the year ended December 31, 2020, the Company reviewed the aggregate carrying value of the receivable amounts due in connection with the Garrett Indemnity and Tax Matters Agreement and reduced the aggregate carrying value of the receivable by $509 million to reflect the present value of the amounts owed to the Company over the full term of these agreements.

On April 26, 2021, the Bankruptcy Court confirmed Garrett’s amended Chapter 11 plan of reorganization (the Confirmed Plan), and on April 30, 2021 (the Effective Date), Garrett emerged from bankruptcy. On the Effective Date, and in accordance with the Confirmed Plan, (i) the Company received from Garrett an initial payment of $375 million and 834.8 million shares of Garrett's Series B Preferred Stock in full and final satisfaction of the Garrett Indemnity and Tax Matters Agreement, (ii) the Garrett Indemnity and Tax Matters Agreement were terminated, (iii) the Company and Garrett mutually released each other from the claims asserted in all pending legal actions related to the Garrett Indemnity and Tax Matters Agreement, and (iv) all pending litigation between the Company and Garrett in connection with those agreements was resolved.

The original Series B Preferred Stock Certificate of Designation provides for mandatory redemptions by Garrett of $35 million in 2022 and $100 million per year from 2023 to 2030 (inclusive) at the anniversary of the Effective Date, unless (i) Garrett’s consolidated EBITDA as of the end of the most recently completed fiscal year is less than $425 million, or (ii) Garrett does not have sufficient funds available to pay the redemption, at which point the redemption amounts past due will accrue interest. The Series B Preferred Stock Certificate of Designation also includes rights which allow (a) the Company to put the Series B Preferred Stock to Garrett if certain EBITDA conditions are met, and (b) Garrett to call the Series B Preferred Stock in whole or in part if certain EBITDA conditions are met.

On September 30, 2021, Garrett filed an Amended and Restated Series B Preferred Stock Certificate of Designation (Amendment) with the Secretary of State of Delaware. The Amendment required Garrett to partially redeem a portion of the Series B Preferred Stock on or before March 31, 2022, such that the present value of remaining outstanding shares of the Series B Preferred Stock would be $400 million (First Partial Redemption), subject to applicable law, including that Garrett had funds legally available for the partial redemption. The First Partial Redemption would be applied to the latest scheduled redemption dates, beginning with the shares to be redeemed in 2030. The Amendment also provides that the Company cannot exercise its right to put the Series B Preferred Stock to Garrett until after December 31, 2022, subject to the EBITDA conditions described in the above section, unless the partial redemption does not occur on or before March 31, 2022. All other material terms and conditions in the Amendment were unchanged from the original Series B Preferred Stock Certificate of Designation.

On December 16, 2021, Garrett filed a Second Amended and Restated Series B Preferred Stock Certificate of Designation (Second Amendment) with the Secretary of State of Delaware. The Second Amendment accelerates the First Partial Redemption from March 31, 2022, to December 30, 2021, and allows Garrett to partially redeem an additional portion of the Series B Preferred Stock on or before March 31, 2022, such that the present value of remaining outstanding shares of the Series B Preferred Stock will be $207 million (Second Partial Redemption). The Second Partial Redemption is subject to similar terms as the First Partial Redemption, including that Garrett has funds legally available for the partial redemption. However, the Second Partial Redemption is also contingent upon Garrett completing the First Partial Redemption and either (i) increasing their revolving credit facility, or (ii) the Garrett Board of Directors determining that Garrett otherwise has sufficient liquidity to effect the Second Partial Redemption. The Second Partial Redemption would be applied to the earliest scheduled redemptions beginning with the shares to be redeemed on April 30, 2022.

On December 17, 2021, Garrett announced their intention to effect the First Partial Redemption on December 28, 2021, in the amount of $211 million, and plan to effect the Second Partial Redemption during the first quarter of 2022 for a corresponding payment of $200 million. On December 28, 2021, Garrett paid $211 million for the amount due as the First Partial Redemption.

The Company recorded the Series B Preferred Stock at fair value at the Effective Date. The Company believes the present value of the mandatory redemptions is an appropriate basis for determining the fair value of the Series B Preferred Stock. The Company's present value reflects amortized cost determined by the present value of the mandatory redemptions discounted at 7.25%, which is the rate reflected in the Series B Preferred Stock Certificate of Designation. The discount amount will accrete into interest income over the mandatory redemption period. In addition to the Series B Preferred Stock, the Company subscribed for 4.2 million shares of Garrett's Series A Preferred Stock, which are convertible into Garrett’s Common Stock if certain conditions are met. Prior to and following Garrett’s emergence from bankruptcy, the Company also held 2.9 million shares of Garrett’s Common Stock. As of December 31, 2021, Short-term investments included $34 million and Investments and long-term receivables included $423 million for the Company's investments in Garrett's Series B Preferred Stock, Series A Preferred Stock and Common Stock.

OTHER MATTERS

The Company is subject to a number of other lawsuits, investigations and disputes (some of which involve substantial amounts claimed) arising out of the conduct of the Company's business, including matters relating to commercial transactions, government contracts, product liability, prior acquisitions and divestitures, employee benefit plans, intellectual property, and environmental, health and safety matters (including the matter described below). The Company recognizes liabilities for any contingency that is probable of occurrence and reasonably estimable. The Company continually assesses the likelihood of adverse judgments or outcomes in such matters, as well as potential ranges of possible losses (taking into consideration any insurance recoveries), based on a careful analysis of each matter with the assistance of outside legal counsel and, if applicable, other experts.

Such matters include:

•Petrobras and Unaoil – The Company continues to cooperate with investigations by the U.S. Department of Justice (DOJ), the Securities and Exchange Commission (SEC) and the Brazilian authorities relating to the Company's use of third parties who previously worked for the Company's UOP business in Brazil in relation to Petróleo Brasileiro S.A. (Petrobras) in connection with a project awarded in 2010. The investigations focus on compliance with the U.S. Foreign Corrupt Practices Act and similar Brazilian laws (the UOP Matters), and involve, among other things, document production and interviews with former and current management and employees. The DOJ and the SEC are also examining a matter involving a foreign subsidiary’s prior contract with Unaoil S.A.M. in Algeria executed in 2011. The Company continues to be engaged in discussions with the authorities with respect to a potential comprehensive resolution of these matters.

As the discussions are both ongoing and at different stages with regards to each respective authority, there can be no assurance as to whether the Company will reach a resolution with such authorities or as to the potential timing, terms, or collateral consequences of any such resolution. As a result, the Company cannot predict the ultimate outcome of these UOP Matters or the potential impact on the Company. Based on available information to date, the Company estimates that a potential comprehensive resolution of these UOP Matters would result in a probable loss of at least $160 million, and the Company has recorded a charge in this amount in the Company's Consolidated Statement of Operations, and accrued a corresponding liability on the Consolidated Balance Sheet. Amounts payable to authorities pursuant to any potential final comprehensive resolution could differ from the amount recorded in the Company's consolidated financial statements. Based on available information to date, the Company does not expect that any such difference would be material with respect to the Company's consolidated financial position.

Given the uncertainty inherent in litigation and investigations, the Company does not believe it is possible to develop estimates of reasonably possible losses (or a range of possible losses) in excess of current accruals for such matters. Considering the Company's past experience and existing accruals, the Company does not expect the outcome of such matters, either individually or in the aggregate, to have a material adverse effect on the Company's consolidated financial position. Because most contingencies are resolved over long periods of time, potential liabilities are subject to change due to new developments, changes in settlement strategy or the impact of evidentiary requirements, which could cause us to pay damage awards or settlements (or become subject to equitable remedies) that could have a material adverse effect on the Company's consolidated results of operations or operating cash flows in the periods recognized or paid.

WARRANTIES AND GUARANTEES

In the normal course of business, the Company issues product warranties and product performance guarantees. The Company accrues for the estimated cost of product warranties and performance guarantees based on contract terms and historical experience at the time of sale. Adjustments to initial obligations for warranties and guarantees are made as changes to the obligations become reasonably estimable. The following table summarizes information concerning the Company's recorded obligations for product warranties and product performance guarantees.


	Years Ended December 31,
	2021			2020			2019
Beginning of year		$	243		$	269		$	310
Accruals for warranties/guarantees issued during the year		146			164			173
Adjustment of pre-existing warranties/guarantees		(7)			(18)			(34)
Settlement of warranty/guarantee claims		(159)			(172)			(180)
End of year		$	223		$	243		$	269

Product warranties and product performance guarantees are included in the following balance sheet accounts:


	December 31,
	2021			2020
Accrued liabilities		$	180		$	183
Other liabilities		43			60
		$	223		$	243

OTHER LIABILITIES

12 Months Ended

Dec. 31, 2021

Other Liabilities Disclosure [Abstract]

Other Liabilities


	December 31,
	2021			2020
Income taxes		$	2,152		$	2,009
Pension and other employee related		1,672			1,923
Deferred income		1,324			1,356
Operating lease liabilities		847			641
Environmental		393			435
Insurance		299			280
Product warranties and performance guarantees		43			60
Asset retirement obligations		26			31
Other		331			240
		$	7,087		$	6,975

COMMITMENTS AND CONTINGENCIES 2 (Details) - USD ($)	12 Months Ended
COMMITMENTS AND CONTINGENCIES 2 (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Loss Contingency Accrual [Roll Forward]
Asbestos Related Liabilities, Beginning of Period	$ 2,220,000,000	$ 2,357,000,000	$ 2,514,000,000
Accrual for update to estimated liability	95,000,000	98,000,000	100,000,000
Change in estimated cost of future claims	29,000,000	42,000,000	(22,000,000)
Update of expected resolution values for pending claims	3,000,000	10,000,000	(4,000,000)
Asbestos related liability payments	(286,000,000)	(287,000,000)	(231,000,000)
Asbestos Related Liabilities, End of Period	2,061,000,000	2,220,000,000	2,357,000,000
Asbestos Related Liabilities Insurance Recoveries [Roll Forward]
Insurance Recoveries, beginning of period	402,000,000	434,000,000	477,000,000
Probable insurance recoveries related to estimated liability	7,000,000	10,000,000	3,000,000
Insurance receipts for asbestos related liabilities	(46,000,000)	(58,000,000)	(68,000,000)
Insurance receivables settlements and write offs	0	16,000,000	22,000,000
Insurance recoveries, end of period	363,000,000	402,000,000	434,000,000
Bendix Asbestos Loss Contingency Liability [Member]
Loss Contingency Accrual [Roll Forward]
Asbestos Related Liabilities, Beginning of Period	1,441,000,000	1,499,000,000	1,623,000,000
Accrual for update to estimated liability	64,000,000	80,000,000	78,000,000
Change in estimated cost of future claims	29,000,000	42,000,000	(22,000,000)
Update of expected resolution values for pending claims	3,000,000	10,000,000	(4,000,000)
Asbestos related liability payments	(165,000,000)	(190,000,000)	(176,000,000)
Asbestos Related Liabilities, End of Period	1,372,000,000	1,441,000,000	1,499,000,000
Asbestos Related Liabilities Insurance Recoveries [Roll Forward]
Insurance Recoveries, beginning of period	148,000,000	153,000,000	170,000,000
Probable insurance recoveries related to estimated liability	7,000,000	10,000,000	3,000,000
Insurance receipts for asbestos related liabilities	(13,000,000)	(33,000,000)	(39,000,000)
Insurance receivables settlements and write offs	0	18,000,000	19,000,000
Insurance recoveries, end of period	142,000,000	148,000,000	153,000,000
Narco Asbestos Loss Contingency Liability [Member]
Loss Contingency Accrual [Roll Forward]
Asbestos Related Liabilities, Beginning of Period	779,000,000	858,000,000	891,000,000
Accrual for update to estimated liability	31,000,000	18,000,000	22,000,000
Change in estimated cost of future claims	0	0	0
Update of expected resolution values for pending claims	0	0	0
Asbestos related liability payments	(121,000,000)	(97,000,000)	(55,000,000)
Asbestos Related Liabilities, End of Period	689,000,000	779,000,000	858,000,000
Asbestos Related Liabilities Insurance Recoveries [Roll Forward]
Insurance Recoveries, beginning of period	254,000,000	281,000,000	307,000,000
Probable insurance recoveries related to estimated liability	0	0	0
Insurance receipts for asbestos related liabilities	(33,000,000)	(25,000,000)	(29,000,000)
Insurance receivables settlements and write offs	0	(2,000,000)	3,000,000
Insurance recoveries, end of period	$ 221,000,000	$ 254,000,000	$ 281,000,000

DERIVATIVE INSTRUMENTS AND HEDGING TRANSACTIONS 3 (Details) - Designated as Hedging Instrument [Member] - Long-term debt [Member] - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Summary Of Derivative Instruments By Hedge Designation [Line Items]
Carrying Amount of the Hedged Item	$ 3,210	$ 4,144
Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Item	$ 60	$ 194

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Foreign exchange translation adjustment	$ 302,000,000	$ (211,000,000)	$ 143,000,000
Pensions and other postretirement benefit adjustments	186,000,000	74,000,000	86,000,000
Changes in fair value of available for sale investments	(3,000,000)	4,000,000	0
Changes in fair value of designated cash flow hedges	(3,000,000)	(44,000,000)	11,000,000
Components of other comprehensive income (loss), net of tax	482,000,000	(180,000,000)	240,000,000
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Cumulative foreign exchange translation adjustment	(2,478,000,000)	(2,780,000,000)
Pensions and other postretirement benefit adjustments	(415,000,000)	(601,000,000)
Fair value adjustments of available for sale investments	1,000,000	4,000,000
Fair value adjustments of designated cash flow hedges	(3,000,000)	0
Accumulated other comprehensive income (loss)	(2,895,000,000)	(3,377,000,000)	(3,197,000,000)	$ (3,437,000,000)
Accumulated Other Comprehensive Income (Loss) [Member]
Other Comprehensive Income (Loss), before Tax [Abstract]
Foreign exchange translation adjustment	302,000,000	(214,000,000)	143,000,000
Pension and other postretirement benefit adjustments	245,000,000	76,000,000	115,000,000
Changes in fair value of available for sale investments	(3,000,000)	4,000,000
Changes in fair value of designated cash flow hedges	(4,000,000)	(61,000,000)	20,000,000
Changes in accumulated other comprehensive income, pretax	540,000,000	(195,000,000)	278,000,000
Other Comprehensive Income (Loss), Tax [Abstract]
Foreign exchange translation adjustment	0	0	0
Pensions and other postretirement benefit adjustments	(59,000,000)	(2,000,000)	(29,000,000)
Changes in fair value of available for sale investments	0	0
Changes in fair value of designated cash flow hedges	1,000,000	17,000,000	(9,000,000)
Other comprehensive income (loss), tax	(58,000,000)	15,000,000	(38,000,000)
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Foreign exchange translation adjustment	302,000,000	(214,000,000)	143,000,000
Pensions and other postretirement benefit adjustments	186,000,000	74,000,000	86,000,000
Changes in fair value of available for sale investments	(3,000,000)	4,000,000
Changes in fair value of designated cash flow hedges	(3,000,000)	(44,000,000)	11,000,000
Components of other comprehensive income (loss), net of tax	$ 482,000,000	$ (180,000,000)	$ 240,000,000

DERIVATIVE INSTRUMENTS AND HEDGING TRANSACTIONS 4 (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Revenue	$ 34,392,000,000	$ 32,637,000,000	$ 36,709,000,000
Cost of products and services sold	23,394,000,000	22,169,000,000	24,339,000,000
Selling, general and administrative expenses	4,798,000,000	4,772,000,000	5,519,000,000
Other (income) expense	(1,378,000,000)	(675,000,000)	(1,065,000,000)
Interest and other financial charges	343,000,000	359,000,000	357,000,000
Foreign Currency Exchange Contracts [Member] \| Revenue [Member]
Derivative Instrument Gain (Loss) [Abstract]
Gain or (loss) on derivatives not designated as hedging instruments	0	0	0
Foreign Currency Exchange Contracts [Member] \| Products [Member]
Derivative Instrument Gain (Loss) [Abstract]
Gain or (loss) on derivatives not designated as hedging instruments	0	0	0
Foreign Currency Exchange Contracts [Member] \| Services [Member]
Derivative Instrument Gain (Loss) [Abstract]
Gain or (loss) on derivatives not designated as hedging instruments	0	0	0
Foreign Currency Exchange Contracts [Member] \| SG&A [Member]
Derivative Instrument Gain (Loss) [Abstract]
Gain or (loss) on derivatives not designated as hedging instruments	0	0	0
Foreign Currency Exchange Contracts [Member] \| Other (Income) Expense [Member]
Derivative Instrument Gain (Loss) [Abstract]
Gain or (loss) on derivatives not designated as hedging instruments	195,000,000	(166,000,000)	106,000,000
Foreign Currency Exchange Contracts [Member] \| Interest and Other Financial Charges [Member]
Derivative Instrument Gain (Loss) [Abstract]
Gain or (loss) on derivatives not designated as hedging instruments	0	0	0
Products [Member]
Revenue	25,643,000,000	24,737,000,000	27,629,000,000
Cost of products and services sold	18,344,000,000	17,638,000,000	19,269,000,000
Services [Member]
Revenue	8,749,000,000	7,900,000,000	9,080,000,000
Cost of products and services sold	5,050,000,000	4,531,000,000	5,070,000,000
Designated as Hedging Instrument [Member] \| Foreign Currency Exchange Contracts [Member]
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax [Abstract]
Gain (Loss) on net investment hedges recognized in accumulated other comprehensive income	40,000,000	(94,000,000)
Designated as Hedging Instrument [Member] \| Gain or {loss) on cash flow hedges [Member] \| Foreign Currency Exchange Contracts [Member] \| Revenue [Member]
Derivative Instrument Gain (Loss) [Abstract]
Amount reclassified from accumulated other comprehensive inome into income	5,000,000	(3,000,000)	3,000,000
Amount excluded from effectiveness testing recognized in earnings using an amortization approach		0	0
Designated as Hedging Instrument [Member] \| Gain or {loss) on cash flow hedges [Member] \| Foreign Currency Exchange Contracts [Member] \| Products [Member]
Derivative Instrument Gain (Loss) [Abstract]
Amount reclassified from accumulated other comprehensive inome into income	8,000,000	43,000,000	35,000,000
Amount excluded from effectiveness testing recognized in earnings using an amortization approach		10,000,000	16,000,000
Designated as Hedging Instrument [Member] \| Gain or {loss) on cash flow hedges [Member] \| Foreign Currency Exchange Contracts [Member] \| Services [Member]
Derivative Instrument Gain (Loss) [Abstract]
Amount reclassified from accumulated other comprehensive inome into income	2,000,000	11,000,000	9,000,000
Amount excluded from effectiveness testing recognized in earnings using an amortization approach		3,000,000	6,000,000
Designated as Hedging Instrument [Member] \| Gain or {loss) on cash flow hedges [Member] \| Foreign Currency Exchange Contracts [Member] \| SG&A [Member]
Derivative Instrument Gain (Loss) [Abstract]
Amount reclassified from accumulated other comprehensive inome into income	9,000,000	(4,000,000)	1,000,000
Amount excluded from effectiveness testing recognized in earnings using an amortization approach		0	0
Designated as Hedging Instrument [Member] \| Gain or {loss) on cash flow hedges [Member] \| Foreign Currency Exchange Contracts [Member] \| Other (Income) Expense [Member]
Derivative Instrument Gain (Loss) [Abstract]
Amount reclassified from accumulated other comprehensive inome into income	0	28,000,000	73,000,000
Amount excluded from effectiveness testing recognized in earnings using an amortization approach		29,000,000	35,000,000
Designated as Hedging Instrument [Member] \| Gain or {loss) on cash flow hedges [Member] \| Foreign Currency Exchange Contracts [Member] \| Interest and Other Financial Charges [Member]
Derivative Instrument Gain (Loss) [Abstract]
Amount reclassified from accumulated other comprehensive inome into income	0	0	0
Amount excluded from effectiveness testing recognized in earnings using an amortization approach		0	0
Designated as Hedging Instrument [Member] \| Gain or (loss) on fair value hedges [Member] \| Interest rate swap agreements [Member] \| Revenue [Member]
Derivative Instrument Gain (Loss) [Abstract]
Hedged items	0	0	0
Derivatives designated as hedges	0	0	0
Designated as Hedging Instrument [Member] \| Gain or (loss) on fair value hedges [Member] \| Interest rate swap agreements [Member] \| Products [Member]
Derivative Instrument Gain (Loss) [Abstract]
Hedged items	0	0	0
Derivatives designated as hedges	0	0	0
Designated as Hedging Instrument [Member] \| Gain or (loss) on fair value hedges [Member] \| Interest rate swap agreements [Member] \| Services [Member]
Derivative Instrument Gain (Loss) [Abstract]
Hedged items	0	0	0
Derivatives designated as hedges	0	0	0
Designated as Hedging Instrument [Member] \| Gain or (loss) on fair value hedges [Member] \| Interest rate swap agreements [Member] \| SG&A [Member]
Derivative Instrument Gain (Loss) [Abstract]
Hedged items	0	0	0
Derivatives designated as hedges	0	0	0
Designated as Hedging Instrument [Member] \| Gain or (loss) on fair value hedges [Member] \| Interest rate swap agreements [Member] \| Other (Income) Expense [Member]
Derivative Instrument Gain (Loss) [Abstract]
Hedged items	0	0	0
Derivatives designated as hedges	0	0	0
Designated as Hedging Instrument [Member] \| Gain or (loss) on fair value hedges [Member] \| Interest rate swap agreements [Member] \| Interest and Other Financial Charges [Member]
Derivative Instrument Gain (Loss) [Abstract]
Hedged items	135,000,000	(169,000,000)	(70,000,000)
Derivatives designated as hedges	(135,000,000)	169,000,000	70,000,000
Designated as Hedging Instrument [Member] \| Gain or (loss) on net investment hedges [Member] \| Foreign Currency Exchange Contracts [Member] \| Revenue [Member]
Derivative Instrument Gain (Loss) [Abstract]
Amount excluded from effectiveness testing recognized in earnings using an amortization approach	0	0	0
Designated as Hedging Instrument [Member] \| Gain or (loss) on net investment hedges [Member] \| Foreign Currency Exchange Contracts [Member] \| Products [Member]
Derivative Instrument Gain (Loss) [Abstract]
Amount excluded from effectiveness testing recognized in earnings using an amortization approach	0	0	0
Designated as Hedging Instrument [Member] \| Gain or (loss) on net investment hedges [Member] \| Foreign Currency Exchange Contracts [Member] \| Services [Member]
Derivative Instrument Gain (Loss) [Abstract]
Amount excluded from effectiveness testing recognized in earnings using an amortization approach	0	0	0
Designated as Hedging Instrument [Member] \| Gain or (loss) on net investment hedges [Member] \| Foreign Currency Exchange Contracts [Member] \| SG&A [Member]
Derivative Instrument Gain (Loss) [Abstract]
Amount excluded from effectiveness testing recognized in earnings using an amortization approach	0	0	0
Designated as Hedging Instrument [Member] \| Gain or (loss) on net investment hedges [Member] \| Foreign Currency Exchange Contracts [Member] \| Other (Income) Expense [Member]
Derivative Instrument Gain (Loss) [Abstract]
Amount excluded from effectiveness testing recognized in earnings using an amortization approach	0	0	0
Designated as Hedging Instrument [Member] \| Gain or (loss) on net investment hedges [Member] \| Foreign Currency Exchange Contracts [Member] \| Interest and Other Financial Charges [Member]
Derivative Instrument Gain (Loss) [Abstract]
Amount excluded from effectiveness testing recognized in earnings using an amortization approach	16,000,000	18,000,000	$ 19,000,000
Designated as Hedging Instrument [Member] \| Euro-denominated long-term debt
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax [Abstract]
Gain (Loss) on net investment hedges recognized in accumulated other comprehensive income	284,000,000	(256,000,000)
Designated as Hedging Instrument [Member] \| Euro-denominated commercial paper [Member]
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax [Abstract]
Gain (Loss) on net investment hedges recognized in accumulated other comprehensive income	57,000,000	(8,000,000)
Designated as Hedging Instrument [Member] \| Net Investment Cross Currency Swap [Member]
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax [Abstract]
Gain (Loss) on net investment hedges recognized in accumulated other comprehensive income	$ 88,000,000	$ (109,000,000)

EARNINGS PER SHARE

12 Months Ended

Dec. 31, 2021

Earnings Per Share [Abstract]

Earnings Per Share

The details of the earnings per share calculations for the years ended December 31, 2021, 2020 and 2019 are as follows (shares in millions):


Basic	Years Ended December 31,
	2021			2020			2019
Net income attributable to Honeywell		$	5,542		$	4,779		$	6,143
Weighted average shares outstanding		692.3			704.1			721.0
Earnings per share of common stock		$	8.01		$	6.79		$	8.52


Assuming Dilution	Years Ended December 31,
	2021			2020			2019
Net income attributable to Honeywell		$	5,542		$	4,779		$	6,143
Average Shares
Weighted average shares outstanding		692.3			704.1			721.0
Dilutive securities issuable—stock plans		8.1			7.1			9.3
Total weighted average diluted shares outstanding		700.4			711.2			730.3
Earnings per share of common stock—assuming dilution		$	7.91		$	6.72		$	8.41

The diluted earnings per share calculations exclude the effect of stock options when the options’ assumed proceeds exceed the average market price of the common shares during the period. In 2021, 2020 and 2019 the weighted number of stock options excluded from the computations were 1.7 million, 5.5 million and 2.5 million, respectively. These stock options were outstanding at the end of each of the respective periods.

CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)	12 Months Ended
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Net Cash Provided by (Used in) Operating Activities [Abstract]
Net income	$ 5,610,000,000	$ 4,865,000,000	$ 6,230,000,000
Less: Net income attributable to the noncontrolling interest	68,000,000	86,000,000	87,000,000
Net income attributable to Honeywell	5,542,000,000	4,779,000,000	6,143,000,000
Adjustments to reconcile net income attributable to Honeywell to net cash provided by operating activities [Abstract]
Depreciation	674,000,000	644,000,000	673,000,000
Amortization	549,000,000	358,000,000	415,000,000
Loss (gain) on sale of non-strategic businesses and assets	(102,000,000)	3,000,000	1,000,000
Repositioning and other charges	569,000,000	575,000,000	546,000,000
Net payments for repositioning and other charges	(692,000,000)	(833,000,000)	(376,000,000)
Pension and other postretirement income	(1,114,000,000)	(798,000,000)	(516,000,000)
Pension and other postretirement benefit payments	(43,000,000)	(47,000,000)	(78,000,000)
Stock compensation expense	217,000,000	168,000,000	153,000,000
Deferred income taxes	178,000,000	(175,000,000)	179,000,000
Reimbursement receivables charge	0	509,000,000	0
Other	(28,000,000)	(338,000,000)	(287,000,000)
Changes in assets and liabilities, net of the effects of acquisitions and divestitures: [Abstract]
Accounts receivable	(8,000,000)	669,000,000	11,000,000
Inventories	(685,000,000)	(67,000,000)	(100,000,000)
Other current assets	(276,000,000)	191,000,000	(430,000,000)
Accounts payable	744,000,000	15,000,000	118,000,000
Accrued liabilities	513,000,000	555,000,000	445,000,000
Net cash provided by (used for) operating activities	6,038,000,000	6,208,000,000	6,897,000,000
Cash flows from investing activities: [Abstract]
Expenditures for property, plant and equipment	(895,000,000)	(906,000,000)	(839,000,000)
Proceeds from disposals of property, plant and equipment	27,000,000	57,000,000	43,000,000
Increase in investments	(2,373,000,000)	(3,236,000,000)	(4,253,000,000)
Decrease in investments	2,525,000,000	3,508,000,000	4,464,000,000
Receipts from Garrett Motion Inc.	586,000,000	0	0
Receipts (payments) from settlements of derivative contracts	192,000,000	(149,000,000)	102,000,000
Cash paid for acquisitions, net of cash acquired	(1,326,000,000)	(261,000,000)	(50,000,000)
Proceeds from sales of businesses, net of fees paid	203,000,000	0	0
Net cash provided by (used for) investing activities	(1,061,000,000)	(987,000,000)	(533,000,000)
Cash flows from financing activities: [Abstract]
Proceeds from issuance of commercial paper and other short-term borrowings	5,194,000,000	10,474,000,000	14,199,000,000
Payments of commercial paper and other short-term borrowings	(5,190,000,000)	(10,400,000,000)	(14,199,000,000)
Proceeds from issuance of common stock	229,000,000	393,000,000	498,000,000
Proceeds from issuance of long-term debt	2,517,000,000	10,125,000,000	2,726,000,000
Payments of long-term debt	(4,917,000,000)	(4,308,000,000)	(2,903,000,000)
Repurchases of common stock	(3,380,000,000)	(3,714,000,000)	(4,400,000,000)
Cash dividends paid	(2,626,000,000)	(2,592,000,000)	(2,442,000,000)
Other	(81,000,000)	(59,000,000)	(79,000,000)
Net cash provided by (used for) financing activities	(8,254,000,000)	(81,000,000)	(6,600,000,000)
Effect of foreign exchange rate changes on cash and cash equivalents	(39,000,000)	68,000,000	16,000,000
Net increase (decrease) in cash and cash equivalents	(3,316,000,000)	5,208,000,000	(220,000,000)
Cash and cash equivalents at beginning of period	14,275,000,000	9,067,000,000	9,287,000,000
Cash and cash equivalents at end of period	$ 10,959,000,000	$ 14,275,000,000	$ 9,067,000,000

INCOME TAX 5 (Details) - USD ($) $ in Millions	12 Months Ended
INCOME TAX 5 (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Balance at beginning of year	$ 991	$ 1,164	$ 1,089
Gross increases related to current period tax positions	93	94	51
Gross increases related to prior periods tax positions	39	68	83
Gross decreases related to prior periods tax positions	(27)	(256)	(34)
Decrease related to resolutions of audits with tax authorities	(1)	(35)	(3)
Expiration of the statue of limitations for the assessment of taxes	(12)	(76)	(13)
Foreign currency translation	(22)	32	(9)
Balance at end of year	$ 1,061	$ 991	$ 1,164

CONSOLIDATED STATEMENT OF OPERATIONS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Statement [Abstract]
Net Sales	$ 34,392	$ 32,637	$ 36,709
Costs and Expenses [Abstract]
Cost of products and services sold	23,394	22,169	24,339
Selling, general and administrative expenses	4,798	4,772	5,519
Other (income) expense	(1,378)	(675)	(1,065)
Interest and other financial charges	343	359	357
Cost, operating and non-operating expenses	27,157	26,625	29,150
Income before taxes	7,235	6,012	7,559
Tax expense	1,625	1,147	1,329
Net income	5,610	4,865	6,230
Less: Net income attributable to the noncontrolling interest	68	86	87
Net income attributable to Honeywell	$ 5,542	$ 4,779	$ 6,143
Earnings per share of common stock - basic	$ 8.01	$ 6.79	$ 8.52
Earnings per share of common stock - assuming dilution	$ 7.91	$ 6.72	$ 8.41
Products [Member]
Income Statement [Abstract]
Net Sales	$ 25,643	$ 24,737	$ 27,629
Costs and Expenses [Abstract]
Cost of products and services sold	18,344	17,638	19,269
Services [Member]
Income Statement [Abstract]
Net Sales	8,749	7,900	9,080
Costs and Expenses [Abstract]
Cost of products and services sold	$ 5,050	$ 4,531	$ 5,070

DERIVATIVE INSTRUMENTS AND HEDGING TRANSACTIONS

12 Months Ended

Dec. 31, 2021

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Instruments and Hedging Activities Disclosure [Text Block]

DERIVATIVES AND HEDGING ACTIVITIES

The Company uses derivative financial instruments to manage its risks related to interest rates and foreign currency exchange rate fluctuations. Derivative financial instruments are not used for trading or other speculative purposes. To qualify as a hedge, derivative financial instruments must be evaluated for hedge effectiveness at the inception of the contract and designated as a hedge. Changes in fair value of the derivative contract must be highly correlated with changes in fair value of the underlying hedged item at inception and over the life of the hedge contract.

FOREIGN CURRENCY RISK MANAGEMENT

The Company operates a global business in a wide variety of foreign currencies. The Company's exposure to market risk for changes in foreign currency exchange rates arises from international financing activities between subsidiaries, foreign currency denominated monetary assets and liabilities, and transactions arising from international trade. The Company's objective is to preserve the U.S. Dollar value of foreign currency denominated cash flows and earnings. The Company monitors its collective foreign currency exposure and enters into foreign currency exchange forward and option contracts (foreign currency exchange contracts) with third parties, when necessary, to minimize the impact of changes in foreign currency exchange rates.

The Company has monetary assets and liabilities denominated in non-functional currencies. Prior to conversion into U.S. dollars, these assets and liabilities are remeasured at spot exchange rates in effect on the balance sheet date. The effects of changes in spot rates are recognized in earnings and included in Other (income) expense. The Company uses foreign currency exchange contracts to hedge its foreign currency exposure. These contracts are marked-to-market with the resulting gains and losses recognized in earnings offsetting the gains and losses on the non-functional currency denominated monetary assets and liabilities being hedged. The Company uses foreign currency contracts to hedge forecasted sales and purchases, which are denominated in non-functional currencies. Changes in the forecasted non-functional currency cash flows due to movements in exchange rates are substantially offset by changes in the fair value of these foreign currency exchange contracts designated as hedges. Market value gains and losses on these contracts are recognized in earnings when the hedged transaction is recognized. As of December 31, 2021, and 2020, the Company held contracts with notional amounts of $12,671 million and $16,123 million to exchange foreign currencies, principally the U.S. Dollar, Euro, Canadian Dollar, British Pound, Mexican Peso, Chinese Renminbi, and Indian Rupee.

The Company also designates certain foreign currency debt and derivative contracts as hedges against portions of its net investment in foreign operations. Gains or losses of the foreign currency debt and derivative contracts designated as net investment hedges are recorded in the same manner as foreign currency translation adjustments.

INTEREST RATE RISK MANAGEMENT

Financial instruments, including derivatives, expose the Company to market risk related to changes in interest rates. The Company uses a combination of financial instruments, including long-term, medium-term, and short-term financing, variable-rate commercial paper, and interest rate swaps to convert the interest rate mix of the Company's total debt portfolio and related overall cost of borrowing.

CREDIT RISK MANAGEMENT

The Company continues to monitor the creditworthiness of its counterparties to mitigate the risk of nonperformance. Financial instruments, including derivatives, expose the Company to counterparty credit risk. In addition, the Company grants credit terms to its customers in the normal course of business. The terms and conditions of the Company's credit sales are designed to mitigate or eliminate concentrations of credit risk with any single customer. The Company's sales are not materially dependent on a single customer or a small group of customers.

DERIVATIVE AND HEDGING INSTRUMENTS

The following table summarizes the notional amounts and fair values of the Company’s outstanding derivatives by risk category and instrument type within the Consolidated Balance Sheet:


	Notional						Fair Value Asset						Fair Value (Liability)
	December 31, 2021			December 31, 2020			December 31, 2021			December 31, 2020			December 31, 2021			December 31, 2020
Derivatives in Fair Value Hedging Relationships:
Interest rate swap agreements		$	3,150		$	3,950		$	60		$	194		$	—		$	—
Derivatives in Cash Flow Hedging Relationships:
Foreign currency exchange contracts		647			488			4			65			—			(58)
Derivatives in Net Investment Hedging Relationships:
Foreign currency exchange contracts		746			806			92			45			—			(1)
Cross currency swap agreements		1,200			1,200			39			—			—			(50)
Total Derivatives Designated as Hedging Instruments		5,743			6,444			195			304			—			(109)
Derivatives Not Designated as Hedging Instruments:
Foreign currency exchange contracts		11,278			14,829			278			92			(282)			(91)
Total Derivatives at Fair Value		$	17,021		$	21,273		$	473		$	396		$	(282)		$	(200)

All derivative assets are presented in Other current assets or Other assets. All derivative liabilities are presented in Accrued liabilities or Other liabilities.

In addition to the foreign currency derivative contracts designated as net investment hedges, certain of the Company's foreign currency denominated debt instruments are designated as net investment hedges. The carrying value of those debt instruments designated as net investment hedges, which includes the adjustment for the foreign currency transaction gain or loss on those instruments, was $4,074 million and $4,414 million as of December 31, 2021 and 2020, respectively.

Interest rate swap agreements are designated as hedge relationships with gains or losses on the derivative recognized in Interest and other financial charges offsetting the gains and losses on the underlying debt being hedged. Gains and losses on interest rate swap agreements recognized in earnings were $135 million of expense, $169 million of income and $70 million of expense for the years ended December 31, 2021, 2020 and 2019, respectively. Gains and losses are fully offset by losses and gains on the underlying debt being hedged.

The following table sets forth the amounts recorded on the Consolidated Balance Sheet related to cumulative basis adjustments for fair value hedges:


Line in the Consolidated Balance Sheet of Hedged Item	Carrying Amount of the Hedged Item						Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Item
Line in the Consolidated Balance Sheet of Hedged Item	December 31, 2021			December 31, 2020			December 31, 2021			December 31, 2020
Long-term debt		$	3,210		$	4,144		$	60		$	194

The following tables summarize the location and impact to the Consolidated Statement of Operations related to derivative instruments:


	Year Ended December 31, 2021
	Net Sales			Cost of Products Sold			Cost of Services Sold			Selling, general and administrative expenses			Other (Income) Expense			Interest and Other Financial Charges
		$	34,392		$	18,344		$	5,050		$	4,798		$	(1,378)		$	343
Gain or (loss) on cash flow hedges:
Foreign Currency Exchange Contracts:
Amount reclassified from accumulated other comprehensive income into income		5			8			2			9			—			—

Gain or (loss) on fair value hedges:
Interest Rate Swap Agreements:
Hedged items		—			—			—			—			—			135
Derivatives designated as hedges		—			—			—			—			—			(135)
Gain or (loss) on net investment hedges:
Foreign Currency Exchange Contracts:
Amount excluded from effectiveness testing recognized in earnings using an amortization approach		—			—			—			—			—			16
Gain or (loss) on derivatives not designated as hedging instruments:
Foreign currency exchange contracts		—			—			—			—			195			—


	Year Ended December 31, 2020
	Net Sales			Cost of Products Sold			Cost of Services Sold			Selling, general and administrative expenses			Other (Income) Expense			Interest and Other Financial Charges
		$	32,637		$	17,638		$	4,531		$	4,772		$	(675)		$	359
Gain or (loss) on cash flow hedges:
Foreign Currency Exchange Contracts:
Amount reclassified from accumulated other comprehensive income into income		(3)			43			11			(4)			28			—
Amount excluded from effectiveness testing recognized in earnings using an amortization approach		—			10			3			—			29			—
Gain or (loss) on fair value hedges:
Interest Rate Swap Agreements:
Hedged items		—			—			—			—			—			(169)
Derivatives designated as hedges		—			—			—			—			—			169
Gain or (loss) on net investment hedges:
Foreign Currency Exchange Contracts:
Amount excluded from effectiveness testing recognized in earnings using an amortization approach		—			—			—			—			—			18
Gain or (loss) on derivatives not designated as hedging instruments:
Foreign currency exchange contracts		—			—			—			—			(166)			—


	Year Ended December 31, 2019
	Net Sales			Cost of Products Sold			Cost of Services Sold			Selling, general and administrative expenses			Other (Income) Expense			Interest and Other Financial Charges
		$	36,709		$	19,269		$	5,070		$	5,519		$	(1,065)		$	357
Gain or (loss) on cash flow hedges:
Foreign Currency Exchange Contracts:
Amount reclassified from accumulated other comprehensive income into income		3			35			9			1			73			—
Amount excluded from effectiveness testing recognized in earnings using an amortization approach		—			16			6			—			35			—
Gain or (loss) on fair value hedges:
Interest Rate Swap Agreements:
Hedged items		—			—			—			—			—			(70)
Derivatives designated as hedges		—			—			—			—			—			70
Gain or (loss) on net investment hedges:
Foreign Currency Exchange Contracts:
Amount excluded from effectiveness testing recognized in earnings using an amortization approach		—			—			—			—			—			19
Gain or (loss) on derivatives not designated as hedging instruments:
Foreign currency exchange contracts		—			—			—			—			106			—

As of December 31, 2021, the Company estimates that approximately $10 million of net derivative gains related to its cash flow hedges included in Accumulated other comprehensive income (loss) will be reclassified into earnings within the next 12 months.

The following table summarizes the amounts of gain or (loss) on net investment hedges recognized in Accumulated other comprehensive income (loss):


Derivatives Net Investment Hedging Relationships	Years Ended December 31,
	2021			2020
Euro-denominated long-term debt		$	284		$	(256)
Euro-denominated commercial paper		57			(8)
Cross currency swap		88			(109)
Foreign currency exchange contracts		40			(94)

PENSION AND OTHER POSTRETIREMENT BENEFITS 2 (Details) - USD ($)	3 Months Ended	9 Months Ended	12 Months Ended
	Dec. 31, 2020	Sep. 30, 2020	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Other Postretirement Benefits [Member]
Actuarial assumptions used to determine benefit obligations as of December 31: [Abstract]
Discount rate	2.20%			2.66%	2.20%	3.03%
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Discount rate - benefit obligation	2.36%	3.03%		2.20%	2.36%	4.07%
UNITED STATES
Actuarial assumptions used to determine benefit obligations as of December 31: [Abstract]
Discount rate	2.50%			2.87%	2.50%	3.22%
Expected annual rate of compensation increase	3.25%			3.25%	3.25%	3.25%
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Discount rate - benefit obligation				2.50%	3.22%	4.35%
Expected rate of return on plan assets				6.15%	6.15%	6.75%
Expected annual rate of compensation increase				3.25%	3.25%	3.25%
Defined Benefit Plan, Pension Plan with Project Benefit Obligation in Excess of Plan Assets [Abstract]
Projected benefit obligations	$ 353,000,000			$ 359,000,000	$ 353,000,000
Accumulated benefit obligations	341,000,000			346,000,000	341,000,000
Fair value of plan assets	0			0	0
Defined Benefit Plan Accumulated Benefit Obligation [Abstract]
Accumulated benefit obligation	$ 17,900,000,000			$ 17,300,000,000	$ 17,900,000,000
UNITED STATES \| Service Cost
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Discount rate - benefit obligation				2.68%	3.33%	4.47%
UNITED STATES \| Interest Costs
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Discount rate - benefit obligation				1.76%	2.76%	3.94%
UNITED STATES \| Forecast [Member]
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Expected rate of return on plan assets			6.40%
UNITED STATES \| Forecast [Member] \| Service Cost
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Discount rate - benefit obligation			2.97%
UNITED STATES \| Forecast [Member] \| Interest Costs
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Discount rate - benefit obligation			2.26%
Foreign Plan [Member]
Actuarial assumptions used to determine benefit obligations as of December 31: [Abstract]
Discount rate	1.23%			1.79%	1.23%	1.81%
Expected annual rate of compensation increase	2.43%			2.56%	2.43%	2.47%
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Discount rate - benefit obligation				1.24%	1.81%	2.63%
Expected rate of return on plan assets				4.03%	4.66%	5.14%
Expected annual rate of compensation increase				2.43%	2.47%	2.46%
Defined Benefit Plan, Pension Plan with Project Benefit Obligation in Excess of Plan Assets [Abstract]
Projected benefit obligations	$ 2,116,000,000			$ 964,000,000	$ 2,116,000,000
Accumulated benefit obligations	2,042,000,000			932,000,000	2,042,000,000
Fair value of plan assets	1,208,000,000			256,000,000	1,208,000,000
Defined Benefit Plan Accumulated Benefit Obligation [Abstract]
Accumulated benefit obligation	$ 7,600,000,000			$ 6,900,000,000	$ 7,600,000,000
Foreign Plan [Member] \| Service Cost
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Discount rate - benefit obligation				1.00%	1.48%	2.26%
Foreign Plan [Member] \| Interest Costs
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Discount rate - benefit obligation				1.00%	1.56%	2.34%

STOCK-BASED COMPENSATION PLANS - RSUS (Details) - 2016 Plan [Member] - Restricted Stock Units (RSUs) [Member] - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Nonvested options recognized over weighted average period, years	2 years 2 months 23 days
Unrecognized compensation on nonvested stock options	$ 273
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Non-vested at beginning of period,	3,396,523	3,240,065	3,657,873
Granted	992,854	1,551,675	1,200,202
Vested	(1,123,547)	(1,001,101)	(1,160,333)
Forfeited	(308,293)	(394,116)	(457,677)
Non-vested at end of period,	2,957,536	3,396,523	3,240,065
Weighted average grant date fair value per share [Abstract]
Non-vested at beginning of period,	$ 148.23	$ 143.07	$ 125.35
Granted	214.61	158.52	162.43
Vested	144.34	117.84	104.32
Forfeited	156.74	145.42	134.50
Non-vested at end of period,	$ 171.73	$ 148.23	$ 143.07
Income Statement Impact From RSUs [Abstract]
Compensation expense	$ 162	$ 118	$ 106
Future income tax benefit recognized	$ 23	$ 24	$ 21
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting periods	3 years
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting periods	6 years

COMMITMENTS ND CONTINGENCIES 7 (Details) shares in Millions	12 Months Ended
COMMITMENTS ND CONTINGENCIES 7 (Details) shares in Millions	Dec. 31, 2021 USD ($) shares	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)	Mar. 31, 2022 USD ($)	Apr. 30, 2021 USD ($)
Garrett Litigation And Bankruptcy Proceedings [Line Items]
Reimbursement receivables charge	$ 0	$ 509,000,000	$ 0
Cash Received By Honeywell	$ 586,000,000	0	0
Investment Owned, Balance, Shares \| shares	834.8
Long-term investment		0	$ 0		$ 577,000,000
Short-term investments	$ 564,000,000	945,000,000
Investments and long-term receivables	1,222,000,000	685,000,000
Series B Preferred Stock [Member]
Garrett Litigation And Bankruptcy Proceedings [Line Items]
Short-term investments	$ 34,000,000
Mandatory Redemption Discount Rate	0.0725
Common Class A [Member]
Garrett Litigation And Bankruptcy Proceedings [Line Items]
Investment Owned, Balance, Shares \| shares	2.9
Series B Preferred Stock, Series A Preferred Stock and Common Stock investments in Garrett [Member]
Garrett Litigation And Bankruptcy Proceedings [Line Items]
Investments and long-term receivables	$ 423,000,000
Garrett Indemnity And Tax Matters Agreement [Member]
Garrett Litigation And Bankruptcy Proceedings [Line Items]
Reimbursement receivables charge		$ 509,000,000
The Confirmed Plan [Member]
Garrett Litigation And Bankruptcy Proceedings [Line Items]
Garrett Minimum EBITDA	425,000,000
The Confirmed Plan [Member] \| Series B Preferred Stock [Member] \| First Partial Redemption [Member]
Garrett Litigation And Bankruptcy Proceedings [Line Items]
Preferred Stock, Redemption Amount	211,000,000
The Confirmed Plan [Member] \| Series B Preferred Stock [Member] \| Second Partial Redemption [Member]
Garrett Litigation And Bankruptcy Proceedings [Line Items]
Long-term investment	$ 207,000,000
The Confirmed Plan [Member] \| Series B Preferred Stock [Member] \| Forecast [Member] \| First Partial Redemption [Member]
Garrett Litigation And Bankruptcy Proceedings [Line Items]
Long-term investment				$ 400,000,000
The Confirmed Plan [Member] \| Series B Preferred Stock [Member] \| Forecast [Member] \| Second Partial Redemption [Member]
Garrett Litigation And Bankruptcy Proceedings [Line Items]
Preferred Stock, Redemption Amount				$ 200,000,000
The Confirmed Plan [Member] \| Series A Preferred Stock [Member]
Garrett Litigation And Bankruptcy Proceedings [Line Items]
Investment Owned, Balance, Shares \| shares	4.2
The Confirmed Plan [Member] \| 2022 [Member] \| Series B Preferred Stock [Member]
Garrett Litigation And Bankruptcy Proceedings [Line Items]
Preferred Stock, Redemption Amount	$ 35,000,000
The Confirmed Plan [Member] \| 2023 through 2030[Member] \| Series B Preferred Stock [Member]
Garrett Litigation And Bankruptcy Proceedings [Line Items]
Preferred Stock, Redemption Amount	100,000,000
The Confirmed Plan [Member] \| Garrett Indemnity And Tax Matters Agreement [Member] \| Initial Payment [Member]
Garrett Litigation And Bankruptcy Proceedings [Line Items]
Cash Received By Honeywell	$ 375,000,000
Investment Owned, Balance, Shares \| shares	834.8

PROPERTY, PLANT AND EQUIPMENT-NET

12 Months Ended

Dec. 31, 2021

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment


	December 31,
	2021			2020
Land and improvements		$	226		$	259
Machinery and equipment		10,143			10,008
Buildings and improvements		3,225			3,245
Construction in progress		856			825
		14,450			14,337
Less—Accumulated depreciation		(8,888)			(8,767)
		$	5,562		$	5,570

Depreciation expense was $674 million, $644 million and $673 million for the years ended December 31, 2021, 2020 and 2019, respectively.

AUDIT INFORMATION	12 Months Ended
AUDIT INFORMATION	Dec. 31, 2021
Audit Information [Abstract]
Auditor Name	DELOITTE & TOUCHE LLP
Auditor Firm ID	34
Auditor Location	Charlotte, North Carolina

INVENTORIES (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Inventory, Combining Work in Process and Raw Materials Alternative, Gross [Abstract]
Raw materials	$ 1,352	$ 1,079
Work in process	861	798
Finished products	2,925	2,612
Inventories	$ 5,138	$ 4,489

PENSION AND OTHER POSTRETIREMENT BENEFITS (Tables)

12 Months Ended

Dec. 31, 2021

Retirement Benefits [Abstract]

Defined Benefit Plans Disclosure


	Pension Benefits
	U.S. Plans						Non-U.S. Plans
	2021			2020			2021			2020
Change in benefit obligation:
Benefit obligation at beginning of year		$	18,054		$	17,283		$	7,670		$	6,897
Service cost		105			99			26			23
Interest cost		306			461			77			106
Plan amendments		—			—			(3)			2
Actuarial (gains) losses(1)		141			1,331			(403)			509
Benefits paid		(1,221)			(1,100)			(249)			(246)
Settlements and curtailments		—			(21)			—			—
Foreign currency translation		—			—			(121)			291
Other		6			1			2			88
Benefit obligation at end of year		17,391			18,054			6,999			7,670
Change in plan assets:
Fair value of plan assets at beginning of year		20,396			18,995			8,450			7,307
Actual return on plan assets		1,344			2,475			166			918
Company contributions		35			46			101			116
Benefits paid		(1,221)			(1,100)			(249)			(246)
Settlements and curtailments		—			(21)			—			—
Foreign currency translation		—			—			(74)			253
Other		6			1			2			102
Fair value of plan assets at end of year		20,560			20,396			8,396			8,450
Funded status of plans		$	3,169		$	2,342		$	1,397		$	780
Amounts recognized in Consolidated Balance Sheet consist of:
Prepaid pension benefit cost(2)		$	3,528		$	2,695		$	2,105		$	1,688
Accrued pension liabilities—current(3)		(33)			(29)			(14)			(14)
Accrued pension liabilities—noncurrent(4)		(326)			(324)			(694)			(894)
Net amount recognized		$	3,169		$	2,342		$	1,397		$	780

(2)Included in Other assets on the Consolidated Balance Sheet

(3)Included in Accrued liabilities on the Consolidated Balance Sheet

(4)Included in Other liabilities on the Consolidated Balance Sheet


	Other Postretirement Benefits
	2021			2020
Change in benefit obligation:
Benefit obligation at beginning of year		$	229		$	325
Service cost		—			—
Interest cost		5			8
Plan amendments		—			(65)
Actuarial (gains) losses		(8)			(8)
Benefits paid		(30)			(31)
Benefit obligation at end of year		196			229
Change in plan assets:
Fair value of plan assets at beginning of year		—			—
Actual return on plan assets		—			—
Company contributions		—			—
Benefits paid		—			—
Fair value of plan assets at end of year		—			—
Funded status of plans		$	(196)		$	(229)
Amounts recognized in Consolidated Balance Sheet consist of:
Accrued liabilities		$	(25)		$	(27)
Postretirement benefit obligations other than pensions(1)		(171)			(202)
Net amount recognized		$	(196)		$	(229)

(1)Excludes non-U.S. plan of $37 million and $40 million as of December 31, 2021 and 2020.

Other Changes in Plan Assets Recognized in Other Comprehensive Income


	Pension Benefits
	U.S. Plans						Non-U.S. Plans
	2021			2020			2021			2020
Prior service (credit) cost		$	(92)		$	(134)		$	20		$	23
Net actuarial (gain) loss		492			505			397			629
Net amount recognized		$	400		$	371		$	417		$	652


	Other Postretirement Benefits
	2021			2020
Prior service (credit) cost		$	(92)		$	(165)
Net actuarial (gain) loss		(34)			(28)
Net amount recognized		$	(126)		$	(193)

Net Periodic Benefit Cost


Net Periodic Benefit Cost	Pension Benefits
	U.S. Plans									Non-U.S. Plans
	2021			2020			2019			2021			2020			2019
Service cost		$	105		$	99		$	82		$	26		$	23		$	22
Interest cost		306			461			613			77			106			142
Expected return on plan assets		(1,220)			(1,135)			(1,117)			(348)			(336)			(331)
Amortization of prior service (credit) cost		(42)			(42)			(42)			—			—			—
Recognition of actuarial losses		31			26			35			9			18			88
Settlements and curtailments		—			4			4			—			—			—
Net periodic benefit (income) cost		$	(820)		$	(587)		$	(425)		$	(236)		$	(189)		$	(79)


Other Changes in Plan Assets and Benefits Obligations Recognized in Other Comprehensive (Income) Loss	U.S. Plans									Non-U.S. Plans
	2021			2020			2019			2021			2020			2019
Actuarial (gains) losses		$	(14)		$	(9)		$	(277)		$	(221)		$	(73)		$	176
Prior service (credit) cost		—			—			—			(3)			2			—
Prior service credit recognized during year		43			42			42			(1)			—			—
Actuarial losses recognized during year		—			(30)			(39)			(9)			(18)			(88)
Foreign currency translation		—			—			—			(1)			19			14
Total recognized in other comprehensive (income) loss		$	29		$	3		$	(274)		$	(235)		$	(70)		$	102
Total recognized in net periodic benefit (income) cost and other comprehensive (income) loss		$	(791)		$	(584)		$	(699)		$	(471)		$	(259)		$	23


Net Periodic Benefit Cost	Other Postretirement Benefits
	Years Ended December 31,
	2021			2020			2019
Service cost		$	—		$	—		$	—
Interest cost		5			8			14
Amortization of prior service (credit) cost		(74)			(66)			(62)
Recognition of actuarial (gains) losses		(2)			—			—
Net periodic benefit (income) cost		$	(71)		$	(58)		$	(48)


Other Changes in Plan Assets and Benefits Obligations Recognized in Other Comprehensive (Income) Loss	Years Ended December 31,
	2021			2020			2019
Actuarial (gains) losses		$	(8)		$	(8)		$	(16)
Prior service (credit) cost		—			(65)			(2)
Prior service credit recognized during year		74			66			62
Actuarial (gains) losses recognized during year		2			—			—
Total recognized in other comprehensive (income) loss		$	68		$	(7)		$	44
Total recognized in net periodic benefit (income) cost and other comprehensive (income) loss		$	(3)		$	(65)		$	(4)

Assumptions Used in Calculations


	Pension Benefits
	U.S. Plans									Non-U.S. Plans
	2021			2020			2019			2021			2020			2019
Actuarial assumptions used to determine benefit obligations as of December 31:
Discount rate		2.87	%		2.50	%		3.22	%		1.79	%		1.23	%		1.81	%
Expected annual rate of compensation increase		3.25	%		3.25	%		3.25	%		2.56	%		2.43	%		2.47	%
Actuarial assumptions used to determine net periodic benefit (income) cost for years ended December 31:
Discount rate—benefit obligation		2.50	%		3.22	%		4.35	%		1.24	%		1.81	%		2.63	%
Discount rate—service cost		2.68	%		3.33	%		4.47	%		1.00	%		1.48	%		2.26	%
Discount rate—interest cost		1.76	%		2.76	%		3.94	%		1.00	%		1.56	%		2.34	%
Expected rate of return on plan assets		6.15	%		6.15	%		6.75	%		4.03	%		4.66	%		5.14	%
Expected annual rate of compensation increase		3.25	%		3.25	%		3.25	%		2.43	%		2.47	%		2.46	%


	Other Postretirement Benefits
	2021			2020			2019
Actuarial assumptions used to determine benefit obligations as of December 31:
Discount rate		2.66	%		2.20	%		3.03	%
Actuarial assumptions used to determine net periodic benefit cost for years ended December 31:
Discount rate(1)		2.20	%		2.36	%		4.07	%

(1)Discount rate was 3.03% for January 1, 2020 through September 30, 2020. The rate was changed to 2.36% for the remainder of 2020 due to a Plan remeasurement as of October 1, 2020.

Accumulated Benefit Obligations in Excess of Plan Assets


	December 31,
	U.S. Plans						Non-U.S. Plans
	2021			2020			2021			2020
Projected benefit obligation		$	359		$	353		$	964		$	2,116
Accumulated benefit obligation		$	346		$	341		$	932		$	2,042
Fair value of plan assets		$	—		$	—		$	256		$	1,208

Fair Value of Plan Assets


	U.S. Plans
	December 31, 2021
	Total			Level 1			Level 2			Level 3
Equities:
Honeywell common stock		$	3,251		$	3,251		$	—		$	—
U.S. equities		—			—			—			—


Fixed income:
Short term investments		1,767			1,767			—			—
Government securities		1,373			—			1,373			—
Corporate bonds		9,588			—			9,588			—
Mortgage/Asset-backed securities		1,072			—			1,072			—
Insurance contracts		8			—			8			—
Direct investments:
Direct private investments		1,336			—			—			1,336
Real estate properties		843			—			—			843
Total		$	19,238		$	5,018		$	12,041		$	2,179
Investments measured at NAV:
Private funds		1,244
Real estate funds		14

Commingled Funds		64
Total assets at fair value		$	20,560


	U.S. Plans
	December 31, 2020
	Total			Level 1			Level 2			Level 3
Equities:
Honeywell common stock		$	3,319		$	3,319		$	—		$	—
U.S. equities		—			—			—			—


Fixed income:
Short term investments		1,314			1,314			—			—
Government securities		1,520			—			1,520			—
Corporate bonds		10,190			—			10,190			—
Mortgage/Asset-backed securities		982			—			982			—
Insurance contracts		7			—			7			—
Direct investments:
Direct private investments		1,220			—			—			1,220
Real estate properties		651			—			—			651
Total		$	19,203		$	4,633		$	12,699		$	1,871
Investments measured at NAV:
Private funds		1,105
Real estate funds		26

Commingled funds		62
Total assets at fair value		$	20,396


	Non-U.S. Plans
	December 31, 2021
	Total			Level 1			Level 2			Level 3
Equities:
U.S. equities		$	229		$	1		$	228		$	—
Non-U.S. equities		824			—			824			—
Fixed income:
Short-term investments		571			571			—			—
Government securities		3,893			—			3,893			—
Corporate bonds		1,681			—			1,681			—
Mortgage/Asset-backed securities		79			—			79			—
Insurance contracts		123			—			123			—
Insurance buy-in contracts		691			—			—			691
Investments in private funds:
Private funds		74			—			41			33
Real estate funds		163			—			—			163
Total		$	8,328		$	572		$	6,869		$	887
Investments measured at NAV:
Private funds		17
Real estate funds		51
Total assets at fair value		$	8,396


	Non-U.S. Plans
	December 31, 2020
	Total			Level 1			Level 2			Level 3
Equities:
U.S. equities		$	207		$	—		$	207		$	—
Non-U.S. equities		1,614			66			1,548			—
Fixed income:
Short-term investments		596			596			—			—
Government securities		3,105			—			3,105			—
Corporate bonds		1,649			—			1,649			—
Mortgage/Asset-backed securities		93			—			93			—
Insurance contracts		142			—			142			—
Insurance buy-in contracts		767			—			—			767
Investments in private funds:
Private funds		65			—			36			29
Real estate funds		147			—			—			147
Total		$	8,385		$	662		$	6,780		$	943
Investments measured at NAV:
Private funds		18
Real estate funds		47
Total assets at fair value		$	8,450

Changes in Fair Value of Level 3 Plan Assets


	U.S. Plans						Non-U.S. Plans
	Direct Private Investments			Real Estate Properties			Private Funds			Real Estate Funds			Insurance Buy-in Contracts
Balance at December 31, 2019		$	950		$	619		$	34		$	150		$	—
Actual return on plan assets:
Relating to assets still held at year-end		100			(4)			(5)			(3)			—
Relating to assets sold during the year		53			—			—			—			—
Purchases		221			59			—			—			767
Sales and settlements		(104)			(23)			—			—			—
Balance at December 31, 2020		1,220			651			29			147			767
Actual return on plan assets:
Relating to assets still held at year-end		11			96			4			23			(76)
Relating to assets sold during the year		174			—			—			4			—
Purchases		194			99			—			—			—
Sales and settlements		(263)			(3)			—			(11)			—
Balance at December 31, 2021		$	1,336		$	843		$	33		$	163		$	691

Estimated Future Benefit Payments


	U.S. Plans		Non-U.S. Plans
2022	$	1,135	$	261
2023	1,124		263
2024	1,115		268
2025	1,107		275
2026	1,097		284
2027-2031	5,152		1,455

Assumed Health Care Cost Trend Rates


	December 31,
	2021			2020
Assumed health care cost trend rate:
Health care cost trend rate assumed for next year		6.50	%		7.00	%
Rate that the cost trend rate gradually declines to		5.00	%		5.00	%
Year that the rate reaches the rate it is assumed to remain at		2029			2029

Schedule Of Benefit Payments Reflecting Expected Future Service [Table Text Block]


	Without Impact of Medicare Subsidy		Net of Medicare Subsidy
2022	$	27	$	25
2023	25		24
2024	14		14
2025	14		13
2026	13		12
2027-2031	57		53

ACQUISITIONS AND DIVESTITURES (Details) - USD ($)	12 Months Ended
ACQUISITIONS AND DIVESTITURES (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Business Acquisition [Line Items]
Goodwill	$ 17,756,000,000	$ 16,058,000,000
Assets	64,470,000,000	64,586,000,000	$ 58,679,000,000
Non-cash adjustment to APIC	460,000,000	0	0
Noncontrolling interest non-cash contribution	419,000,000	0	0
Divestiture [Abstract]
Pretax gain on sale	102,000,000	(3,000,000)	(1,000,000)
Income before taxes	7,235,000,000	6,012,000,000	7,559,000,000
Proceeds from sales of businesses, net of fees paid	$ 203,000,000	0	$ 0
Honeywell International [Member]
Business Acquisition [Line Items]
Noncontrolling Interest, Ownership Percentage by Parent	4.20%
Retail Footwear [Member]
Divestiture [Abstract]
Pretax gain on sale	$ 95,000,000
Proceeds from sales of businesses, net of fees paid	$ 230,000,000
Total Acquisitions [Member]
Business Acquisition [Line Items]
Purchase price		$ 261,000,000
Sparta Systems [Member]
Business Acquisition [Line Items]
Name of acquired entity	Sparta Systems
Purchase price	$ 1,303,000,000
Goodwill	$ 1,011,000,000
Controlling Interest Ownership Percentage By Parent	100.00%
Intangible Assets	$ 383,000,000
Quantinuum [Member]
Business Acquisition [Line Items]
Name of acquired entity	Quantinuum
Goodwill	$ 943,000,000
Intangible Assets	90,000,000
Payments to Acquire Interest in Joint Venture	270,000,000
Non-cash adjustment to APIC	460,000,000
Fair value adjustment of initial ownership interest in acquired entity	$ 22,000,000
Quantinuum [Member] \| Honeywell International [Member]
Business Acquisition [Line Items]
Controlling Interest Ownership Percentage By Parent	54.00%
Noncontrolling Interest, Ownership Percentage by Parent	4.20%
Quantinuum [Member] \| Cambridge Quantum Computing [Member]
Business Acquisition [Line Items]
Payments to Acquire Interest in Joint Venture	$ 12,000,000
Noncontrolling interest non-cash contribution	$ 419,000,000
Rocky Research And Sine Group [Member]
Business Acquisition [Line Items]
Name of acquired entity		Rocky Research and Sine Group
Goodwill		$ 167,000,000

PENSION AND OTHER POSTRETIREMENT BENEFITS 5 (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2022
UNITED STATES
Future Benefit Payments [Abstract]
2022	$ 1,135
2023	1,124
2024	1,115
2025	1,107
2026	1,097
2027-2031	5,152
Funding Policy Paragraph Details [Line Items]
Pension notional amount	4,415	$ 3,673
Foreign Plan [Member]
Future Benefit Payments [Abstract]
2022	261
2023	263
2024	268
2025	275
2026	284
2027-2031	1,455
Funding Policy Paragraph Details [Line Items]
Pension notional amount	311	$ 564
Cash pension contributions	$ 94
Foreign Plan [Member] \| Forecast [Member]
Funding Policy Paragraph Details [Line Items]
Contributions to pension plans			$ 11
Other Postretirement Benefits [Member]
Defined Benefit Plan, Assumed Health Care Cost Trend Rates [Abstract]
Health care cost trend rate assumed for next year	6.50%	7.00%
Rate that the cost trend rate gradually declines to	5.00%	5.00%
Defined Benefit Plan, Year Health Care Cost Trend Rate Reaches Ultimate Trend Rate	2029	2029
Other Postretirement Benefits [Member] \| Without Impact of Medicare Subsidy [Member]
Future Benefit Payments [Abstract]
2022	$ 27
2023	25
2024	14
2025	14
2026	13
2027-2031	57
Other Postretirement Benefits [Member] \| Net of Medicare Subsidy [Member]
Future Benefit Payments [Abstract]
2022	25
2023	24
2024	14
2025	13
2026	12
2027-2031	$ 53

LEASES 3 (Details) - USD ($) $ in Millions	12 Months Ended
LEASES 3 (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for operating leases	$ 215	$ 206
Operating cash flows for finance leases	24	32
Financing cash flows for finance leases	67	65
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	350	245
Finance leases	$ 32	$ 27

STOCK-BASED COMPENSATION PLANS (Tables)

12 Months Ended

Dec. 31, 2021

Share-based Payment Arrangement [Abstract]

Income Statement Impact from Stock Options


	Years Ended December 31,
	2021			2020			2019
Compensation expense		$	55		$	50		$	47
Future income tax benefit recognized		11			10			10

Share based compensation fair value assumptions


	Years Ended December 31,
	2021				2020				2019
Weighted average fair value per share of options granted during the year(1)		$	32.42			$	21.30			$	21.57
Assumptions:
Expected annual dividend yield		2.31		%		2.59		%		2.65		%
Expected volatility		24.69		%		18.76		%		18.40		%
Risk-free rate of return		0.48		%		1.32		%		2.46		%
Expected option term (years)		4.54				4.62				4.87

(1)Estimated on date of grant using Black-Scholes option-pricing model.

Stock Options Activity


	Number of Options		Weighted Average Exercise Price
Outstanding at December 31, 2018		22,478,581		$	97.83
Granted		3,136,058		155.43
Exercised		(5,897,060)		84.31
Lapsed or canceled		(986,017)		136.15
Outstanding at December 31, 2019		18,731,562		109.87
Granted		3,192,693		176.93
Exercised		(4,424,754)		88.96
Lapsed or canceled		(930,972)		156.62
Outstanding at December 31, 2020		16,568,529		125.75
Granted		2,065,574		204.99
Exercised		(2,016,489)		113.01
Lapsed or canceled		(764,675)		175.42
Outstanding at December 31, 2021		15,852,939		$	135.31
Vested and expected to vest at December 31, 2021(1)		14,694,701		$	131.08
Exercisable at December 31, 2021		10,664,625		$	113.30

Schedule of share based compensation by price ranges


Range of Exercise Prices	Options Outstanding										Options Exercisable
	Number Outstanding		Weighted Average Life(1)		Weighted Average Exercise Price per share			Aggregate Intrinsic Value			Number Exercisable		Weighted Average Exercise Price per share			Aggregate Intrinsic Value
$27.00–$64.99		90,181		0.17		$	56.97		$	14		90,181		$	56.97		$	14
$65.00–$89.99		2,293,585		1.68		79.39			296			2,293,585		79.39			296
$90.00–$99.99		3,341,048		3.44		98.80			367			3,341,048		98.80			366
$100.00–$134.99		2,435,321		5.04		119.69			216			2,314,755		119.19			214
$135.00–$232.99		7,692,804		7.55		173.71			271			2,625,056		158.14			232
		15,852,939		5.41		$	135.28		$	1,164		10,664,625		$	113.30		$	1,122

(1)Average remaining contractual life in years.

Financial Statement Impact From Stock Options Exercised


Options Exercised	Years Ended December 31,
	2021			2020			2019
Intrinsic value(1)		$	219		$	379		$	483
Tax benefit realized		48			84			117

(1)Represents the amount by which the stock price exceeded the exercise price of the options on the date of exercise.

Restricted stock units activity

ended December 31, 2021:


	Number of Restricted Stock Units		Weighted Average Grant Date Fair Value Per Share
Non-vested at December 31, 2018		3,657,873		$	125.35
Granted		1,200,202		162.43
Vested		(1,160,333)		104.32
Forfeited		(457,677)		134.50
Non-vested at December 31, 2019		3,240,065		143.07
Granted		1,551,675		158.52
Vested		(1,001,101)		117.84
Forfeited		(394,116)		145.42
Non-vested at December 31, 2020		3,396,523		148.23
Granted		992,854		214.61
Vested		(1,123,547)		144.34
Forfeited		(308,293)		156.74
Non-vested at December 31, 2021		2,957,536		$	171.73

Income Statement Impact from RSUs

The following table summarizes the impact to the Consolidated Statement of Operations from RSUs:


	Years Ended December 31,
	2021			2020			2019
Compensation expense		$	162		$	118		$	106
Future income tax benefit recognized		23			24			21

REPOSITIONING AND OTHER CHARGES

12 Months Ended

Dec. 31, 2021

Restructuring and Related Activities [Abstract]

Repositioning and Other Charges

A summary of repositioning and other charges follows:


	Years Ended December 31,
	2021			2020			2019
Severance		$	80		$	475		$	260
Asset impairments		117			21			95
Exit costs		134			69			83
Reserve adjustments		(13)			(47)			(5)
Total net repositioning charge		318			518			433
Asbestos related litigation charges, net of insurance and reimbursements		129			50			42
Probable and reasonably estimable environmental liabilities, net of reimbursements		22			27			59
Other charges		100			(20)			12
Total net repositioning and other charges		$	569		$	575		$	546

The following table summarizes the pre-tax distribution of total net repositioning and other charges by classification in the Consolidated Statement of Operations:


	Years Ended December 31,
	2021			2020			2019
Cost of products and services sold		$	457		$	308		$	276
Selling, general and administrative expenses		112			267			270
Other (income) expense		—			—			—
		$	569		$	575		$	546


	Years Ended December 31,
	2021			2020			2019
Aerospace		$	62		$	157		$	33
Honeywell Building Technologies		13			100			108
Performance Materials and Technologies		24			167			93
Safety and Productivity Solutions		268			41			71
Corporate and All Other		202			110			241
		$	569		$	575		$	546

In 2021, the Company recognized repositioning charges totaling $331 million, including severance costs of $80 million related to workforce reductions of 6,432 manufacturing and administrative positions mainly in the Company's Safety and Productivity Solutions and Aerospace segments. The workforce reductions were primarily related to the re-alignment of a product line in the Company's Safety and Productivity Solutions segment, site transitions, mainly in Aerospace, to more cost-effective locations, and the Company's productivity and ongoing functional transformation initiatives. The repositioning charge included asset impairments of $117 million primarily related to the write-down of certain manufacturing and other equipment. The repositioning charge included exit costs of $134 million primarily for current period exit costs incurred for previously approved repositioning projects, closure obligations associated with site transitions, and lease obligations for equipment. Also, $13 million of previously established reserves, primarily for severance, were returned to income due to adjustments to the scope of previously announced repositioning actions.

In 2021, Other charges include $105 million of incremental long-term contract labor cost inefficiencies due to severe supply chain disruptions (attributable to the COVID-19 pandemic) relating to the warehouse automation business within the Safety and Productivity Solutions segment. Certain of these costs incurred include amounts and provisions for anticipated losses recognized during the fourth quarter when total estimated costs at completion for certain of the business’ long-term contracts exceeded total estimated revenue. These costs represent unproductive labor costs due to unexpected supply delays and the resulting downstream installation issues, demobilization and remobilization of contract workers, and resolution of contractor disputes. These costs do not include normal operational inefficiencies experienced during a challenging operating environment in 2021.

In 2020, the Company recognized repositioning charges totaling $565 million, including severance costs of $475 million related to workforce reductions of 14,159 manufacturing and administrative positions across the Company's segments, with a majority of the workforce reductions in Aerospace and Performance Materials and Technologies. The workforce reductions primarily related to the Company aligning its cost structure with the slowdown in demand for many of its products and services due to the global recession, the Company's productivity and ongoing functional transformation initiatives, and to site consolidations and hub strategies. The repositioning charge included exit costs of $69 million primarily related to current period exit costs incurred for previously approved repositioning projects. Also, $47 million of previously established reserves, primarily for severance, were returned to income mainly as a result of higher attrition than anticipated in prior severance actions resulting in lower payments.

In 2019, the Company recognized repositioning charges totaling $438 million, including severance costs of $260 million related to workforce reductions of 5,336 manufacturing and administrative positions across the Company's segments. The workforce reductions related to the Company's productivity and ongoing functional transformation initiatives and to site transitions, mainly in Honeywell Building Technologies, as the Company transitions manufacturing to more cost-effective locations. The repositioning charge included asset impairments of $95 million largely related to a write down in connection with assets held for sale. The repositioning charge included exit costs of $83 million primarily related to current period exit costs incurred for previously approved repositioning projects, termination fees associated with the early cancellation of supply agreements for certain raw materials in Performance Materials and Technologies and Honeywell Building Technologies and for closure obligations associated with site transitions.

The following table summarizes the status of the Company's total repositioning reserves:


	Severance Costs			Asset Impairments			Exit Costs			Total
Balance at December 31, 2018		$	489		$	—		$	77		$	566
Charges		260			95			83			438
Usage—cash		(186)			—			(63)			(249)
Usage—noncash		—			(100)			—			(100)
Divestitures		—			—			—			—
Adjustments		(8)			5			(2)			(5)
Foreign currency translation		—			—			1			1
Balance at December 31, 2019		555			—			96			651
Charges		475			21			69			565
Usage—cash		(474)			—			(90)			(564)
Usage—noncash		—			(21)			—			(21)
Divestitures		—			—			—			—
Adjustments		(44)			—			(3)			(47)
Foreign currency translation		15			—			2			17
Balance at December 31, 2020		527			—			74			601
Charges		80			117			134			331
Usage—cash		(299)			—			(83)			(382)
Usage—noncash		—			(119)			—			(119)
Divestitures		—			—			—			—
Adjustments		(14)			2			(1)			(13)
Foreign currency translation		(5)			—			(2)			(7)
Balance at December 31, 2021		$	289		$	—		$	122		$	411

Certain repositioning projects will recognize exit costs in future periods when the actual liability is incurred. Such exit costs incurred in 2021, 2020, and 2019 were not significant.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Dec. 31, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	ACCOUNTING PRINCIPLES The financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America. The following is a description of Honeywell’s significant accounting policies. PRINCIPLES OF CONSOLIDATION The Consolidated Financial Statements include the accounts of Honeywell International Inc. and all of its subsidiaries and entities in which a controlling interest is maintained. The Company's consolidation policy requires equity investments that the Company exercises significant influence over but do not control the investee and are not the primary beneficiary of the investee’s activities to be accounted for using the equity method. Investments through which the Company is not able to exercise significant influence over the investee and which the Company does not have readily determinable fair values are accounted for under the cost method. All intercompany transactions and balances are eliminated in consolidation. RECLASSIFICATIONS Certain prior year amounts have been reclassified to conform to the current year presentation. RECENT ACCOUNTING PRONOUNCEMENTS The Company considers the applicability and impact of all Accounting Standards Updates (ASUs) issued by the Financial Accounting Standards Board (FASB). ASUs not listed below were assessed and determined to be either not applicable or are expected to have minimal impact on the Company's consolidated statement of operations, balance sheet and cash flows (Consolidated Financial Statements). In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes. The standard’s amendments include changes in various subtopics of accounting for income taxes including, but not limited to, accounting for “hybrid” tax regimes, tax basis step-up in goodwill obtained in a transaction that is not a business combination, intraperiod tax allocation exception to incremental approach, ownership changes in investments, interim-period accounting for enacted changes in tax law, and year-to-date loss limitation in interim-period tax accounting. Effective January 1, 2021, the Company adopted this standard. The adoption of this standard did not have a material impact on the Company's Consolidated Financial Statements. In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying generally accepted accounted principles to contracts, hedging relationships, and other transactions affected by the transition away from reference rates expected to be discontinued to alternative reference rates. In January 2021, the FASB issued ASU 2021-01, Reference Rate Reform (Topic 848): Scope, to expand the scope of this guidance to include derivatives. The guidance was effective upon issuance and may be applied prospectively to contract modifications made and hedging relationships entered into on or before December 31, 2022. The Company will apply the guidance to impacted transactions during the transition period. The Company does not expect the adoption of this standard to have a material impact on the Company’s Consolidated Financial Statements. In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805) - Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers. This ASU should be applied prospectively to acquisitions occurring on or after the effective date of December 15, 2022, and early adoption is permitted. The Company is currently evaluating the impacts of this guidance on the Company’s Consolidated Financial Statements. The Company does not expect the adoption of this standard to have a material impact on the Company’s Consolidated Financial Statements. RESEARCH AND DEVELOPMENT Research and development costs for projects are expensed as incurred, unless these costs relate to contracts with customers where the Company receives reimbursements. Amounts expensed as incurred for Company-sponsored research and development projects are included in Cost of products and services sold and were $1,333 million, $1,334 million and $1,556 million for the years ended December 31, 2021, 2020 and 2019, respectively. Costs related to contracts with customers for customer-sponsored research and development projects are included as a contract cost and included in Cost of products and services sold when revenue from such contracts is recognized, consistent with the Company's sales recognition policies. This revenue was $1,284 million, $1,200 million and $1,079 million for the years ended December 31, 2021, 2020 and 2019, respectively. CASH AND CASH EQUIVALENTS Cash and cash equivalents include cash on hand and highly liquid investments having an original maturity of three months or less. INVENTORIES Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out (FIFO) basis. Carrying value adjustments for inventory obsolescence is equal to the difference between the cost and net realizable value. Net realizable value is the estimate selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. PROPERTY, PLANT AND EQUIPMENT Property, plant and equipment are recorded at cost, including any asset retirement obligations, less accumulated depreciation. For financial reporting, the straight-line method of depreciation is used over the estimated useful lives of 10 to 50 years for buildings and improvements and 3 to 16 years for machinery and equipment. Recognition of the fair value of obligations associated with the retirement of tangible long-lived assets is required when there is a legal obligation to incur such costs. Upon initial recognition of a liability, the cost is capitalized as part of the related long-lived asset and depreciated over the corresponding asset’s useful life. GOODWILL AND INDEFINITE-LIVED INTANGIBLE ASSETS Goodwill and indefinite-lived intangible assets are subject to impairment testing annually as of March 31, or if a triggering event occurs or changes in circumstances indicate that the carrying amount may not be fully recoverable. This testing compares carrying values to fair values and, when appropriate, the carrying value of these assets is reduced to fair value. The Company completed its annual goodwill impairment test as of March 31, 2021, and determined that there was no impairment as of that date. The Company is not aware of any additional triggering events. FINITE-LIVED INTANGIBLE ASSETS Other intangible assets with determinable lives consist of customer lists, technology, patents and trademarks and other intangibles and are amortized over their estimated useful lives, ranging from 2 to 22 years. FOREIGN CURRENCY TRANSLATION Assets and liabilities of subsidiaries operating outside the United States with a functional currency other than U.S. Dollars are translated into U.S. Dollars using year-end exchange rates. Sales, costs and expenses are translated at the average exchange rates in effect during the year. Foreign currency translation gains and losses are included as a component of Accumulated other comprehensive income (loss). For subsidiaries operating in highly inflationary environments, inventories and property, plant and equipment, including related expenses, are remeasured at the exchange rate in effect on the date the assets were acquired, while monetary assets and liabilities are remeasured at year-end exchange rates. Remeasurement adjustments for these subsidiaries are included in earnings. DERIVATIVE FINANCIAL INSTRUMENTS All derivative financial instruments are recorded on the balance sheet as assets or liabilities and measured at fair value. For derivatives designated as hedges of the fair value of assets or liabilities, the changes in fair values of both the derivatives and the hedged items are recorded in current earnings. For derivatives designated as cash flow hedges, the changes in fair value of the derivatives are recorded in Accumulated other comprehensive income (loss) and subsequently recognized in earnings when the hedged items impact earnings. Derivative financial instruments designated as hedges must be designated and effective as a hedge of the identified risk exposure at the inception of the contract. Changes in fair value of the derivative contract must be highly correlated with changes in fair value of the underlying hedged item at inception and over the life of the hedge contract. Cash flows of such derivative financial instruments are classified consistent with the underlying hedged item. The Company elected to exclude the time value of the derivatives (i.e., the forward points) from the assessment of hedge effectiveness and recognize the initial value of the excluded component in earnings using the amortization approach. For derivative instruments that are designated and qualify as a net investment hedge, the gain or loss is reported as a component of Other comprehensive income (loss) and recorded in Accumulated other comprehensive income (loss). The gain or loss will be subsequently reclassified into net earnings when the hedged net investment is either sold or substantially liquidated. LEASES At the inception of a contract, the Company assesses whether the contract is, or contains, a lease. The assessment is based on (1) whether the contract involves the use of a distinct identified asset, (2) whether the Company obtains the right to substantially all the economic benefit from the use of the asset throughout the period, and (3) whether the Company has the right to direct the use of the asset. All significant lease arrangements are generally recognized at lease commencement. Operating lease right-of-use (ROU) assets and lease liabilities are recognized at commencement. An ROU asset and corresponding lease liability are not recorded for leases with an initial term of 12 months or less (short-term leases), and we recognize lease expense for these leases as incurred over the lease term. ROU assets represent the Company's right to use an underlying asset during the reasonably certain lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. The Company's lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Lease payments may be fixed or variable, however, only fixed payments or in-substance fixed payments are included in determining the lease liability. Variable lease payments are recognized in operating expenses in the period in which the obligation for those payments are incurred. The operating lease ROU asset also includes any lease payments related to initial direct cost and prepayments and excludes lease incentives. Lease expense is recognized on a straight-line basis over the lease term. The Company has lease agreements with lease and non-lease components, which are generally accounted for separately. The Company primarily uses its incremental borrowing rate, which is based on the information available at the lease commencement date, in determining the present value of the lease payments. In determining the borrowing rate, the Company considers the lease term, secured incremental borrowing rate, and for leases denominated in a currency different than U.S. dollar, the collateralized borrowing rate in the foreign currency using the U.S. dollar and foreign currency swap spread, when available. PENSION BENEFITS The Company presents net periodic pensions costs by disaggregating the service cost component of such costs and reports those costs in the same line item or items in the Consolidated Statement of Operations as other compensation costs arising from services rendered by the pertinent employees during the period. The other non-service components of such costs are required to be presented separately from the service cost component. The Company records the service cost component of Pension ongoing (income) expense in Costs of products and services sold and Selling, general and administrative expenses. The remaining components of costs within Pension ongoing (income) expense, primarily interest costs and assumed return on plan assets, are recorded in Other (income) expense. The Company recognizes net actuarial gains or losses in excess of 10% of the greater of the fair value of plan assets or the plan's projected benefit obligation (the corridor) annually in the fourth quarter each year (MTM Adjustment). The MTM Adjustment is also reported in Other (income) expense. See Note 22 Segment Financial Data for a definition of Pension ongoing (income) expense. SALES RECOGNITION Product and service sales are recognized when or as the Company transfers control of the promised products or services to its customers. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods or providing services. Service sales, principally representing repair, maintenance and engineering activities, are recognized over the contractual period or as services are rendered. Sales under long-term contracts with performance obligations satisfied over time are recognized using either an input or output method. The Company recognizes revenue over time as the Company performs on these contracts because of the continuous transfer of control to the customer. With control transferring over time, revenue is recognized based on the extent of progress towards completion of the performance obligation. The Company generally uses the cost-to-cost input method of progress for contracts because it best depicts the transfer of control to the customer that occurs as the Company incurs costs. Under the cost-to-cost input method, the extent of progress towards completion is measured based on the proportion of costs incurred to date to the total estimated costs at completion of the performance obligation. The Company reviews its cost estimates on significant contracts on a periodic basis, or when circumstances change and warrant a modification to a previous estimate. Cost estimates are largely based on negotiated or estimated purchase contract terms, historical performance trends and other economic projections. Significant factors that influence these estimates include inflationary trends, technical and schedule risk, internal and subcontractor performance trends, business volume assumptions, asset utilization, and anticipated labor agreements. Provisions for anticipated losses on long-term contracts are recorded in full when such losses become evident, to the extent required. The customer funding for costs incurred for nonrecurring engineering and development activities of the Company's products under agreements with commercial customers is deferred and subsequently recognized as revenue as products are delivered to the customers. Additionally, expenses incurred, up to the customer agreed funded amount, are deferred as an asset and recognized as cost of sales when products are delivered to the customer. The deferred customer funding and costs result in recognition of deferred costs (asset) and deferred revenue (liability) on the Company's Consolidated Balance Sheet. Capitalized contract fulfillment costs were approximately $1.3 billion as of December 31, 2021 and 2020. The amounts recognized as Cost of products and services sold were approximately $0.1 billion for the years ended December 31, 2021, 2020 and 2019. Revenues for the Company's mechanical service programs are recognized as performance obligations that are satisfied over time, with recognition reflecting a series of distinct services using the output method. The terms of a contract or the historical business practice can give rise to variable consideration due to, but not limited to, cash-based incentives, rebates, performance awards, or credits. The Company estimates variable consideration at the most likely amount the Company will receive from customers. The Company includes estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized for such transaction will not occur, or when the uncertainty associated with the variable consideration is resolved. The Company's estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely on an assessment of the Company's anticipated performance and all information (historical, current and forecasted) that is reasonably available to the Company. STOCK-BASED COMPENSATION PLANS The principal awards issued under the Company's stock-based compensation plans, which are described in Note 15 Stock-Based Compensation Plans, are non-qualified stock options and restricted stock units. The cost for such awards is measured at the grant date based on the fair value of the award. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods (generally the vesting period of the equity award) and is included in Selling, general and administrative expenses. Forfeitures are estimated at the time of grant to recognize expense for those awards that are expected to vest and are based on the Company's historical forfeiture rates. INCOME TAXES Significant judgment is required in evaluating tax positions. The Company establishes reserves for income taxes when, despite the belief that tax positions are fully supportable, there remain certain positions that do not meet the minimum recognition threshold. The approach for evaluating certain and uncertain tax positions is defined by the authoritative guidance which determines when a tax position is more likely than not to be sustained upon examination by the applicable taxing authority. In the normal course of business, the Company and its subsidiaries are examined by various federal, state and foreign tax authorities. The Company regularly assesses the potential outcomes of these examinations and any future examinations for the current or prior years in determining the adequacy of the Company's provision for income taxes. The Company continually assesses the likelihood and amount of potential adjustments and adjust the income tax provision, the current tax liability and deferred taxes in the period in which the facts that give rise to a change in estimate become known. For additional information, see Note 5 Income Taxes. EARNINGS PER SHARE Basic earnings per share is based on the weighted average number of common shares outstanding. Diluted earnings per share is based on the weighted average number of common shares outstanding and all dilutive potential common shares outstanding. ENVIRONMENTAL The Company accrues costs related to environmental matters when it is probable that it has incurred a liability related to a contaminated site and the amount can be reasonably estimated. For additional information, see Note 19 Commitments and Contingencies. ASBESTOS RELATED LIABILITIES AND INSURANCE RECOVERIES The Company recognizes a liability for any asbestos related contingency that is probable of occurrence and reasonably estimable. In connection with the recognition of liabilities for asbestos related matters, the Company records asbestos related insurance recoveries that are deemed probable. For additional information, see Note 19 Commitments and Contingencies. REIMBURSEMENT RECEIVABLES In conjunction with the Resideo Technologies, Inc. (Resideo) spin-off, the Company entered into a reimbursement agreement under which Honeywell receives cash payments as reimbursement primarily related to net spending for environmental matters at certain sites as defined in the reimbursement agreement. Accordingly, the Company recorded receivables based on estimates of the underlying reimbursable Honeywell environmental spend, and the Company monitors the recoverability of such receivables, which are subject to the terms of applicable credit agreements and general ability to pay.

LEASES 2 (Details) - USD ($) $ in Millions	12 Months Ended
LEASES 2 (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Leases [Abstract]
Operating lease cost	$ 228	$ 214
Variable lease cost	14	18
Short-term lease cost	15	17
Amortization of right-of-use assets	65	69
Interest on lease liability	24	27
Total finance lease cost	89	96
Total lease cost	$ 346	$ 345

ACCRUED LIABILITIES

12 Months Ended

Dec. 31, 2021

Accrued Liabilities, Current [Abstract]

Accrued Liabilities


	December 31,
	2021			2020
Customer advances and deferred income		$	3,163		$	2,932
Compensation, benefit and other employee related		1,273			1,244
Repositioning		411			601
Asbestos related liabilities		261			300
Income taxes		393			307
Other taxes		269			281
Environmental costs		225			225
Operating lease liabilities		185			187
Product warranties and performance guarantees		180			183
Insurance		101			140
Accrued interest		100			102
Other (primarily operating expenses)		1,118			903
		$	7,679		$	7,405

ACCRUED LIABILITIES (Tables)

12 Months Ended

Dec. 31, 2021

Accrued Liabilities Current (Tables) [Abstract]

Accrued liabilities


	December 31,
	2021			2020
Customer advances and deferred income		$	3,163		$	2,932
Compensation, benefit and other employee related		1,273			1,244
Repositioning		411			601
Asbestos related liabilities		261			300
Income taxes		393			307
Other taxes		269			281
Environmental costs		225			225
Operating lease liabilities		185			187
Product warranties and performance guarantees		180			183
Insurance		101			140
Accrued interest		100			102
Other (primarily operating expenses)		1,118			903
		$	7,679		$	7,405

EARNINGS PER SHARE (Tables)

12 Months Ended

Dec. 31, 2021

Earnings Per Share (Tables) [Abstract]

Earnings per share basic


Basic	Years Ended December 31,
	2021			2020			2019
Net income attributable to Honeywell		$	5,542		$	4,779		$	6,143
Weighted average shares outstanding		692.3			704.1			721.0
Earnings per share of common stock		$	8.01		$	6.79		$	8.52

Earnings per share diluted


Assuming Dilution	Years Ended December 31,
	2021			2020			2019
Net income attributable to Honeywell		$	5,542		$	4,779		$	6,143
Average Shares
Weighted average shares outstanding		692.3			704.1			721.0
Dilutive securities issuable—stock plans		8.1			7.1			9.3
Total weighted average diluted shares outstanding		700.4			711.2			730.3
Earnings per share of common stock—assuming dilution		$	7.91		$	6.72		$	8.41

PROPERTY, PLANT AND EQUIPMENT-NET (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 14,450	$ 14,337
Less: Accumulated depreciation	(8,888)	(8,767)
Property, plant and equipment - net	5,562	5,570
Property, Plant and Equipment Paragraph Details [Abstract]
Depreciation	674	644	$ 673
Land and Land Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	226	259
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	10,143	10,008
Buildings and Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	3,225	3,245
Construction in Progress [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 856	$ 825

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) 2 (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance beginning of period December 31	$ (3,377,000,000)	$ (3,197,000,000)	$ (3,437,000,000)
Other comprehensive income (loss) before reclassifications	596,000,000	(72,000,000)	408,000,000
Amounts reclassified from accumulated other comprehensive income	(114,000,000)	(108,000,000)	(168,000,000)
Net current period other comprehensive income (loss)	482,000,000	(180,000,000)	240,000,000
Balance end of period	(2,895,000,000)	(3,377,000,000)	(3,197,000,000)
Foreign Exchange Translation Adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance beginning of period December 31	(2,780,000,000)	(2,566,000,000)	(2,709,000,000)
Other comprehensive income (loss) before reclassifications	314,000,000	(201,000,000)	156,000,000
Amounts reclassified from accumulated other comprehensive income	(12,000,000)	(13,000,000)	(13,000,000)
Net current period other comprehensive income (loss)	302,000,000	(214,000,000)	143,000,000
Balance end of period	(2,478,000,000)	(2,780,000,000)	(2,566,000,000)
Pension and Other Postretirement Adjustments [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance beginning of period December 31	(601,000,000)	(675,000,000)	(761,000,000)
Other comprehensive income (loss) before reclassifications	268,000,000	115,000,000	149,000,000
Amounts reclassified from accumulated other comprehensive income	(82,000,000)	(41,000,000)	(63,000,000)
Net current period other comprehensive income (loss)	186,000,000	74,000,000	86,000,000
Balance end of period	(415,000,000)	(601,000,000)	(675,000,000)
Changes in Fair Value of Available for Sale Investments [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance beginning of period December 31	4,000,000	0	0
Other comprehensive income (loss) before reclassifications	(3,000,000)	4,000,000	0
Amounts reclassified from accumulated other comprehensive income	0	0	0
Net current period other comprehensive income (loss)	(3,000,000)	4,000,000	0
Balance end of period	1,000,000	4,000,000	0
Changes in Fair Value of Cash Flow Hedges
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance beginning of period December 31	0	44,000,000	33,000,000
Other comprehensive income (loss) before reclassifications	17,000,000	10,000,000	103,000,000
Amounts reclassified from accumulated other comprehensive income	(20,000,000)	(54,000,000)	(92,000,000)
Net current period other comprehensive income (loss)	(3,000,000)	(44,000,000)	11,000,000
Balance end of period	$ (3,000,000)	$ 0	$ 44,000,000

- Definition

Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.

+ References + Details

- Definition

Amount after tax and reclassification adjustments of other comprehensive income (loss).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 55
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

+ Details

CONSOLIDATED STATEMENT OF SHAREOWNERS EQUITY - USD ($) shares in Millions	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Treasury Stock [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Noncontrolling Interest [Member]
Balance at, beginning of period at Dec. 31, 2018			$ 6,452,000,000	$ (19,771,000,000)	$ 33,978,000,000	$ (3,437,000,000)	$ 178,000,000
Treasury Stock, Shares, Beginning Balance at Dec. 31, 2018				(228.0)
Reacquired stock or repurchases of common stock				$ (4,400,000,000)
Reacquired stock or repurchases of common stock, shares				(26.5)
Issued for employee savings and option plans			271,000,000	$ 335,000,000
Issued for employee savings and option plans, shares				8.0
Stock-based compensation expense			153,000,000
Non-cash adjustment to APIC	$ 0		0
Net income attributable to Honeywell	6,143,000,000				6,143,000,000
Dividends on common stock					(2,428,000,000)
Foreign exchange translation adjustment	143,000,000					143,000,000	(5,000,000)
Dividends paid							(45,000,000)
Pensions and other postretirement benefit adjustments	86,000,000					86,000,000
Changes in fair value of available for sale investments						0
Changes in fair value of cash flow hedges	11,000,000					11,000,000
Acquisitions, divestitures, and other							(3,000,000)
Net income attributable to the noncontrolling interest	87,000,000						87,000,000
Contributions from noncontrolling interest holders							0
Balance at, end of period at Dec. 31, 2019	$ 18,706,000,000	$ 958,000,000	6,876,000,000	$ (23,836,000,000)	37,693,000,000	(3,197,000,000)	212,000,000
Treasury Stock, Shares, Ending Balance at Dec. 31, 2019				(246.5)
Cash dividends per share of common stock	$ 3.360
Common Stock Shares Issued		957.6
Common stock, shares	711.1
Reacquired stock or repurchases of common stock				$ (3,714,000,000)
Reacquired stock or repurchases of common stock, shares				(20.7)
Issued for employee savings and option plans			248,000,000	$ 321,000,000
Issued for employee savings and option plans, shares				6.4
Stock-based compensation expense			168,000,000
Non-cash adjustment to APIC	$ 0		0
Net income attributable to Honeywell	4,779,000,000				4,779,000,000
Dividends on common stock					(2,567,000,000)
Foreign exchange translation adjustment	(211,000,000)					(214,000,000)	3,000,000
Dividends paid							(54,000,000)
Pensions and other postretirement benefit adjustments	74,000,000					74,000,000
Changes in fair value of available for sale investments						4,000,000
Changes in fair value of cash flow hedges	(44,000,000)					(44,000,000)
Acquisitions, divestitures, and other							(6,000,000)
Net income attributable to the noncontrolling interest	86,000,000						86,000,000
Contributions from noncontrolling interest holders							0
Balance at, end of period at Dec. 31, 2020	$ 17,790,000,000	$ 958,000,000	7,292,000,000	$ (27,229,000,000)	39,905,000,000	(3,377,000,000)	241,000,000
Treasury Stock, Shares, Ending Balance at Dec. 31, 2020				(260.8)
Cash dividends per share of common stock	$ 3.630
Common Stock Shares Issued		957.6
Common stock, shares	696.8
Reacquired stock or repurchases of common stock				$ (3,380,000,000)
Reacquired stock or repurchases of common stock, shares				(15.8)
Issued for employee savings and option plans			184,000,000	$ 147,000,000
Issued for employee savings and option plans, shares				3.8
Stock-based compensation expense			217,000,000
Non-cash adjustment to APIC	$ 460,000,000		448,000,000
Net income attributable to Honeywell	5,542,000,000				5,542,000,000
Dividends on common stock					(2,620,000,000)
Foreign exchange translation adjustment	302,000,000					302,000,000	(4,000,000)
Dividends paid							(33,000,000)
Pensions and other postretirement benefit adjustments	186,000,000					186,000,000
Changes in fair value of available for sale investments						(3,000,000)
Changes in fair value of cash flow hedges	(3,000,000)					(3,000,000)
Acquisitions, divestitures, and other							397,000,000
Net income attributable to the noncontrolling interest	68,000,000						68,000,000
Contributions from noncontrolling interest holders							4,000,000
Balance at, end of period at Dec. 31, 2021	$ 19,242,000,000	$ 958,000,000	$ 8,141,000,000	$ (30,462,000,000)	$ 42,827,000,000	$ (2,895,000,000)	$ 673,000,000
Treasury Stock, Shares, Ending Balance at Dec. 31, 2021				(272.8)
Cash dividends per share of common stock	$ 3.770
Common Stock Shares Issued		957.6
Common stock, shares	684.8

COMMITMENTS AND CONTINGENCIES 4 (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Loss Contingency By Nature Of Contingency [Line Items]
Accrued liabilities	$ 261	$ 300
Narco Asbestos Loss Contingency Liability [Member]
Loss Contingency By Nature Of Contingency [Line Items]
Annual Trust Cap	145
Bendix Asbestos Loss Contingency Liability [Member] \| Settlement Agreement [Member]
Loss Contingency By Nature Of Contingency [Line Items]
Accrued liabilities	$ 10

GEOGRAPHIC AREAS FINANCIAL DATA

12 Months Ended

Dec. 31, 2021

Geographic Areas Financial Data [Abstract]

Geographic Areas - Financial Data


	Net Sales(1)									Long-lived Assets(2)
	Years Ended December 31,									Years Ended December 31,
	2021			2020			2019			2021			2020			2019
United States		$	20,662		$	19,665		$	21,910		$	3,964		$	3,823		$	3,649
Europe		6,800			6,356			7,424			566			628			579
Other International		6,930			6,616			7,375			1,032			1,119			1,097
		$	34,392		$	32,637		$	36,709		$	5,562		$	5,570		$	5,325

(1)Sales between geographic areas approximate market value and are not significant. Net sales are classified according to their country of origin. Included in United States Net sales are export sales of $4,037 million, $4,000 million and $5,415 million for the years ended December 31, 2021, 2020 and 2019, respectively.

(2)Long-lived assets are comprised of Property, plant and equipment - net.

SEGMENT FINANCIAL DATA (Details)	12 Months Ended
SEGMENT FINANCIAL DATA (Details)	Dec. 31, 2021 USD ($) Segments	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)
Segment Reporting Information [Line Items]
Revenue	$ 34,392,000,000	$ 32,637,000,000	$ 36,709,000,000
Depreciation and amortization	1,138,000,000	1,003,000,000	1,088,000,000
Segment Reporting Segment Profit Loss	7,212,000,000	6,665,000,000	7,739,000,000
Capital expenditures	895,000,000	906,000,000	839,000,000
Total Assets	$ 64,470,000,000	64,586,000,000	58,679,000,000
Number of Operating Segments \| Segments	4
Products [Member]
Segment Reporting Information [Line Items]
Revenue	$ 25,643,000,000	24,737,000,000	27,629,000,000
Services [Member]
Segment Reporting Information [Line Items]
Revenue	8,749,000,000	7,900,000,000	9,080,000,000
Aerospace [Member]
Segment Reporting Information [Line Items]
Revenue	11,026,000,000	11,544,000,000	14,054,000,000
Aerospace [Member] \| Products [Member]
Segment Reporting Information [Line Items]
Revenue	6,158,000,000	7,194,000,000	8,766,000,000
Aerospace [Member] \| Services [Member]
Segment Reporting Information [Line Items]
Revenue	4,868,000,000	4,350,000,000	5,288,000,000
Honeywell Building Technologies [Member]
Segment Reporting Information [Line Items]
Revenue	5,539,000,000	5,189,000,000	5,717,000,000
Honeywell Building Technologies [Member] \| Products [Member]
Segment Reporting Information [Line Items]
Revenue	4,098,000,000	3,868,000,000	4,395,000,000
Honeywell Building Technologies [Member] \| Services [Member]
Segment Reporting Information [Line Items]
Revenue	1,441,000,000	1,321,000,000	1,322,000,000
Performance Materials And Technologies [Member]
Segment Reporting Information [Line Items]
Revenue	10,013,000,000	9,423,000,000	10,834,000,000
Performance Materials And Technologies [Member] \| Products [Member]
Segment Reporting Information [Line Items]
Revenue	8,008,000,000	7,548,000,000	8,732,000,000
Performance Materials And Technologies [Member] \| Services [Member]
Segment Reporting Information [Line Items]
Revenue	2,005,000,000	1,875,000,000	2,102,000,000
Safety And Productivity Solutions [Member]
Segment Reporting Information [Line Items]
Revenue	7,814,000,000	6,481,000,000	6,104,000,000
Safety And Productivity Solutions [Member] \| Products [Member]
Segment Reporting Information [Line Items]
Revenue	7,379,000,000	6,127,000,000	5,736,000,000
Safety And Productivity Solutions [Member] \| Services [Member]
Segment Reporting Information [Line Items]
Revenue	435,000,000	354,000,000	368,000,000
Corporate and All Other [Member]
Segment Reporting Information [Line Items]
Revenue	0	0	0
Depreciation and amortization	102,000,000	44,000,000	76,000,000
Segment Reporting Segment Profit Loss	(226,000,000)	(96,000,000)	(256,000,000)
Capital expenditures	94,000,000	52,000,000	128,000,000
Total Assets	17,174,000,000	19,788,000,000	14,557,000,000
Corporate and All Other [Member] \| Services [Member]
Segment Reporting Information [Line Items]
Revenue	0	0	0
Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenue	34,392,000,000	32,637,000,000	36,709,000,000
Operating Segments [Member] \| Aerospace [Member]
Segment Reporting Information [Line Items]
Revenue	11,026,000,000	11,544,000,000	14,054,000,000
Depreciation and amortization	278,000,000	241,000,000	234,000,000
Segment Reporting Segment Profit Loss	3,051,000,000	2,904,000,000	3,607,000,000
Capital expenditures	284,000,000	248,000,000	272,000,000
Total Assets	11,490,000,000	11,035,000,000	11,378,000,000
Operating Segments [Member] \| Honeywell Building Technologies [Member]
Segment Reporting Information [Line Items]
Revenue	5,539,000,000	5,189,000,000	5,717,000,000
Depreciation and amortization	67,000,000	55,000,000	63,000,000
Segment Reporting Segment Profit Loss	1,238,000,000	1,099,000,000	1,165,000,000
Capital expenditures	62,000,000	66,000,000	43,000,000
Total Assets	6,543,000,000	6,351,000,000	5,968,000,000
Operating Segments [Member] \| Performance Materials And Technologies [Member]
Segment Reporting Information [Line Items]
Revenue	10,013,000,000	9,423,000,000	10,834,000,000
Depreciation and amortization	454,000,000	440,000,000	493,000,000
Segment Reporting Segment Profit Loss	2,120,000,000	1,851,000,000	2,433,000,000
Capital expenditures	265,000,000	252,000,000	314,000,000
Total Assets	18,021,000,000	16,772,000,000	16,888,000,000
Operating Segments [Member] \| Safety And Productivity Solutions [Member]
Segment Reporting Information [Line Items]
Revenue	7,814,000,000	6,481,000,000	6,104,000,000
Depreciation and amortization	237,000,000	223,000,000	222,000,000
Segment Reporting Segment Profit Loss	1,029,000,000	907,000,000	790,000,000
Capital expenditures	190,000,000	288,000,000	82,000,000
Total Assets	$ 11,242,000,000	$ 10,640,000,000	$ 9,888,000,000

REPOSITIONING AND OTHER CHARGES 2 (Details) - USD ($)	12 Months Ended
REPOSITIONING AND OTHER CHARGES 2 (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Net Repositioning And Other Charges By Income Statement Classification [Line Items]
Total net repositioning charges	$ 569,000,000	$ 575,000,000	$ 546,000,000
Cost of products and services sold [Member]
Net Repositioning And Other Charges By Income Statement Classification [Line Items]
Total net repositioning charges	457,000,000	308,000,000	276,000,000
Selling, general and administrative expenses [Member]
Net Repositioning And Other Charges By Income Statement Classification [Line Items]
Total net repositioning charges	112,000,000	267,000,000	270,000,000
Other (Income) Expense [Member]
Net Repositioning And Other Charges By Income Statement Classification [Line Items]
Total net repositioning charges	$ 0	$ 0	$ 0

COMMITMENTS AND CONTINGENCIES 6 (Details) - Environmental Liabilities [Member] - Resideo [Member] - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Loss Contingency Indemnification Agreements Disclosure [Line Items]
Indemnification and reimbursement agreement annual cap	$ 140
Indemnification and reimbursement agreement minimum amount	25
Reimbursements from indemnification and reimbursement agreement	140	$ 140
Reimbursement Receivable Indemnification And Reimbursement Agreement	146	146
Indemnity and reimbursement receivable recorded in Other Current Assets	140	140
Indemnity and reimbursement receivable recorded in Other Assets	$ 457	$ 451

REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS 2 (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Jan. 01, 2020	Jan. 01, 2019
Change in Contract with Customer, Asset and Liability [Abstract]
Contract assets	$ 2,060	$ 1,618	$ 1,618	$ 1,602
Contract with Customer, Asset, Reclassified to Receivable	442	16
Contract liability	(4,290)	(4,033)	$ (4,033)	$ (3,501)
Change in contract liability - (increase) decrease	(257)	(532)
Net change	185	(516)
Contract With Customer Liability Revenue Recognized	1,925	1,709
Unbilled Contracts Receivable	$ 2,035	$ 1,589

FAIR VALUE MEASUREMENTS

12 Months Ended

Dec. 31, 2021

Fair Value Disclosures [Abstract]

Financial Instruments and Fair Value Measures

FAIR VALUE MEASUREMENTS

The accounting guidance for fair value measurements and disclosures establishes a three-level fair value hierarchy.

•Level 1 - Inputs are based on quoted prices in active markets for identical assets and liabilities.

•Level 2 - Inputs are based on observable inputs other than quoted prices in active markets for identical or similar assets and liabilities.

•Level 3 - One or more inputs are unobservable and significant.

Financial and nonfinancial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

The following table sets forth the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis:


	December 31,
	2021			2020
Assets:
Foreign currency exchange contracts		$	374		$	202
Available for sale investments		742			1,118
Interest rate swap agreements		60			194
Cross currency swap agreements		39			—
Investments in equity securities		57			11
Liabilities:
Foreign currency exchange contracts		$	282		$	150

Cross currency swap agreements		—			50

The foreign currency exchange contracts, interest rate swap agreements, and cross currency swap agreements are valued using broker quotations, or market transactions in either the listed or over-the-counter markets. As such, these derivative instruments are classified within level 2. The Company also holds investments in commercial paper, certificates of deposits, and time deposits that are designated as available for sale, as well as investments in equity securities, which are valued using published prices based on observable market data. As such, these investments are classified within level 2.

The Company holds certain available for sale investments in U.S. government and corporate debt securities, as well as investments in equity securities, which are valued utilizing published prices based on quoted market pricing, which are classified within level 1.

The carrying value of cash and cash equivalents, trade accounts and notes receivables, payables, commercial paper and short-term borrowings contained in the Consolidated Balance Sheet approximates fair value.

The following table sets forth the Company’s financial assets and liabilities that were not carried at fair value:


	December 31, 2021						December 31, 2020
	Carrying Value			Fair Value			Carrying Value			Fair Value
Assets:
Short-term investment		$	34		$	34		$	—		$	—
Long-term receivables		170			152			137			132
Long-term investment		366			366			—			—
Liabilities:
Long-term debt and related current maturities		$	16,057		$	17,022		$	18,787		$	20,176

The Company determined the fair value of the long-term receivables by utilizing transactions in the listed markets for identical or similar assets. As such, the fair value of these receivables is considered level 2.

The fair value of the short-term and long-term investments are based on the present value of the mandatory redemptions as reflected within Garrett Motion Inc.'s (Garrett) Series B Preferred Stock (Series B Preferred Stock) Certificate of Designation, as amended. Fair Value of the Series B Preferred Stock is not impacted by early redemptions until receipt of payment. The investment is designated as held to maturity and was initially recognized at fair value. The fair value of Garrett's Series B Preferred Stock was determined using observable market data and is considered level 2. Refer to Note 19 Commitments and Contingencies for further discussion of the Company’s investment in Garrett's Series B Preferred Stock.The Company determined the fair value of the long-term debt and related current maturities utilizing transactions in the listed markets for identical or similar liabilities. As such, the fair value of the long-term debt and related current maturities is considered level 2.

REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disaggregation of Revenue [Line Items]
Revenue	$ 34,392,000,000	$ 32,637,000,000	$ 36,709,000,000
Disaggregation of revenue, timing of recognition - percentage	100.00%	100.00%	100.00%
Products [Member]
Disaggregation of Revenue [Line Items]
Revenue	$ 25,643,000,000	$ 24,737,000,000	$ 27,629,000,000
Disaggregation of revenue, timing of recognition - percentage	75.00%	76.00%	75.00%
Products [Member] \| Transferred at Point in Time [Member]
Disaggregation of Revenue [Line Items]
Disaggregation of revenue, timing of recognition - percentage	58.00%	61.00%	61.00%
Products [Member] \| Transferred over Time [Member]
Disaggregation of Revenue [Line Items]
Disaggregation of revenue, timing of recognition - percentage	17.00%	15.00%	14.00%
Services [Member]
Disaggregation of Revenue [Line Items]
Revenue	$ 8,749,000,000	$ 7,900,000,000	$ 9,080,000,000
Disaggregation of revenue, timing of recognition - percentage	25.00%	24.00%	25.00%
Services [Member] \| Transferred at Point in Time [Member]
Disaggregation of Revenue [Line Items]
Disaggregation of revenue, timing of recognition - percentage	8.00%	8.00%	9.00%
Services [Member] \| Transferred over Time [Member]
Disaggregation of Revenue [Line Items]
Disaggregation of revenue, timing of recognition - percentage	17.00%	16.00%	16.00%
Corporate and All Other [Member]
Disaggregation of Revenue [Line Items]
Revenue	$ 0	$ 0	$ 0
Corporate and All Other [Member] \| Services [Member]
Disaggregation of Revenue [Line Items]
Revenue	0	0	0
Aerospace [Member]
Disaggregation of Revenue [Line Items]
Revenue	11,026,000,000	11,544,000,000	14,054,000,000
Aerospace [Member] \| Commercial Aviation Original Equipment [Member]
Disaggregation of Revenue [Line Items]
Revenue	1,720,000,000	1,940,000,000	2,999,000,000
Aerospace [Member] \| Commercial Aviation Aftermarket [Member]
Disaggregation of Revenue [Line Items]
Revenue	4,155,000,000	3,812,000,000	5,761,000,000
Aerospace [Member] \| Defense and Space [Member]
Disaggregation of Revenue [Line Items]
Revenue	5,151,000,000	5,792,000,000	5,294,000,000
Aerospace [Member] \| Products [Member]
Disaggregation of Revenue [Line Items]
Revenue	6,158,000,000	7,194,000,000	8,766,000,000
Aerospace [Member] \| Services [Member]
Disaggregation of Revenue [Line Items]
Revenue	4,868,000,000	4,350,000,000	5,288,000,000
Honeywell Building Technologies [Member]
Disaggregation of Revenue [Line Items]
Revenue	5,539,000,000	5,189,000,000	5,717,000,000
Honeywell Building Technologies [Member] \| Products [Member]
Disaggregation of Revenue [Line Items]
Revenue	3,243,000,000	2,971,000,000	3,293,000,000
Honeywell Building Technologies [Member] \| Building Solutions [Member]
Disaggregation of Revenue [Line Items]
Revenue	2,296,000,000	2,218,000,000	2,424,000,000
Honeywell Building Technologies [Member] \| Products [Member]
Disaggregation of Revenue [Line Items]
Revenue	4,098,000,000	3,868,000,000	4,395,000,000
Honeywell Building Technologies [Member] \| Services [Member]
Disaggregation of Revenue [Line Items]
Revenue	1,441,000,000	1,321,000,000	1,322,000,000
Performance Materials And Technologies [Member]
Disaggregation of Revenue [Line Items]
Revenue	10,013,000,000	9,423,000,000	10,834,000,000
Performance Materials And Technologies [Member] \| UOP [Member]
Disaggregation of Revenue [Line Items]
Revenue	2,348,000,000	2,177,000,000	2,890,000,000
Performance Materials And Technologies [Member] \| Process Solutions [Member]
Disaggregation of Revenue [Line Items]
Revenue	4,611,000,000	4,590,000,000	5,146,000,000
Performance Materials And Technologies [Member] \| Specialty Products [Member]
Disaggregation of Revenue [Line Items]
Revenue	3,054,000,000	2,656,000,000	2,798,000,000
Performance Materials And Technologies [Member] \| Products [Member]
Disaggregation of Revenue [Line Items]
Revenue	8,008,000,000	7,548,000,000	8,732,000,000
Performance Materials And Technologies [Member] \| Services [Member]
Disaggregation of Revenue [Line Items]
Revenue	2,005,000,000	1,875,000,000	2,102,000,000
Safety And Productivity Solutions [Member]
Disaggregation of Revenue [Line Items]
Revenue	7,814,000,000	6,481,000,000	6,104,000,000
Safety And Productivity Solutions [Member] \| Safety and Retail [Member]
Disaggregation of Revenue [Line Items]
Revenue	2,387,000,000	2,414,000,000	2,215,000,000
Safety And Productivity Solutions [Member] \| Productivity Solutions and Services [Member]
Disaggregation of Revenue [Line Items]
Revenue	1,610,000,000	1,270,000,000	1,285,000,000
Safety And Productivity Solutions [Member] \| Warehouse and Workflow Solutions [Member]
Disaggregation of Revenue [Line Items]
Revenue	2,944,000,000	1,965,000,000	1,719,000,000
Safety And Productivity Solutions [Member] \| Advanced Sensing Technologies
Disaggregation of Revenue [Line Items]
Revenue	873,000,000	832,000,000	885,000,000
Safety And Productivity Solutions [Member] \| Products [Member]
Disaggregation of Revenue [Line Items]
Revenue	7,379,000,000	6,127,000,000	5,736,000,000
Safety And Productivity Solutions [Member] \| Services [Member]
Disaggregation of Revenue [Line Items]
Revenue	$ 435,000,000	$ 354,000,000	$ 368,000,000

PROPERTY, PLANT AND EQUIPMENT-NET (Tables)

12 Months Ended

Dec. 31, 2021

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment [Table Text Block]


	December 31,
	2021			2020
Land and improvements		$	226		$	259
Machinery and equipment		10,143			10,008
Buildings and improvements		3,225			3,245
Construction in progress		856			825
		14,450			14,337
Less—Accumulated depreciation		(8,888)			(8,767)
		$	5,562		$	5,570

REPOSITIONING AND OTHER CHARGES 3 (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Pretax Impact Of Total Net Repositioning And Other Charges By Segment [Line Items]
Total net repositioning charges	$ 569	$ 575	$ 546
Corporate and All Other [Member]
Pretax Impact Of Total Net Repositioning And Other Charges By Segment [Line Items]
Total net repositioning charges	202	110	241
Aerospace [Member]
Pretax Impact Of Total Net Repositioning And Other Charges By Segment [Line Items]
Total net repositioning charges	62	157	33
Honeywell Building Technologies [Member]
Pretax Impact Of Total Net Repositioning And Other Charges By Segment [Line Items]
Total net repositioning charges	13	100	108
Performance Materials And Technologies [Member]
Pretax Impact Of Total Net Repositioning And Other Charges By Segment [Line Items]
Total net repositioning charges	24	167	93
Safety And Productivity Solutions [Member]
Pretax Impact Of Total Net Repositioning And Other Charges By Segment [Line Items]
Total net repositioning charges	$ 268	$ 41	$ 71

INCOME TAX 3 (Details) - USD ($)	12 Months Ended
INCOME TAX 3 (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Deferred Tax Assets, Net [Abstract]
Postretirement benefits other than pensions	$ 77,000,000	$ 85,000,000
Asbestos and environmental	468,000,000	508,000,000
Employee compensation and benefits	174,000,000	180,000,000
Lease liabilities	242,000,000	197,000,000
Other accruals and reserves	260,000,000	110,000,000
Net operating and capital losses	734,000,000	779,000,000
Capital loss limitation and carryover	151,000,000	0
Tax credit carryforwards	164,000,000	219,000,000
Gross deferred tax assets	2,270,000,000	2,078,000,000
Valuation allowance	(857,000,000)	(766,000,000)
Total deferred tax assets	1,413,000,000	1,312,000,000
Deferred Tax Liabilities, Net [Abstract]
Pension	(948,000,000)	(548,000,000)
Property, plant and equipment	(464,000,000)	(437,000,000)
Right-of-use asset	(230,000,000)	(184,000,000)
Intangibles	(883,000,000)	(898,000,000)
Unremitted earnings of foreign subsidiaries	(426,000,000)	(398,000,000)
Other asset basis differences	(334,000,000)	(169,000,000)
Other	(2,000,000)	(31,000,000)
Total deferred tax liabilities	(3,287,000,000)	(2,665,000,000)
Net deferred tax liability	(1,874,000,000)	(1,353,000,000)
Deferred Tax Assets [Line Items]
Gross deferred tax assets	2,270,000,000	2,078,000,000
Tax charge on earnings of foreign subsidiaries	426,000,000	398,000,000
Undistributed Earnings And Profits Of Foreign Affiliates	17,100,000,000
Valuation allowance	857,000,000	766,000,000
Valuation Allowance Impact To Tax Expense	124,000,000	$ 105,000,000	$ (23,000,000)
Foreign Tax Authority [Member]
Deferred Tax Assets, Net [Abstract]
Gross deferred tax assets	901,000,000
Valuation allowance	(703,000,000)
Deferred Tax Assets [Line Items]
Gross deferred tax assets	901,000,000
Valuation allowance	703,000,000
Domestic Tax Authority [Member]
Deferred Tax Assets, Net [Abstract]
Valuation allowance	(150,000,000)
Deferred Tax Assets [Line Items]
Valuation allowance	$ 150,000,000

INCOME TAXES (Tables)

12 Months Ended

Dec. 31, 2021

Income Tax Disclosure [Abstract]

Income by region


	Years Ended December 31,
	2021			2020			2019
U.S.		$	3,955		$	3,318		$	4,178
Non-U.S.		3,280			2,694			3,381
		$	7,235		$	6,012		$	7,559

Tax Expense Current and Deferred


	Years Ended December 31,
	2021			2020			2019
Tax expense (benefit) consists of
Current:
U.S. Federal		$	415		$	475		$	8
U.S. State		146			79			43
Non-U.S.		886			768			1,099
		$	1,447		$	1,322		$	1,150
Deferred:
U.S. Federal		$	173		$	234		$	332
U.S. State		37			39			63
Non-U.S.		(32)			(448)			(216)
		178			(175)			179
		$	1,625		$	1,147		$	1,329


	Years Ended December 31,
	2021			2020			2019
The U.S. federal statutory income tax rate is reconciled to the effective income tax rate as follows:
U.S. federal statutory income tax rate		21.0	%		21.0	%		21.0	%
Taxes on non-U.S. earnings(1)(2)		(1.4)			(0.8)			(0.5)
U.S. state income taxes(1)		1.5			1.3			1.1
Reserves for tax contingencies		2.2			(2.6)			2.0
Employee share-based payments		(0.7)			(1.2)			(1.2)
Reduction of certain receivables		—			2.0			—
U.S. Tax Cuts and Jobs Act		—			—			(3.6)
Restructuring		(1.4)			—			—
U.S. Valuation Allowance		2.0			0.1			—
All other items—net		(0.7)			(0.7)			(1.2)
		22.5	%		19.1	%		17.6	%

Effective income tax rate reconciliation

(1)Net of changes in valuation allowance

(2)Includes U.S. taxes on non-U.S. earnings

Deferred Tax Assets, Liabilities

The tax effects of temporary differences and tax carryforwards which give rise to future income tax benefits and payables are as follows:


Deferred tax assets:	December 31,
	2021			2020
Postretirement benefits other than pensions		$	77		$	85
Asbestos and environmental		468			508
Employee compensation and benefits		174			180
Lease liabilities		242			197
Other accruals and reserves		260			110
Net operating and capital losses		734			779
Capital loss limitation and carryover		151			—
Tax credit carryforwards		164			219
Gross deferred tax assets		2,270			2,078
Valuation allowance		(857)			(766)
Total deferred tax assets		$	1,413		$	1,312
Deferred tax liabilities:
Pension		$	(948)		$	(548)
Property, plant and equipment		(464)			(437)
Right-of-use asset		(230)			(184)
Intangibles		(883)			(898)
Unremitted earnings of foreign subsidiaries		(426)			(398)
Other asset basis differences		(334)			(169)
Other		(2)			(31)
Total deferred tax liabilities		(3,287)			(2,665)
Net deferred tax liability		$	(1,874)		$	(1,353)

Summary of Operating Loss Carryforwards


Jurisdiction	Expiration Period	Net Operating and Capital Loss Carryforwards			Tax Credit Carryforwards
U.S. Federal	2040		$	684		$	97
U.S. State	2040		390			21
Non-U.S.	2041		466			50
Non-U.S.	Indefinite		2,185			—
			$	3,725		$	168

Change in unrecognized tax benefits


	Years Ended December 31,
	2021			2020			2019
Change in unrecognized tax benefits:
Balance at beginning of year		$	991		$	1,164		$	1,089
Gross increases related to current period tax positions		93			94			51
Gross increases related to prior periods tax positions		39			68			83
Gross decreases related to prior periods tax positions		(27)			(256)			(34)
Decrease related to resolutions of audits with tax authorities		(1)			(35)			(3)
Expiration of the statute of limitations for the assessment of taxes		(12)			(76)			(13)
Foreign currency translation		(22)			32			(9)
Balance at end of year		$	1,061		$	991		$	1,164

Summary of Income Tax Examinations


Jurisdiction	Open Tax Years Based on Originally Filed Returns
	Examination in progress	Examination not yet initiated
U.S. Federal	2017-2018	2019-2021
U.S. State	2013-2019	2017-2021
Australia	n/a	2018-2021
Canada(1)	2015-2018	2019-2021
China	2011-2020	2021
France	2018-2020	2021
Germany(1)	2009-2018	2019-2021
India	1999-2020	2021
Italy	2012-2018	2019-2021
Netherlands	n/a	2018-2021
Switzerland(1)	2016-2018	2019-2021
United Kingdom	2013-2019	2020-2021

COMMITMENTS AND CONTINGENCIES (Details) - USD ($)	12 Months Ended
COMMITMENTS AND CONTINGENCIES (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Loss Contingency, Classification of Accrual [Abstract]
Accrued liabilities	$ 225,000,000	$ 225,000,000
Other liabilities	393,000,000	435,000,000
Total environmental liabilities	618,000,000	660,000,000	$ 709,000,000
Environmental Matters [Abstract]
Beginning of period	660,000,000	709,000,000	755,000,000
Accruals for environmental matters deemed probable and reasonably estimable	168,000,000	173,000,000	213,000,000
Environmental liability payments		(216,000,000)	(256,000,000)
Other	0	(6,000,000)	(3,000,000)
End of period	$ 618,000,000	$ 660,000,000	$ 709,000,000

INCOME TAX 6 (Details) - USD ($) $ in Millions	12 Months Ended
INCOME TAX 6 (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Tax Examination Paragraph Details [Abstract]
Income tax Examination Unrecognized Tax Benefits From Examination	$ 592	$ 556	$ 413
Income Tax Examination Estimated Interest and Penalties From Examination	79	80	73
Income Tax Examination Accrued Interest and Penalties From Examination	$ 580	$ 507	$ 487

LEASES (Details)	Dec. 31, 2021
Minimum [Member]
Lessee, Lease, Description [Line Items]
Lessee, Operating Lease, Term of Contract	1 year
Lessee, Operating Lease, Renewal Term	5 years
Maximum [Member]
Lessee, Lease, Description [Line Items]
Lessee, Operating Lease, Term of Contract	20 years

GEOGRAPHIC AREAS FINANCIAL DATA (Tables)

12 Months Ended

Dec. 31, 2021

Geographic Areas Financial Data [Abstract]

Geographic Areas Financial Data


	Net Sales(1)									Long-lived Assets(2)
	Years Ended December 31,									Years Ended December 31,
	2021			2020			2019			2021			2020			2019
United States		$	20,662		$	19,665		$	21,910		$	3,964		$	3,823		$	3,649
Europe		6,800			6,356			7,424			566			628			579
Other International		6,930			6,616			7,375			1,032			1,119			1,097
		$	34,392		$	32,637		$	36,709		$	5,562		$	5,570		$	5,325

(2)Long-lived assets are comprised of Property, plant and equipment - net.

REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS (Tables)

12 Months Ended

Dec. 31, 2021

Revenue from Contract with Customer [Abstract]

Disaggregation Of Revenue [Table Text Block]


	Years Ended December 31,
	2021			2020			2019
Aerospace
Commercial Aviation Original Equipment		$	1,720		$	1,940		$	2,999
Commercial Aviation Aftermarket		4,155			3,812			5,761
Defense and Space		5,151			5,792			5,294

		11,026			11,544			14,054
Honeywell Building Technologies


Products		3,243			2,971			3,293
Building Solutions		2,296			2,218			2,424
		5,539			5,189			5,717
Performance Materials and Technologies
UOP		2,348			2,177			2,890
Process Solutions		4,611			4,590			5,146
Advanced Materials		3,054			2,656			2,798
		10,013			9,423			10,834
Safety and Productivity Solutions
Safety and Retail		2,387			2,414			2,215
Productivity Solutions and Services		1,610			1,270			1,285
Warehouse and Workflow Solutions		2,944			1,965			1,719
Advanced Sensing Technologies		873			832			885
		7,814			6,481			6,104
Corporate and All Other		—			—			—
Net sales		$	34,392		$	32,637		$	36,709


	Years Ended December 31,
	2021			2020			2019
Products, transferred point in time		58	%		61	%		61	%
Products, transferred over time		17			15			14
Net product sales		75			76			75
Services, transferred point in time		8			8			9
Services, transferred over time		17			16			16
Net service sales		25			24			25
Net sales		100	%		100	%		100	%

Contract with Customer, Asset and Liability [Table Text Block]


	2021			2020
Contract assets—January 1		$	1,618		$	1,602
Contract assets—December 31		2,060			1,618
Change in contract assets—increase (decrease)		$	442		$	16
Contract liabilities—January 1		$	(4,033)		$	(3,501)
Contract liabilities—December 31		(4,290)			(4,033)
Change in contract liabilities—(increase) decrease		$	(257)		$	(532)
Net change		$	185		$	(516)

Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Table Text Block]


	December 31, 2021
Aerospace		$	9,423
Honeywell Building Technologies		6,871
Performance Materials and Technologies		7,243
Safety and Productivity Solutions		4,143
Corporate and All Other(1)		2
		$	27,682

(1) The remaining performance obligations within Corporate and All Other relate to the Quantinuum business.

OTHER LIABILITIES (Tables)

12 Months Ended

Dec. 31, 2021

Other Liabilities Current (Tables) [Abstract]

Other liabilities


	December 31,
	2021			2020
Income taxes		$	2,152		$	2,009
Pension and other employee related		1,672			1,923
Deferred income		1,324			1,356
Operating lease liabilities		847			641
Environmental		393			435
Insurance		299			280
Product warranties and performance guarantees		43			60
Asset retirement obligations		26			31
Other		331			240
		$	7,087		$	6,975